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SUMMARY 
Changes in the redox state of protein cysteines in response to dynamic alterations of the 
cellular redox state modulate the activity and structure of proteins. Therefore, several vital 
cellular processes are redox regulated, including nitric oxide production, apoptosis, immune 
response, and signaling processes. The aim of this dissertation was to characterize in detail the 
redox regulation of two interesting target proteins: methionine adenosyltransferase of the 
malaria parasite Plasmodium falciparum (PfalMAT) and the dye-decolorizing peroxidase 1 of 
the fungus Mycetinis scorodonius (MscDyP1). 
PfalMAT is an attractive drug target since its product, S-adenosylmethionine, is the major 
biochemical methyl group donor and a precursor for crucial downstream pathways such as 
polyamine metabolism and DNA methylation. However, PfalMAT has so far been poorly 
characterized. This dissertation provides a detailed kinetic analysis, including inhibitor and 
oligomerization studies to expand the biochemical characterization of this enzyme. 
Furthermore, the dimeric human homolog hMATIII was characterized here using the same 
assay system to allow a direct comparison of both enzymes. Previous pull-down experiments 
identified PfalMAT as a target of the plasmodial redoxins thioredoxin 1, glutaredoxin, and 
plasmoredoxin and as part of the S-glutathionylome and S-nitrosylome of P. falciparum. A 
second aim of this dissertation was to characterize the interplay of PfalMAT with the 
plasmodial redoxins and study in detail the impact of S-glutathionylation and S-nitrosylation. 
In order to identify potential sites of these redox modifications in PfalMAT, a homology 
model was created since a crystal structure was not yet available. This model indicated that 
among the eight cysteines of PfalMAT, only Cys52, Cys113, and Cys187 were solvent 
accessible in the dimeric enzyme. Hence, these cysteines were conservatively mutated via 
site-directed mutagenesis into serines, and their kinetic and oligomerization behaviors were 
studied using a spectrophotometric assay and gel filtration experiments, respectively. As 
indicated before, PfalMAT activity was indeed affected by redox regulatory processes; 
reduction of cysteines by the reducing agent dithiothreitol and reduced glutathione activated 
PfalMAT, whereas enzyme inhibition followed oxidative events, i.e. S-glutathionylation and 
S-nitrosylation. Consequently, the impact of the selected cysteines on these redox regulatory 
processes was studied, showing that thioredoxin 1 and plasmoredoxin potently activated 
PfalMAT at subcellular concentrations by changing the oxidation state of Cys52, Cys113, and 
Cys187, whereas glutaredoxin did not alter PfalMAT activity. Protein-S-glutathionylation 
inhibited PfalMAT through the specific formation of mixed disulfides between glutathione 
and Cys113, which was indicated with Western blots using an anti-GSH antibody and less 
inhibition of the respective mutant upon GSSG treatment compared to the wildtype. Protein-
S-glutathionylation of PfalMAT was reversible by thioredoxin 1 and plasmoredoxin, which 
restored the activity of PfalMAT at physiological concentrations, suggesting a likely in vivo 
regulation. Furthermore, PfalMAT was inhibited upon S-nitrosylation under NO-stress, which 
was mediated by several cysteines, including Cys52, Cys113, and Cys187. These results 
indicate a coupling of the S-adenosylmethionine status to the cellular redox state of P. 
falciparum via redox regulation of PfalMAT. 
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The second enzyme on which this dissertation focussed, is MscDyP1. This dye-decolorizing 
peroxidase (DypPrx) is a member of the recently identified eponymous novel class of heme 
peroxidases, which differ structurally from classic heme peroxidases. They possess 
remarkably high substrate versatility and are therefore of great interest to environmental 
biotechnology and the food industry. Interestingly, MscDyP1 is, according to current 
knowledge, the only DypPrx capable of degrading carotenoids, for which it has been 
previously patented and is currently beeing used industrially to bleach whey.  
During this dissertation, upon systematic screening and optimization of different 
crystallization conditions, high resolution protein crystals of MscDyP1 were obtained, which 
made it possible to solve its three-dimensional structure. This structure revealed interesting 
features. Two surface-exposed methionine residues, Met302 and Met305, which are not 
conserved among DypPrx, appeared to play an important structural role. Furthermore, several 
substrate oxidation sites, despite the active site of MscDyP1, were identified, including a 
second heme accession channel and a cavity around the single conserved cysteine residue 
Cys360 at the proximal heme site. Although the conservation of Cys360 indicates it has an 
important role, it has not yet been investigated. The crystal structure indicated that it is 
accessible to small redox-active molecules and therefore might present a target of redox-
regulatory processes. In order to study the role of Met302, Met305, and Cys360 for catalysis 
and their structural functionality, site-directed mutagenesis was performed, and both the 
wildtype and the mutants were heterologously overexpressed in E. coli. Their activity and 
kinetic behavior were studied in two assay systems, using either ABTS as an electron donor or 
β-carotene. Both mutants, the double mutant lacking the selected methionine residues and the 
protein variant lacking Cys360, displayed significantly decreased activity compared to the 
wildtype produced in E. coli. Furthermore, the cysteine deletion mutant showed decreased 
affinity to hydrogen peroxide. Moreover, the mutants appeared to be less susceptible to 
suicide inactivation caused by excess amounts of hydrogen peroxide. These results confirmed 
the important structural role of the methionines and suggested that Cys360 participates in the 
regulation of MscDyP1 via redox processes. Nevertheless, the native enzyme and the one 
used for crystallization, a recombinant MscDyP1 overexpressed in A. niger, are highly 
glycosylated, in contrast to the recombinant enzyme produced in E. coli, which was not 
glycosylated. Moreover, previous biochemical characterizations of the native enzyme 
indicated that MscDyP1 is a dimer, and the crystal structure pointed out that glycosylation 
relevantly contributes to dimerization. Therefore, the recombinant enzyme produced in A. 
niger was treated with the thiol-blocking agents methylmethanethiosulfonate and 
iodoacetamide to block all solvent-accessible, sulfur-containing amino acids. Whereas (E. 
coli) rMscDyP1 was inhibited by 40% following this treatment, the activity of (A. niger) 
rMscDyP1 was not affected. This indicated that glycosylation protected these redox-sensitive 
residues and suggested that in the native highly glycosylated MscDyP1, contrary to the 
findings for PfalMAT, Cys360 appears to have a structural rather than catalytic or regulatory 
function.  
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ZUSAMMENFASSUNG 
Veränderungen des zellulären Redoxmillieus gehen mit Änderungen des Redoxstatus von 
Cysteinen zellulärer Proteine einher. Dies hat Auswirkungen auf ihre Aktivität und Struktur. 
Die Redoxregulation von Proteinen spielt deshalb eine wichtige Rolle in vielen 
lebenswichtigen zellulären Prozessen, wie Apoptose, Signaltransduktion oder 
Immunreaktionen. Im Fokus dieser Dissertation stand die Untersuchung der Redoxregulation 
von zwei unterschiedlichen, jedoch sehr interessanten Zielproteinen: Der 
Methioninadenosyltransferase des Malariaparasiten Plasmodium falciparum (PfalMAT) und 
der DyP-Peroxidase 1 (Dye-decolorizing) des Basidiomyceten Mycetinis scorodonius 
(MscDyP1).  
PfalMAT stellt ein attraktives Ziel für die Medikamentenentwicklung dar. Aufgrund seiner 
hohen Wachstums- und Teilungsrate, ist der Malariaparasit in besonderem Maße abhängig 
von der S-Adenosylmethioninproduktion, da dieses, als wichtigster Methylgruppendonor der 
Zelle, eine Vorstufe für lebenswichtige Stoffwechselwege und zelluläre Prozesse, wie den 
Polyaminstoffwechsel und die DNA-Methylierung, darstellt. Das S-Adenosylmethionin-
synthetisierende Enzym, PfalMAT, ist bisher nur unzureichend untersucht. Die vorliegende 
Dissertation erweitert das biochemische Verständnis für dieses Enzym durch detaillierte 
kinetische Analysen und Inhibitorstudien. Darüber hinaus wurde PfalMAT mit dem dimeren 
humanen Homolog hMATIII verglichen, welches dazu ebenfalls heterolog in E. coli 
exprimiert und im gleichen Assaysystem wie PfalMAT charakterisiert wurde. Bereits im 
Vorfeld dieser Dissertation lagen durch Pull-down-Experimente Hinweise auf eine mögliche 
Redoxregulation des Enzyms vor: PfalMAT stellte sich als Substrat der redoxaktiven Proteine 
Thioredoxin, Glutaredoxin und Plasmoredoxin heraus und wurde als Bestandteil des S-
Glutathionylom und S-Nitrosylom von P. falciparum identifiziert. Deshalb war ein weiteres 
Ziel dieser Dissertation, die Interaktion der plasmodialen Redoxine mit PfalMAT sowie den 
Einfluss der genannten posttranslationalen Modifikationen im Hinblick auf Aktivität und 
Konformation zu charakterisieren. Um die redox-modifizierbaren Thiole zu identifizieren 
wurde ein Homologiemodell von PfalMAT erstellt, da bisher noch keine Kristallstruktur 
veröffentlicht wurde. Dieses Model ließ vermuten, dass von den acht Cysteinen von PfalMAT 
nur Cys52, Cys113 und Cys187 in der dimeren Konformation des Enzyms für redox-aktive 
Moleküle zugänglich sind. Darum wurden diese Cysteine durch gerichtete Mutagenese zu 
Serinen mutiert. Die entsprechenden Mutanten wurden mit Hilfe eines 
spektrophotometrischen Assays kinetisch charakterisiert und ihre Oligomerisierung wurde in 
Gelfiltrationsexperimenten untersucht. PfalMAT wurde redoxreguliert, dabei führten 
Reduktion durch Glutathion und Reduktionsmittel, wie Dithiothreitol, zur Aktivierung und 
Oxidationsvorgänge, wie S-Glutathionylierung und S-Nitrosylierung zur Inhibierung von 
PfalMAT. Auf diese Beobachtung hin wurde der Einfluss der selektierten Cysteine auf diese 
Prozesse untersucht. Subzelluläre Konzentrationen an Thioredoxin 1 und Plasmoredoxin 
erhöhten die enzymatische Aktivität von PfalMAT, ein Effekt, der auf eine Reduktion der drei 
genannten Cysteine zurückgeführt werden konnte. Protein-S-Glutathionylierung inhibierte 
PfalMAT durch die spezifische Bildung eines gemischten Disulfids zwischen Glutathion und 
Cys113, wobei die S-Glutathionylierung durch den Zusatz von Thioredoxin 1 und 
Plasmoredoxin in physiologischen Konzentrationen vollständig reversibel war. Dies lässt eine 
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Regulation von PfalMAT durch die beiden redoxaktiven Proteine auch in vivo vermuten. Auch 
die S-Nitrosylierung inhibierte PfalMAT, wurde jedoch durch die Modifikation mehrerer 
Cysteine, einschließlich Cys52, Cys113 und Cys187, vermittelt. Diese Ergebnisse deuten auf 
eine Kopplung des S-Adenosylmethioninspiegels an den zellulären Redoxstatus von P. 
falciparum hin, die über die Redoxregulation von PfalMAT vermittelt wird.  
Das zweite Enzym, das im Fokus dieser Dissertation stand, war MscDyP1. Diese DyP-type 
Peroxidase zählt zu einer erst kürzlich entdeckten Klasse von Hämperoxidasen, die sich 
strukturell und katalytisch stark von den klassischen Hämperoxidasen unterscheidet. Im 
Rahmen dieser Dissertation konnten durch ein systematisches Screening von 
Kristallisationsbedingungen Proteinkristalle von MscDyP1 mit einer hohen Auflösung 
generiert werden. Diese ermöglichten die Auflösung der dreidimensionalen Struktur des 
Enzyms, die interessante strukturelle Besonderheiten offenbarte. Auffällig waren zwei nicht-
konservierte oberflächenexponierte Methionine (Met302 und Met305), die eine wichtige 
strukturelle Rolle zu spielen schienen. Außerdem wurden neben dem aktiven Zentrum von 
MscDyP1 zwei weitere mögliche Stellen für die Substratoxidation identifiziert: ein zweiter 
Zugangskanal zum Hämzentralatom und eine Höhle, die das einzige und konservierte Cystein 
(Cys360) umschließt. Obwohl die Konservierung von Cys360 eine wichtige Bedeutung für 
das Protein vermuten lässt, wurde es zuvor noch nicht untersucht. Die Kristallstruktur deutet 
darauf hin, dass Cys360 für kleinere redoxaktive Moleküle zugänglich ist und es deshalb 
Redoxmodifikationen unterliegen könnte. Um eine mögliche katalytische oder funktionelle 
Rolle der beiden Methionine und des Cysteins zu untersuchen, wurden diese mutiert und die 
entsprechenden Mutanten sowie der Wildtyp in E. coli überexprimiert und in zwei 
Assaysystemen kinetisch charakterisiert. Beide Mutanten, die Doppelmutante ohne Met302 
und Met305 sowie die Cysteindeletionsmutante, zeigten eine signifikant verringerte 
spezifische Aktivität im Vergleich zum in E.coli rekombinant erzeugten Wildtyp. Des 
Weiteren hatte die Cysteindeletionsmutante eine geringere Affinität zu Wasserstoffperoxid. 
Darüber hinaus schienen beide Mutanten weniger anfällig gegenüber der unter 
Hämperoxidasen häufig beobachteten Inhibierung durch hohe Wasserstoffperoxid-
konzentrationen zu sein. Diese Ergebnisse bestätigten die strukturelle Bedeutung der beiden 
Methionine und ließen eine Redoxregulation von MscDyP1 über Cys360 vermuten. Im 
Gegensatz zum in E. coli rekombinant hergestellten Enzym, das nicht glykosyliert ist, sind 
das native Enzym sowie das für die Kristallisationsexperimente genutzte in Aspergillus niger 
rekombinant hergestellte Enzym stark glykosyliert. Außerdem wurde durch eine 
biochemische Charakterisierung des nativen Enzyms im Vorfeld gezeigt, dass MscDyP1 als 
Dimer vorliegt. Die Kristallstruktur deutet auf eine entscheidende Rolle der Glykosylreste bei 
der Dimerisierung des Enzmys hin. Das in A. niger rekombinant hergestellte MscDyP1 wurde 
aus diesem Grund mit den thiolblockierenden Agentien Methylmethanthiosulfonat und 
Iodoazetamid behandelt, um alle lösungsmittelzugänglichen schwefelhaltigen Aminosäuren 
zu blockieren. Während die Aktivität des in E. coli hergestellten Enzyms um 40% sank, 
variierte die Aktivität des in A. niger produzierten Enzyms nicht. Dies lässt den Schluss zu, 
dass die Glykosylierung vermutlich die redoxsensitiven Reste schützt und dass im nativen 
stark glykosylierten Enzym, im Gegensatz zu den Beobachtungen der PfalMAT, Cys360 eher 
eine strukturelle als eine katalytische oder regulatorische Funktion einnimmt. 
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1 INTRODUCTION 
The development of living organisms required the presence of oxygen, and most organisms 
rely on it. But to live in an aerobic environment under oxidative conditions also means they 
must combat oxygen-derived radicals, which requires a fine, tight, and complex regulation of 
processes involved in maintaining the cellular redox state. 
1.1 Redox regulation 
The cellular redox state, which depends on the level of oxidants and antioxidants, affects 
proteins and lipids and thereby regulates cellular processes and functions. A number of vital 
physiological processes are redox regulated, including nitric oxide (NO) production, vascular 
tone, cell adhesion, apoptosis, immune responses, and signaling processes (reviewed in Valko 
et al., 2007).  
1.1.1 Oxidative stress and radicals in cell metabolism 
Oxidative stress is a condition of imbalance in the cellular redox homeostasis due to a 
deficient antioxidant defense and/or an excessive overproduction of reactive oxygen and/or 
nitrogen species (ROS and RNS) (Finkel et al., 2000), which leads to decreased cellular 
glutathione and NADPH levels (Lewis, 2002).  
The cell is confronted with approximately 1.5 x 105 oxidative adducts per day (Nakajima et 
al., 1996; Beckman et al., 1997), generated endogenously under basal physiological 
conditions as byproducts during cellular metabolism or derived from exogenous sources. The 
main sources of intracellular ROS are complex I (NADH:ubiquinone oxidoreductase) and 
complex III (ubiquinone-cytochrome c reductase) of the mitochondrial electron transport 
chain during oxidative phosphorylation in aerobic energy metabolism (Turrens et al., 1980; 
Turrens et al., 1985; Lewis, 2002). Peroxisomal enzymes, e.g. acyl-CoA oxidases, xanthine 
oxidase, polyamine oxidase, or inducible nitric oxide synthase (iNOS), generate ROS and 
RNS during their catalytic activity (Fransen et al., 2012). Cytochrome P450 enzyme systems 
required for cellular detoxification contribute to ROS formation (Ekstrom et al., 1989). 
Additionally, the immune system is a site of excessive ROS formation, especially during the 
oxidative burst, catalyzed by NADPH oxidase in macrophages and neutrophil granulocytes 
during phagocytosis. Exogenous sources such as irradiation by UV light, x-rays and gamma-
rays, thermal stress, drugs (e.g. cyclosporine (Mun et al., 2008) or gentamicin (Martinez-
Salgado et al., 2002)), environmental toxins (e.g. alcohol or cigarette smoke), or metal-
catalyzed reactions (e.g. by iron, arsenic, copper, cobalt or vanadium) during Fenton reaction 
(Finkel et al., 2000; Valko et al., 2006; Pham-Huy et al., 2008) contribute to the formation of 
oxidative or nitrosative agents that the cell has to cope with.  
Redox homeostasis is maintained by enzymatic and non-enzymatic antioxidant systems. 
Enzymatic antioxidant defense is mediated mainly by superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GPx), and peroxiredoxins. Furthermore, a number of non-
enzymatic, low molecular weight molecules such as glutathione (GSH), ascorbate, pyruvate, 
flavonoids, and carotenoids contribute to intracellular ROS detoxification (Finkel et al., 
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2000). Under physiological conditions at low and moderate cellular levels, ROS and RNS 
play a central role in cell growth, signaling processes, metabolism, and cell cycle regulation. 
A reducing cellular environment stimulates cell proliferation, whereas a more oxidizing 
cellular environment stimulates cell differentiation (reviewed in Valko et al., 2007). An 
imbalance in the cellular redox state towards either too low or too high ROS or RNS levels 
impairs physiological processes. Numerous diseases are linked to oxidative or nitrosative 
stress, including cardiovascular diseases, diabetes, neurological disorders, age-related 
diseases, and cancer (reviewed in Dalle-Donne et al., 2006; Valko et al., 2007), due to 
oxidative damage of DNA (Ayala et al., 2014), e.g. deamination and nitration of purines 
(Dalle-Donne et al., 2006), and oxidation of proteins, altering their biological properties. 
Additionally, lipid peroxidation affects biological membranes by modifying fluidity, cell 
permeability, and membrane-associated receptors (Stocker et al., 2004; Dalle-Donne et al., 
2006). 
1.1.2 Oxidative protein modifications 
Proteins are particularly sensitive to oxidative modifications in response to alterations of the 
cellular redox state. Cysteine, methionine, tryptophan, tyrosine, and histidine are the most 
susceptible amino acids (reviewed in Valderrama et al., 2002).  
2.3.2.1 Methionine oxidation and reduction in protein redox regulation 
Although methionine residues can be oxidized, the reaction is slower compared to cysteine 
oxidation and is rapidly reversed by methionine sulfoxide reductases (MrsA and MrsB) (Wani 
et al., 2014). Therefore, methionine oxidation plays a minor role under physiological 
conditions, e.g. in cellular redox signaling. However, research focused on the role of 
methionine oxidation in signaling is increasing. Due to their close proximity to serine, 
tyrosine, and threonine residues, three known protein phosphorylation sites, a possible role for 
methionine residues in phosphorylation-mediated signaling is suggested (Czernik et al., 1987; 
Rao et al., 2013). Methionine oxidation and reduction has been suggested to present a 
possible mechanism to regulate protein function because the site chain of methionine is 
flexible and non-polar, whereas the one in methionine sulfoxide is stiffer and more polar 
(Hoshi et al., 2001). Therefore, methionine oxidation can change the physical and chemical 
properties of proteins, which might lead to dysfunctional proteins or contribute to the 
regulation of cell function (Hoshi et al., 2001). Reversible methionine oxidation to 
methionine sulfoxide (MetO) is suggested to exert a scavenger function to protect other amino 
acids from irreversible overoxidation in order to maintain protein functionality, similar to 
cysteine redox modifications. Therefore, methionines can act as antioxidants, protecting 
proteins under conditions of oxidative stress (reviewed in Rao et al., 2015). However, 
overoxidation by excess ROS leads to irreversible formation of methionine sulfone (MetO2), 
which can irreversibly damage proteins. The reverse reaction of methionine sulfoxide to 
methionine via thioredoxin-dependent methionine sulfoxide reductase (MrsA) is linked to the 
cellular redox state via thioredoxin reductase and NADPH (Hoshi et al., 2001). This suggests 
a possible contribution of methionine residues to redox regulation of protein function or an 
alteration of the structure, depending on the cellular redox state. 
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2.3.2.2 Cysteines, key players in redox regulation 
Cysteines represent one of the least prominent amino acids within proteins (Jones, 2008). 
Nevertheless, they are the most conserved residues and are often located at functionally or 
structurally important protein sites (Fomenko et al., 2008). Cysteine content increases with 
the complexity of organisms from 0.4-0.5% in archaea to 2.26% of the total encoded amino 
acids in mammals, indicating that increased cysteine content was advantageous during 
evolution (Miseta et al., 2000). Cysteines inherit important functions in proteins varying from 
catalytic, redox active, regulatory, or structural cysteines to cysteines participating in metal 
coordination, as sites of post-translational modifications (PTMs), or participation in substrate 
binding or protein-protein interaction (Fomenko et al., 2008; Jacob et al., 2012). Cysteine is 
unique among the encoded amino acids since it carries a reactive sulfhydryl group, or thiol 
group, that readily reacts with another sulfhydryl group, resulting in the formation of a 
disulfide bridge (Wani et al., 2014). Due to their thiol group, which can adapt multiple 
oxidation states ranging from -2 to +6, cysteines are highly susceptible to redox modifications 
(Wani et al., 2014); therefore, they play a crucial role in the redox regulation of proteins. 
Susceptibility of cysteines to redox modifications is known to depend on different factors 
such as the cysteine redox state, proximity to metal centers, its accessibility, electrostatic 
interactions, and its pKa (which is normally ~8.5) (Jacob et al., 2012; Cremers et al., 2013), 
which might be affected by surrounding amino acids, e.g. positively charged residues. 
Furthermore, the environmental pH and intracellular redox state affect redox modifications of 
cysteines (Xiong et al., 2011; Roos et al., 2013). An overview of oxidative cysteine 
modifications is provided in Figure 1. 
Oxidation of a cysteine thiol by ROS or RNS leads to formation of the highly reactive 
sulfenic acid, which due to instability readily reacts with another thiol to form an intra- or 
intermolecular disulfide bond or reacts with RNS or GSSG and is thus S-nitrosylated or S-
glutathionylated, respectively (Cremers et al., 2013). These modifications are reversible. 
Persisting oxidative conditions and oxidative stress can induce overoxidation of sulfenic acid 
to sulfinic acid and sulfonic acid, analogous to sulfoxidation of methionine. Formation of 
sulfinic and sulfonic acids had been considered irreversible; however, some studies were 
published showing sulfinic acids can be reduced enzymatically to thiols e.g. by ATP-
dependent sulfiredoxin as shown for Saccharomyces cerevisiae (Biteau et al., 2003) or as 
shown for peroxiredoxins (Woo et al., 2003), whereas for the latter one, the responsible 
enzyme system has not yet been identified.  
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Figure 1: Cysteine modifications 
Oxidation of a cysteine thiol leads to the formation of the highly reactive sulfenic acid (a), which readily reacts 
with another thiol to form either an intramolecular (d’) or an intermolecular disulfide bond (d), a mixed disulfide 
with a free cysteine (d’’), or it can react with RNS e.g. S-nitrosoglutathione (GSNO) (e) or GSSG (f) and is thus 
S-nitrosylated or S-glutathionylated, respectively. These modifications are reversible by glutathione (GSH) or the 
redox-active proteins thioredoxin (Trx) and glutaredoxin (Grx). High levels of oxidative stress can induce 
overoxidation of sulfenic acid to sulfinic acid (b) and sulfonic acid (c). This figure was modified from (Jortzik et 
al., 2012) and (Dalle-Donne et al., 2009). 
Reversible switches of cysteine redox states in response to dynamic alterations in the cellular 
redox state serve as molecular redox sensors via formation or cleavage of disulfide bonds, 
followed by a direct or indirect modulation of protein function by modulating functionally 
important cysteines or inducing conformational changes that affect critical cysteine residues 
(Nagahara, 2011). These thiol switches are suggested to play a role in regulating cell signaling 
through different compartments or subcellular localizations via redox-sensitive catalytic 
cysteines of signaling enzymes, e.g. protein-tyrosine kinases (Ostman et al., 2011). 
Furthermore, redox-sensing thiol switches participate in regulation of protein expression via 
redox regulation of transcription factor activity, as shown for CprK (Pop et al., 2004) and 
OxyR (Lee et al., 2004), and thereby link protein expression to the cellular redox state 
(Nagahara, 2011). 
2.3.2.3 Protein-S-glutathionylation 
Protein-S-glutathionylation, a post-translational modification and the most abundant oxidative 
thiol modification, is the reversible formation of mixed disulfides between a protein cysteine-
sulfhydryl moiety and the cysteine-sulfhydryl moiety of the tripeptide glutathione (Dalle-
Donne et al., 2007). Under physiological cellular conditions, glutathione is present mostly in 
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its reduced form GSH in millimolar concentrations (1-10 mM) (Meister et al., 1983), with a 
molecular ratio of the glutathione redox couple GSH/GSSG of 10,000:1 (Morgan et al., 2013) 
(a ratio of 100:1 was suggested for a long time (Hwang 1992 Science 257:1496)). GSH is the 
major redox thiol in cells and maintains the reduced state of the cell (Muller, 2015). Protein-S-
glutathionylation occurs under conditions of oxidative and nitrosative stress as well as in 
unstressed cells under physiological conditions (Dalle-Donne et al., 2007).  
Several reactions can mediate protein-S-glutathionylation (according to (Dalle-Donne et al., 
2009). GSH can react directly with cysteines that were previously oxidized by e.g. hydroxyl 
radicals, i.e. sulfenic acids or thiyl radicals, leading to formation of protein-glutathione mixed 
disulfides (PSSG). Protein-S-glutathionylation can occur via thiol-disulfide exchange between 
GSSG and a protein thiol in response to a shift in the GSH/GSSG ratio towards GSSG, i.e. 
under conditions of oxidative stress. Furthermore, reaction of a protein thiol and nitrosothiol, 
i.e. S-nitrosoglutathione, can result in protein-S-glutathionylation and the reaction of S-
nitrosylated proteins with GSH. Furthermore, protein-S-glutathionylation can be catalyzed 
enzymatically by glutaredoxin (Grx) (Lind et al., 1998) and glutathione-S-transferase (GST) 
(Townsend et al., 2009). However, the exact in vivo mechanism of protein-S-glutathionylation 
is not yet fully understood.  
The cellular level of S-glutathionylated proteins increases within cells under conditions of 
oxidative stress compared to physiological conditions (Lind et al., 2002); therefore, protein-S-
glutathionylation is suggested to prevent cysteine residues from irreversible overoxidation. 
Moreover, protein-S-glutathionylation functions as an intracellular storage form of glutathione 
in order to prevent GSSG export from the cell under oxidative stress (Sies et al., 1984; Dalle-
Donne et al., 2009). A prerequisite for its cysteine-protecting and glutathione storage 
functions is the reversibility of protein-S-glutathionylation. The reverse process is called 
deglutathionylation and is catalyzed enzymatically by Grx (Jensen et al., 2014) via a 
monothiol mechanism (Shelton et al., 2005), thioredoxin (Trx) (Greetham et al., 2010; Kehr 
et al., 2011), sulfiredoxin (Findlay et al., 2006), and plasmoredoxin, a redox-active protein 
unique to Plasmodium falciparum (Kehr et al., 2011). The reversibility of protein-S-
glutathionylation suggests a potential role in redox signaling. However, specificity is a 
requirement for a potential role in signaling processes. Although some cysteines are more 
sensitive to S-glutathionylation than others, a specific glutathionylation motif has not yet been 
observed, and the exact parameters facilitating protein-S-glutathionylation specificity are still 
unclear. The cysteine’s accessibility and the pKa, surrounding amino acids which can affect 
the cysteine’s pKa, and therefore its reactivity are still uder debate (Dalle-Donne et al., 2009).  
2.3.2.4 Protein-S-nitrosylation 
NO· is an important messenger molecule in cell signaling processes that participates in 
numerous physiological processes (Moncada et al., 1991) such as cardiovascular function, 
blood vessel dilatation, muscle relaxation, neurotransmission, and immune defense 
mechanisms (reviewed in Knott et al., 2010). It reacts with a wide variety of target molecules, 
e.g. DNA (Tamir et al., 1996), proteins, ROS, and metals (McCleverty, 1979), affecting 
numerous downstream mechanisms. NO can lead to the formation of S-nitrosoglutathione 
(GSNO) in the presence of GSH. Under aerobic conditions NO undergoes autoxidation to 
dinitrogen trioxide (N2O3) (Gardner et al., 2004; Toledo et al., 2012) or forms higher nitrogen 
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oxides, e.g. ONOO-, with harmful cellular effects (Sun et al., 2006). N2O3 is a key mediator of 
protein-S-nitrosylation, a reversible post-translational modification occurring under 
physiological conditions and during nitrosative stress, with effects on protein function, 
conformation, and stability (Kim et al., 2004; Hess et al., 2005). It is the covalent attachment 
of a nitroso group (-NO) to a protein thiol, resulting in the formation of an S-nitrosothiol 
(Hess et al., 2005). Under oxidative stress conditions, protein-S-nitrosylation might have a 
protective function for protein thiols in order to prevent overoxidation and loss of protein 
function (reviewed in Sun et al., 2006), similar to protein-S-glutathionylation. Protein-S-
nitrosylation can occur either directly via interaction of a protein thiol with RNS or via 
transfer of an NO-group from another S-nitrosothiol e.g. GSNO, a process called 
transnitrosylation (Hess et al., 2005). Analogous to protein-S-glutathionylation, which is 
suggested to have a GSH storage function under oxidative stress conditions, protein-S-
nitrosylation is believed to have an NO-storage function due to the longer half-life of RSNO 
compared to NO (Broillet, 1999). However, the NO half-life is supposed to be concentration 
dependent (Wink et al., 1998); under physiological (nanomolar) concentrations, NO has a 
relatively long half-life enabling an interaction of NO with target molecules, whereas under 
pathophysiological (micromolar) concentrations, NO rapidly reacts with ROS or RNS and 
facilitates nitrosative stress (Toledo et al., 2012). Similar to protein-S-glutathionylation, not 
every cysteine undergoes S-nitrosylation. It has been suggested that the specificity of protein-
S-nitrosylation depends on the pKa of the cysteine, its accessibility, a hydrophobic 
environment (Liu et al., 1998; Sun et al., 2006), and the subcellular colocalization of target 
proteins and NOS (Sun et al., 2006). Furthermore, a consensus acid-base motif for S-
nitrosylation has been proposed via database screenings (Stamler et al., 1997; Broillet, 1999) 
and is suggested to control the pKa and nucleophilicity of the target thiol (Sun et al., 2006). 
This motif is composed of XYCZ, with X presenting a polar, uncharged, or nonpolar amino 
acid, Y being either a basic or an acidic amino acid, and Z being an acidic amino acid 
(Stamler et al., 1997; Broillet, 1999). Besides its specificity and spatiotemporal restriction, S-
nitrosylation fulfills another criterion for its role in NO signaling processes: reversibility 
(denitrosylation) (Derakhshan et al., 2007). Denitrosylation, the removal of an NO group 
from a thiol, can either be non-enzymatically driven or enzymatically catalyzed by 
denitrosylases, e.g. by Trx (Benhar et al., 2008), GSH (Zaffagnini et al., 2013), GSNO 
reductase (Liu et al., 2001), superoxide dismutase (SOD) (Jourd'heuil et al., 1999), protein 
disulfide isomerase (Sliskovic et al., 2005), xanthine oxidase (Trujillo et al., 1998), or 
carbonyl reductase (Bateman et al., 2008). A wide variety of proteins are S-nitrosylated, 
including enzymes of energy metabolism (glycerine aldehyde-3-phosphate dehydrogenase 
(Hara et al., 2005)), heat shock proteins (Hsp90 (Martinez-Ruiz et al., 2005)), ion channels 
(L-type Ca2+ channel (Sun et al., 2006)), and transcription factors (NF-κB (Reynaert et al., 
2004)) with regulatory downstream effects on cellular pathways. Furthermore, dysregulated 
S-nitrosylation (hypo- or hyper-S-nitrosylation) is linked to the pathogenesis of neurological 
diseases (e.g. Alzheimer’s and Parkinson’s diseases), cancer, cardiovascular diseases, 
pulmonary diseases (i.e. asthma), and diabetes (Foster et al., 2009). 
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1.3 PfalMAT: a target of redox-regulatory processes 
1.3.1 Malaria and Plasmodium falciparum 
Malaria is a mosquito-borne infectious disease caused by protozoan apicomplexan parasites 
of the genus Plasmodium (CDC, 2015). Infected patients often suffer from cold- or flu-like 
symptoms such as fever, headache, chills, nausea, and vomiting. Left untreated malaria 
patients can develop severe complications and may die (CDC, 2015). Malaria is one of the 
most prevalent infectious diseases worldwide, with more than 40% of the world’s population 
being at risk of malaria (WHO, 2008). In 2012, 207 million estimated malaria cases were 
reported. Each year, around 800,000 people die from malaria (WHO, 2010). The poorest and 
children under 5 years of age are affected the most, partly due to a weakened immune system 
and undernourishment, in tropical and subtropical areas of Africa, Mexico to South America, 
Southeast Asia, and Eastern Mediterranean regions. 
Among the more than 100 Plasmodium species, five are human pathogenic, namely, 
Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi (Tuteja, 2007). 
P. falciparum is the most virulent species, causing severe tropical malaria. Typical features of 
a P. falciparum infection includes severe anemia, the sequestration of infected erythrocytes 
from the blood, and their accumulation in various organs e.g. lung, kidney, placenta, and 
brain. Due to antigenic variation on the surface of infected erythrocytes encoded by var genes, 
parasitized erythrocytes evade splenic elimination and host immune response (Chen et al., 
2000). Instead, parasitized erythrocytes are eliminated from the blood stream via enhanced 
adherence to the endothelium of blood vessels, resulting in vasoconstriction. This 
cytoadherence is caused by the expression of Plasmodium-derived adhesion molecules 
(PfEMP-1) on the surface of infected erythrocytes, which bind to host adhesion molecules 
(i.e. ICAM-1). These vascular constrictions are further aggravated by rosetting, an 
agglutination of infected and uninfected erythrocytes, and can lead to occlusions of small 
blood vessels, e.g. in the brain, which can cause severe cerebral malaria (Mackintosh et al., 
2004; Tuteja, 2007). 
Plasmodium is transmitted by female Anopheles mosquitos. Among the approximately 400 
Anopheles species, 60 serve as vectors under natural conditions and can transmit malaria 
(Tuteja, 2007). Plasmodium undergoes different developmental stages within its complex life 
cycle (Figure 2) in its human and mosquito hosts, which are characterized by different 
environmental conditions (Tuteja, 2007), that the parasite must adapt to. 
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Figure 2: Life cycle of Plasmodium falciparum 
Infective sporozoites are transmitted by the bite of an infected female Anopheles mosquito from her salivary 
glands to the human host, followed by release into the blood stream (Tuteja, 2007). Parasites reach the liver and 
penetrate the hepatocytes. Within hepatocytes (exo-erythrocytic cycle / liver cycle) P. falciparum undergoes 
asexual replication and develops into schizonts. Mature schizonts rupture and release merozoites, which enter 
erythrocytes and start the intraerythrocytic cycle (blood stage). Within the erythrocytic cycle merozoites develop 
asexually into a ring form, which matures into trophozoites. Trophozoites enlarge and develop into schizonts that 
almost completely fill the infected erythrocyte. The mature schizont ruptures and releases merozoites into the 
blood stream, which are able to infect more erythrocytes. This rupture of infected erythrocytes causes the typical 
repetitive fever of tropical malaria. The erythrocytic cycle of P. falciparum, (invasion, multiplication, release, 
invasion) takes 48 hours and occurs relatively synchronously (Tuteja, 2007). A few intraerythrocytic merozoites 
differentiate into the sexual forms, male and female gametocytes, which can be ingested by Anopheles mosquitos 
during blood meals on infected human hosts. Within the insect host (mosquito stage / sporogonic cycle), 
gametocytes reach the midgut, where they develop into micro- and macrogametes. After fertilization of the 
macrogamete by the microgamete, these sexual forms fuse to form a zygote, which transforms into an ookinete. 
The ookinete penetrates the midgut epithelial cell wall and differentiates into an oocyst. Oocysts in the midgut 
grow, rupture, and release sporozoites, which invade the salivary glands and can be transmitted to another 
human host via the next blood meal (CDC, 2015). This figure was taken from (Cowman et al., 2012). 
1.3.2 Redox metabolism of P. falciparum 
Plasmodium is exposed to high levels of oxidative and nitrosative stress during its life cycle. 
The rapid growth, replication, and differentiation of Plasmodium requires a specialized 
protein expression and high metabolic rate, which are accompanied by the formation of 
reactive intermediates (Becker et al., 2004). Furthermore, Plasmodium digests hemoglobin 
from the hosting infected erythrocyte because it is its main amino acid source. The 
degradation of hemoglobin in the acidic parasite food vacuole results in a spontaneous 
oxidation of Fe2+ to Fe3+ in hemoglobin, as well as the formation of toxic free heme 
(ferriprotoporphyrin IX, FP IX) and superoxide anion radicals (O2-˙), which lead to the 
formation of hydrogen peroxide (H2O2) via superoxide dismutase (SOD) and hydroxyl 
radicals (OH˙) (Becker et al., 2004; Muller, 2004). FP IX is detoxified via degradation to 
hemozoin. However, a small amount of FP IX is released into the cytosol and leads to radical 
formation, which causes oxidative stress and can damage membranes, proteins, DNA, and 
lipids (Atamna et al., 1993; Becker et al., 2004; Muller, 2004). Furthermore, Plasmodium has 
to combat host-derived radicals from the oxidative burst as an immune response (Muller, 
2004). Plasmodium superoxide dismutase (SOD) contributes to antioxidant defense. But 
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Plasmodium lacks the classic antioxidant enzymes catalase and glutathione peroxidase. 
Therefore, the two major antioxidant redox systems of Plasmodium, the thioredoxin system 
and the glutathione system, are more important in combating oxidative and nitrosative stress. 
Both systems rely on NADPH provided by the pentose phosphate pathway as an electron 
donor that provides reducing equivalents, and both systems closely interact in order to 
maintain cellular redox equilibrium (reviewed in Mohring, Pretzel et al., 2014).  
2.3.2.1 Thioredoxin system of P. falciparum 
The thioredoxin system of P. falciparum comprises two NADPH-dependent thioredoxin 
reductases (PfTrxR) capable of reducing three thioredoxins (PfTrx 1-3), two thioredoxin-like 
proteins (PfTlp 1-2) that cannot be reduced by PfTrxR (Nickel et al., 2006; Jortzik et al., 
2012), five thioredoxin-dependent peroxiredoxins (PfPrx1a, PfPrx1m, PfPrx5, PfPrx6, and 
PfPrxQ), and the parasite’s unique plasmoredoxin (PfPlrx) (Becker et al., 2003). Similar to 
human TrxR, the two FAD-dependent PfTrxRs belong to high molecular weight TrxRs. But 
unlike the human counterpart, whose C-terminal redox center is composed of a cysteine-
selenocysteine motif, PfTrxR possesses a Cys-xxxx-Cys motif. The two PfTrxR isoforms 
exhibit similar kinetic properties (Nickel et al., 2006), although they have different subcellular 
localizations (cytosolic and mitochondrial) (Kehr et al., 2010). PfTrxR transfers electrons 
from NADPH via FAD to disulfide substrates, mainly Trx, which is subsequently reduced and 
able to reduce disulfides of low molecular weight (LMW) substrates, including glutathione 
disulfide (GSSG), hydrogen peroxide (H2O2), cumene hydroperoxide (CHP), tert-butyl 
hydroperoxide (tBOOH), and S-nitrosoglutathione (GSNO) (Kanzok et al., 2000; Nickel et 
al., 2006; Jortzik et al., 2012). Furthermore, in its reduced state Trx can reduce disulfides of 
several target proteins, including Trx-dependent peroxidases (Rahlfs et al., 2001), proteins 
involved in energy metabolism, protein biosynthesis, transcription, signal transduction, and S-
adenosylmethionine (SAM) and polyamine metabolism (Sturm et al., 2009).  
Among the three PfTrxs, the cytosolic PfTrx1 plays the most important role in redox 
metabolism of P. falciparum (Kehr et al., 2010). Its WCGPC active site motif forms a 
disulfide in the oxidized state and is kept in the reduced dithiol state by PfTrxR (Powis et al., 
2001). In the reduced state, PfTrx1 transfers reducing equivalents from one of the catalytic 
thiols to numerous target proteins of P. falciparum (Sturm et al., 2009) and diverse low 
molecular weight substrates (Rahlfs et al., 2001). Moreover, PfTrx1 is capable of catalyzing 
the deglutathionylation of S-glutathionylated proteins (Kehr et al., 2011). Plasmodium species 
encode an additional member of the Trx-superfamily, the dithiol redox-active protein, 
plasmoredoxin (Plrx), which contains a Trx-fold and a putative WCKYC active site motif 
(Becker et al., 2003; Jortzik et al., 2012). Plrx shares common features with PfTrx and PfGrx, 
i.e. deglutathionylation of S-glutathionylated proteins (Kehr et al., 2011; Jortzik et al., 2012). 
However, Plrx is not a substrate of PfTrxR or P. falciparum glutathione reductase (PfGR) but 
can be reduced by PfTrx, glutaredoxin (PfGrx), and GSH, albeit less efficiently (Jortzik et al., 
2012). Plrx reduces disulfide substrates such as GSSG, peroxiredoxin PfPrx1a, ribonucleotide 
reductase, and insulin (Becker et al., 2003). A total of 21 target proteins interacting with Plrx 
were identified in pull-down experiments, among them PfalMAT (Sturm et al., 2009).  
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2.3.2.2 Glutathione system of P. falciparum 
Glutathione is the major redox buffer that regulates cellular redox homeostasis (Muller, 2015) 
by switching between a reduced form (GSH) and an oxidized form (GSSG) (Jortzik et al., 
2012). Intracellular GSH concentration is approximately 2.4 mM, thus considerably higher 
than the concentration of NADPH (< 100 µM) and Trx (~ 10 µM), additional redox-active 
compounds contributing to cellular redox equilibrium (Jortzik et al., 2012). Plasmodium 
synthesizes GSH de novo in an ATP-dependent manner in a two-step reaction catalyzed by γ-
glutamylcysteine synthetase (γGCS) and glutathione synthetase (GS) (reviewed in Mohring, 
Pretzel et al., 2014; Muller, 2015). The glutathione redox system of P. falciparum is 
composed of glutathione reductase (GR), glutathione-S-transferase (GST), glyoxalases, 
glutaredoxin (Grx), and three Trx-dependent glutaredoxin-like proteins (Glp 1-3). The FAD-
dependent GR reduces GSSG to GSH upon consumption of NADPH (Jortzik et al., 2012). 
GSH provides reducing equivalents for numerous GSH-dependent proteins of P. falciparum, 
including GST, glyoxalases, Grx, and Glps. Upon reduction by GSH, the thiol-disulfide 
oxidoreductase Grx can reduce disulfides of a variety of target proteins: 17 have been 
identified in P. falciparum using a proteomic approach, including proteins involved in 
glycolysis, protein-folding, and S-adenosylmethionine metabolism (PfalMAT) (Sturm et al., 
2009). The glutathione system of P. falciparum efficiently regulates the cellular redox state by 
recycling of GSSG to GSH, and it regulates protein-S-glutathionylation and 
deglutathionylation catalyzed by PfGrx (Kehr et al., 2011).  
2.3.2.3 Redox system of P. falciparum as a drug target 
The X-chromosomal inherited glucose-6-phosphate dehydrogenase (G6PDH) deficiency can 
protect against malaria infections. G6PDH catalyzes the first step in the pentose phosphate 
pathway that converts NADP+ into its reduced form, NADPH, which provides reduction 
equivalents for many downstream antioxidant processes and protects the erythrocyte from 
oxidative stress. A G6PDH deficiency is accompanied by reduced NADPH levels and 
therefore decreases protection against oxidative stress, leaving erythrocytes more susceptible 
to ROS and RNS, which can damage the red blood cells and cause hemolytic anemia. In 
G6PDH deficiency, Plasmodium has to face higher levels of oxidative stress within their 
hosting erythrocytes. This deficiency is highly prevalent in malaria-endemic regions, 
suggesting a selectivity-based protective function against malaria, and highlights the 
importance of oxidative stress when defending against Plasmodium (Ginsburg et al., 1996). 
The susceptibility of Plasmodium to oxidative stress and the vital role of its antioxidant 
defense mechanism make its redox systems an attractive drug target to combat malaria. 
Therefore, many antimalarial drugs in current clinical use lead to oxidative stress by releasing 
ROS itself (methylene blue, pyocyanine, synthetic peroxides, artemisinin and derivatives), by 
preventing the scavenging of pro-oxidant metabolic byproducts e.g. toxic free heme 
(quinolines e.g. mefloquine, azoles, isonitriles, xanthones; and their derivatives), or by 
inhibiting enzymes of the antioxidant defense systems of Plasmodium i.e. PfGR, PfGST, or 
PfTrxR (dehydroepiandrosterone, phenolic Mannich bases, ellagic acid, naphthoquinones, 
artemisinin and its derivatives, methylene blue, and isoalloxazine derivatives) (Pal et al., 
2012); (Mohring, Pretzel et al., 2014). 
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However, a spread of resistance is observable in Plasmodium species against all classes of 
currently used antimalarial drugs: amodiaquine, chloroquine, mefloquine, quinine, 
sulfadoxine-pyrimethamine, and artemisinin (WHO, 2010). Furthermore, resistances of 
Anopheles mosquitos against insecticides are spreading (WHO, 2012). The best way to 
combat malaria infection would be a long-term prophylaxis via vaccination (MMV, 2015). 
However, development of vaccines against malaria is challenging due to the complexity of the 
parasite, its life cycle, and its antigenic variation. The WHO currently lists 27 malaria vaccine 
candidates in clinical trials. However, the only one in late-stage drug development, i.e. most 
advanced vaccine candidate, is RTS,S/AS01 (Mosquirix). It finished phase III clinical trials in 
2014 and WHO could possibly recommend and approve it in 2016 (MMV, 2015; PATH, 2015; 
WHO, 2015). However, this vaccine is not completely protective; it reduces the clinical cases 
of severe infant malaria by 26-36%. Furthermore, it requires a booster dose after 18 months, 
because efficacy decreases over time (PATH, 2015). A completely effective vaccine against 
malaria is still missing. 
Altogether, this threatens our progress in disease control and the partial eradication achieved 
during the last ten years, which were based on vector control using insecticides, efforts to 
block transmission, draining of marshlands, the use of insecticide-treated bed nets, indoor 
residual spraying, and antimalarial drugs (WHO, 2010; 2012). The spread of resistance 
against antimalarial drugs necessitates novel therapeutic approaches. Novel targets and drugs 
against malaria, with modes of action distinct from currently available drugs, are urgently 
needed. 
2.3.2.4 S-adenosylmethionine metabolism as a drug target 
“[…] SAM can be considered as a spider in a biochemical web.” (Loenen, 2006). 
S-adenosylmethionine (SAM, also known as AdoMet), is the major biological methyl group 
donor for methyltransferase-catalyzed reactions and is present in all living organisms. Its 
importance in living cells is based on three downstream key pathways (Figure 3): 
transsulfuration, transmethylation and polyamine biosynthesis (Lu, 2000). SAM serves as a 
precursor of GSH via the transsulfuration pathway, i.e. the conversion to cysteine. The S-
methyl group of SAM is transferred to a variety of substrates including nucleic acids, 
phospholipids, amines, small molecules such as arsenic, and numerous proteins in 
transmethylation reactions (reviewed in Lu, 2000; Loenen, 2006). Therefore, SAM 
metabolism is linked to regulation of gene expression via DNA methylation and influences 
membrane fluidity and receptor mobility (Fontecave et al., 2004). Moreover, SAM is one of 
the most frequently used enzyme substrates after ATP (Loenen, 2006). Furthermore, SAM is a 
precursor for polyamine synthesis, which is essential for cell growth (Thomas et al., 2001). 
Besides, the generation of SAM radicals (5-deoxyadenosyl radical) is necessary for SAM 
radical enzymes, which are involved in DNA repair and biosynthesis of vitamins and 
coenzymes (Tabor et al., 1984; Lu, 2000). SAM is synthesized in the cytosol of each cell, 
mainly in hepatocytes. 85% of all methylation reactions occur in the liver (Hoffman et al., 
1980). Orally administered SAM has been shown, both in animal and man, to have beneficial 
effects in alcoholic liver disease, it prevents the development of liver cancer in rodents, and it 
is well tolerated (Mato et al., 1999). 
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Figure 3: SAM metabolism 
SAM synthesis is catalyzed via methionine adenosyltransferase (MAT) by using L-methionine and ATP. The S-
adenosyl moiety of ATP is transferred to methionine, resulting in the formation of a sulfonium ion that readily 
transfers its methyl group to acceptor substrates (Lu, 2000). SAM is thereby converted to S-adenosyl-L-
homocysteine (SAH), which is converted to adenosine for purine metabolism and homocysteine catalyzed by 
SAH hydrolase (SAHH). Homocysteine can be used by methionine synthase (MS) and betaine-homocysteine 
transferase in order to resynthesize methionine. Within the liver, the transsulfuration pathway, converts 
homocysteine to cystathionine, a reaction catalyzed by cystationine-β-synthase (CBS). Cystathionine is 
converted to cysteine, a precursor for GSH synthesis. Thereon, SAM metabolism is linked to redox metabolism 
and regulation of the cellular redox balance. However, in P. falciparum there is presumably no generation of 
cysteine from methionine via the transsulfuration reaction because the parasite lacks the respective 
cystathionine-β-synthase and cystathionine-γ-lyase genes (Gardner et al., 2002) rather depending on cysteine 
import (Muller et al., 2008). A further downstream pathway of SAM starts upon its decarboxylation via the S-
adenosylmethionine decarboxylase (AdoMetDC), which is a bifunctional enzyme in Plasmodium (AdoMetDC 
fused to ornithine decarboxylase [ODC]). Decarboxylated SAM (dcSAM) is a precursor for the synthesis of the 
polyamines spermidine and spermine by providing the necessary aminopropyl moiety. This figure was modified 
from (Sturm et al., 2009). 
SAM synthesis is presumably crucial for life (Loenen, 2006), because even organisms lacking 
MAT, e.g. Pneumocystis, rely on SAM import from their hosts (Merali et al., 2004). SAM 
depletion, e.g. from low folate levels, polymorphisms of the methylenetetrahydrofolate 
reductase receptor, and high homocysteine levels, is linked to numerous diseases including 
cancer, liver diseases, neural tube defect, and neurological disorders such as Alzheimer’s 
disease and depression (Lu, 2000; Lieber et al., 2002; Loenen, 2006). Due to the prominent 
role of SAM in cell metabolism and its ubiquity among all living organisms, inhibition of 
SAM synthesis affecting downstream pathways is considered as an attractive strategy to 
combat pathogenic organisms such as Leishmania donovani (Trager et al., 1980; Messika et 
al., 1990; Perez-Pertejo et al., 2006), Trypanosoma brucei (Simo et al., 2010), 
Mycobacterium spp. (Berger et al., 2003), and Plasmodium spp. (Muller et al., 2008). 
Inhibition of SAM downstream pathways has antiplasmodial effects, e.g. inhibition of the 
methylation cycle via SAHH, and inhibition of the polyamine synthesis route, which arrests 
growth at the trophozoite stage (Assaraf et al., 1984; Bitonti et al., 1989). Therefore, SAM 
depletion via inhibition of plasmodial MAT likely blocks parasite growth. A P. falciparum 
strain overexpressing this enzyme has been reported to be resistant to sinefungin, an adenine-
containing nucleoside antibiotic with high similarity to SAM that inhibits the growth of P. 
falciparum and L. donovani (Trager et al., 1980; Messika et al., 1990; Perez-Pertejo et al., 
2006; Muller et al., 2008) via depletion of polyamines (Messika et al., 1990). 
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2.3.2.5 P. falciparum methionine adenosyltransferase 
Methionine adenosyltransferases (EC 2.5.1.6) (systematic name: ATP:L-methionine S-
adenosyltransferase [abbreviated as MAT], or synonymous S-adenosyl-L-methionine 
synthetase [SAMS]) catalyze the formation of S-adenosylmethionine from ATP and L-
methionine and can be found in nearly every organism. A high level of conservation, typically 
30%, can be observed among MATs from different species from bacteria to eukaryotes 
(Sanchez-Perez et al., 2004; Markham et al., 2009). According to the SCOP database MATs 
belong to the α/β-protein class. The classical MAT fold consists of three similar intertwined 
domains, each comprising a βαββαβ repeat (Murzin A. G., 1995; SCOP, 2009). The α-helices 
appear at the solvent exposed protein surface and the β-sheets are located in the monomer-
monomer contact zone (Markham et al., 2009). Resulting from the inverted assembly of two 
subunits, two cavities are formed in their interface and present the active sites. Interestingly, 
residues of both subunits contribute to the formation of each active site (Markham et al., 
2009). Conserved sequences of MAT comprise a P-loop signature (HGGGAFSGKD), which 
is in general supposed to contribute to triphosphate binding (e.g. ATP and PPPi) (Deigner et 
al., 1995; Markham et al., 2009), and a preserved substrate-binding motif composed of 
GAGDQG. Furthermore, a flexible loop is located above the active site and acts as a gate or a 
lid that controls access to the active site (Takusagawa et al., 1996; Taylor et al., 2002). It has 
been suggested, that this loop participates in the SAM synthetase reaction rather than the 
tripolyphosphatase reaction, since the kcat of cMAT is decreased upon mutation of this loop 
but the tripolyphosphatase rate is unaffected (Taylor et al., 2002). All amino acids involved in 
the formation of the active site were found to be conserved among MATs of different 
organisms (Takusagawa et al., 1996). 
MATs are bifunctional enzymes demonstrating SAM synthetase activity (synthesis of SAM 
from ATP and L-methionine) and tripolyphosphatase activity (hydrolysis of tripolyphosphate 
into pyrophosphate and orthophosphate) (Mudd, 1963) with the following two reactions: 
(1) ATP + L-methionine → SAM + PPPi 
(2) PPPi + H2O → PPi + Pi. 
The catalytic reaction of MAT is assumed to proceed in a sequential mechanism containing 
four steps (reviewed in Markham et al., 2009): (i) formation of the enzyme-ATP-methionine 
complex, (ii) formation of an intermediate enzyme-SAM-PPPi complex, (iii) subsequent 
hydrolysis of PPPi to PPi and Pi, then (iv) release of the products from the enzyme. A 
swinging movement of the flexible loop above the active site, which results in either opening 
or closing of the active site cavity, regulates substrate access (Taylor et al., 2002; Taylor et al., 
2003). In the open conformation, substrates and the products can enter and leave the active 
site (Komoto et al., 2004). After the substrate enters the active site, the tripolyphosphate chain 
of ATP is recognized by the basic amino acids Arg, Lys and His, of the active site and tightly 
bound to the enzyme via hydrogen bonds and ionic bonds (Komoto et al., 2004). Afterwards, 
the adenosine moiety of ATP is bound to the enzyme via weak interactions including Gly and 
Lys (Takusagawa et al., 1996), and the second substrate L-methionine is bound in a planar 
position, stacking against Phe, which is located on the gate loop (Gonzalez et al., 2000; 
Markham et al., 2009). After substrate binding, the flexible loop enters the active site, binds 
to the substrates via water-mediated hydrogen bonds, and closes the active site entrance 
(Komoto et al., 2004). The catalytic mechanism of MATs is an SN2 displacement mechanism, 
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a bifunctional mechanism occurring in one step, with a nucleophilic attack of the sulfur atom 
of L-methionine (SD) on C5’ of ATP and a simultaneous cleavage of the C5’-O5’ bond of ATP, 
which occurs upon changing the ribose ring conformation from C4’-exo to C4’-endo (Komoto 
et al., 2004). Thus the MAT reaction allows SAM formation via a nucleophilic attack of the 
sulfur atom of L-methionine and a displacement of the cleaved negatively charged PPPi by the 
resulting sulfonium cation in a concerted manner (Markham et al., 2009). Subsequently, the 
tripolyphosphate chain is hydrolyzed to pyrophosphate and orthophosphate. This requires 
Mg2+, which is involved in the coordination of the phosphate groups (Markham et al., 2009). 
Cleavage of PPPi occurs from both sides of the tripolyphosphate chain, between ribose and α-
phosphate and between β- and γ- phosphate (Komoto et al., 2004), whereas, more than 95% 
of the inorganic phosphate (Pi) produced is derived from the γ-phosphoryl group of ATP 
(Markham et al., 1980; Markham et al., 2009). The MAT reaction is exergonic due to 
hydrolysis of PPPi. The hydrolysis energy is assumed to be necessary for product release, 
because products are trapped inside the active site when the ATP analog AMPPNP is used 
instead of ATP, which cannot be hydrolyzed between the β- and γ-phosphate groups (Komoto 
et al., 2004). Moreover, enzyme-PPPi hydrolysis is the rate-limiting step (Markham et al., 
2009).  
P. falciparum encodes one MAT isoform (PfalMAT; formerly PfSAMS, but renamed in 
context of this dissertation according to the consensus nomenclature for methionine 
adenosyltransferases suggested by (Kotb et al., 1997) and in order to distinguish the 
plasmodial enzyme from the recently published respective enzyme of Pyrococcus furiosus 
[PfMAT] (Porcelli et al., 2015)). The respective gene is located on chromosome 9 (reference 
assembly: NC_004330.1) (Gardner et al., 2002). So far PfalMAT has been poorly studied, and 
a crystal structure is not yet available. It was studied on a molecular basis in 1999 by Chiang 
et al. Their homology model, based on the structure of cMAT, suggests a dimeric assembly of 
PfalMAT (Chiang et al., 1999). PfalMAT displays high homology (~40-60%) to MAT from 
other organisms. Accordingly, all active site residues are preserved in PfalMAT, including the 
phosphate-binding P-loop (HGGGAFSGKD), the signature sequence motif of the MAT 
superfamily (GAGDQG), and amino acids for binding ADP, Pi, and metal ions (Chiang et al., 
1999). Furthermore, PfalMAT is weakly inhibited by the classic MAT inhibitor cycloleucine 
(Ki 17 mM), in a competitive manner with respect to the substrate L-methionine (Chiang et 
al., 1999). 
2.3.2.6 Indications for redox regulation of PfalMAT 
Enzymatic activity of MAT from different organisms has been shown to be affected by 
oxidative modifications of different cysteine residues. Chemical cysteine modification of E. 
coli MAT (cMAT) and rat liver MAT (rlMAT) using the sulfhydryl alkylating agent N-
ethylmaleimide (NEM) resulted in complete inactivation of the enzymes and induced a 
dissociation of the active tetramers into inactive dimers, suggesting a role for cysteines in 
enzyme activity and the presence of an intersubunit disulfide contributing to subunit 
association of MAT (Markham et al., 1988; Corrales et al., 1990; Pajares et al., 1991). 
Furthermore, rlMAT has been shown to be S-nitrosylated specifically via Cys121, which is 
located on the gate loop above the active site, resulting in an inhibition of this enzyme (Avila 
et al., 1997). Likewise, the respective loop of PfalMAT contains a cysteine residue (Cys113), 
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which might be regulated in a similar way. Previous experiments of our group demonstrated 
that PfalMAT undergoes redox-based thiol modifications, pointing towards a redox-dependent 
regulation of PfalMAT. In pull-down experiments, using affinity purification and mass-
spectrometric identification of captured proteins from P. falciparum cell lysate, PfalMAT was 
identified as a target protein of PfTrx1, PfGrx, and PfPlrx, by using active site mutants of 
these thiol disulfide reductases lacking the resolving cysteine, resulting in the formation of 
stable, mixed disulfides with target proteins (Sturm et al., 2009). In similar approaches 
PfalMAT was identified as a protein that is S-glutathionylated and S-nitrosylated by blocking 
free thiols of proteins within the parasite cell lysate using NEM or MMTS. Blocked S-
glutathionylated proteins were reduced by recombinant PfGrx, and S-nitrosothiols were 
specifically reduced with sodium ascorbate. The reduced proteins were subsequently 
biotinylated and purified via avidin affinity chromatography (Kehr et al., 2011; Wang et al., 
2014).  
Redox regulation of PfalMAT, might have downstream effects on crucial cellular SAM-
dependent pathways of P. falciparum such as polyamine metabolism and DNA-/histone-
methylation reactions. One aim of this dissertation was to characterize in detail the interplay 
of PfalMAT with the plasmodial thiol disulfide reductases PfTrx1, PfGrx, and PfPlrx with 
respect to a potential regulation of the enzymatic activity of PfalMAT. Furthermore, the 
impact of the post-translational modifications S-glutathionylation and S-nitrosylation, two 
potential cysteine protective mechanisms under oxidative stress, on activity and 
oligomerization of PfalMAT should be addressed. Mutational studies of selected cysteine 
residues should be performed in order to identify the sites of these redox-based thiol 
modifications. 
1.4 MscDyP1: a novel dye-decolorizing peroxidase 
Heme proteins comprise a huge number of diverse proteins that play a crucial role in redox 
chemistry and multiple biochemical pathways (Singh et al., 2015). Among them, heme 
peroxidases (EC 1.11.1.7) were originally classified into two superfamilies, the plant and 
animal peroxidases, but are nowadays subdivided into six superfamilies: catalases, non-
animal peroxidases, animal peroxidases, haloperoxidases, di-heme cytochrom-c-peroxidases, 
and DyP-type peroxidases (Fawal et al., 2013; PeroxiBase, 2015).  
1.4.1 DyP-type peroxidases 
Dye-decolorizing peroxidases (DyP-type peroxidases, DyP, DypPrxs, EC 1.11.1.19) represent 
a novel superfamily of heme peroxidases (Sugano, 2009). DypPrxs differ from other known 
peroxidases in their tertiary structure, catalytic residue, and pH optimum; they lack homology 
to other peroxidases; and they possess a particularly wide substrate specificity (Zubieta et al., 
2007; Yoshida et al., 2015). The first and eponymous member of this enzyme family [DyP 
from Thanatephorus cucumeris, formerly Geotrichum candidum Dec 1, and nowadays 
Bjerkandera adusta DyP (BadDyP), due to reclassification of the strain (Ruiz-Duenas et al., 
2011)] was discovered in 1999 (Kim et al., 1999) and later named based on its ability to 
efficiently oxidize and thereby decolorize various dyes (Sato et al., 2004). According to the 
PeroxiBase database, DypPrxs were phylogenetically subdivided into four classes based on 
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their structural similarities, with classes A, B, and C comprising mostly members of bacterial 
origin and class D containing fungal DypPrx (Fawal et al., 2013; PeroxiBase, 2015). 
However, a reclassification of the DypPrx family was recently proposed, based on structure-
based sequence alignments, in response to the phenomenal number of novel members 
identified in recent years (Yoshida et al., 2015), currently 5,723 members (Interpro, 2015; 
Mitchell et al., 2015). Among those, are three DypPrxs of viral, 31of archaeal, 440 of 
eukaryotic, and more than 5,200 of bacterial origin. This is interesting since the first identified 
members of this family were fungal proteins and therefore DypPrxs were originally suggested 
to be restricted to basidiomycetous fungi. The new DypPrx classes comprise class I 
(“intermediate,” formerly class A), class P (“primitive,” formerly class B), and class V 
(“advanced,” formerly classes C and D) (Yoshida et al., 2015). Members of class P possess a 
short amino acid sequence, and more compact structure compared to classes I and V. Classes I 
and V contain extra sequences, I less than V, resulting in more complex structures than those 
of class P, as shown in Figure 4 (Yoshida et al., 2015).  
 
Figure 4: DyPrx classes 
Structural superposition of members of the DypPrx classes P (2iiz, 3qns, 4gu7), I (PDB IDs: 4gs1, 4gt2, 3o72, 
4grc) and V (PDB IDs: 4g2c, 4au9, 3afv). The UCSF Chimera program was used for superpositioning chain A 
of each structure using the Needleman-Wunsch algorithm and the BLOSUM 55 matrix. This figure was 
modified from (Yoshida et al., 2015). 
2.3.1.1 Structure of DypPrxs 
Although this relatively young enzyme family currently comprises more than 5,000 members, 
the number of published protein crystal structures available in the PDB database is limited, 
and they are derived from only nine different DypPrx enzymes (Berman et al., 2000; PDB, 
2015). Among them, BadDyP and AauDyP (Auricularia auricula-judae DyPrx) are the best 
studied. The overall fold of DypPrxs contains an α/β-ferredoxin-like fold. Members of the 
DypPrx family possess a conserved GXXDG motif, which contains the catalytic aspartic acid. 
Furthermore, DypPrxs contain a conserved heme-binding pocket, with an architecture similar 
to that found in other heme peroxidases. A histidine represents the classic proximal fifth 
ligand of the heme iron. Interestingly, instead of the distal histidine, which contributes to 
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heme binding in classic heme peroxidases, in DypPrxs an asparagine and arginine residue 
assume this function. The conserved H2O2 binding pocket at the distal site of the heme 
cofactor is composed of the aforementioned Asp and Arg and furthermore contains leucine 
and phenylalanine residues. The prosthetic heme cofactor, a penta-coordinated 
ferriprotoporphyrin IX group, is buried within the protein but accessible through a narrowing 
channel leading to the heme plane (Strittmatter et al., 2015).  
2.3.1.2 Catalytic mechanism and substrate specificity of DypPrxs 
“Peroxidases have more functions than a Swiss army knife.” (Passardi et al., 2005)  
This is particularly true for DypPrxs (Figure 5).  
 
Figure 5: Substrate versatility of DypPrxs 
a) Sulfoxidation of aromatic sulfides. b) Oxidative cleavage of azobenzenes. c) β-carotene oxidation to β-ionone 
and β-apo-10’-carotenal. d) Oxidation and thereby degradation of anthraquinone dyes to phthalic acid, 
aminobenzene derivatives and azobenzenes. e) Phenol oxidation to quinone. f) Oxidation of non-phenolic 
aromatics, e.g. veratryl alcohol to veratraldehyde. This figure was created using ChemDraw 15.0, modified from 
(Hofrichter et al., 2010).  
They are capable of oxidizing typical peroxidase substrates, e.g. 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid (ABTS) and 2,6-dimethoxyphenol, but also recalcitrant 
anthraquinone dyes, e.g. Reactive Blue 5 (Sugano et al., 2000). Furthermore, DypPrxs are 
active at a lower pH range (pH~1-4.5) than plant peroxidases (Zubieta et al., 2007; Liers et 
al., 2013). Some DypPrxs share functional properties with lignin peroxidases and oxidize 
high-redox-potential non-phenolic methoxylated aromatics, e.g. veratryl alcohol and non-
phenolic β-O-4 lignin model dimers (Liers et al., 2010), although to a lesser extent than lignin 
peroxidases (Liers et al., 2013). AauDyP has been shown to oxidize ortho-, meta-, and para-
nitrophenols (Buttner et al., 2015). A redox potential ranging from 1.1 to 1.2 V was 
determined for fungal DypPrx, including AauDyP, Mycetinis scorodonius DypPrx 
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(MscDyP1), Exidia glandulosa DypPrx (EglDyP), and Mycena epipterygia DypPrx 
(MepDyP), using a phenol oxidation method (Liers, 2014). This redox potential is slightly 
lower than that of high-redox potential lignin peroxidases (1.26 V) but higher than that of 
low-redox potential plant (0.93 V for soybean peroxidase, SBP) and fungal (1.06 V for 
Coprinopsis cinerea peroxidase, CiP) peroxidases (Liers, 2014). 
This exceptionally broad substrate specificity distinguishes DypPrxs from classic plant or 
animal peroxidases and makes them highly interesting for biotechnological applications. 
The catalytic cycle of heme peroxidases consists of a three-step reaction, initiated by a two-
electron transfer from heme protein (PorFeIII) to H2O2, resulting in the formation of 
compound I (equation 1), a higher oxidation state of the enzyme containing an oxoferryl 
center, and an organic π-cation radical (˙+PorFeIV=O). Upon substrate oxidation, compound I 
is subsequently reduced by two one-electron reductions via formation of compound II 
(PorFeIV=O) (equation 2) back to the native resting iron (III) state of the enzyme (equation 3) 
(Banci, 1997; Liers, 2014): 
(1) PorFeIII + H2O2 → ˙+PorFeIV=O + H2O 
(2) ˙+PorFeIV=O + AH2 → PorFeIV=O + AH˙ 
(3) PorFeIV=O + AH2 → PorFeIII + AH˙ + H2O. 
As mentioned before, classic heme peroxidases contain a proximal histidine as an axial heme 
ligand, contributing to heme stabilization, and a distal histidine presenting the acid-base 
catalytic residue necessary for compound I formation (Yoshida et al., 2011) (Figure 6). 
 
Figure 6: Compound I formation by classic heme peroxidases 
Upon reaction of the resting state enzyme with H2O2, electrons are transferred from the heme molecule to the 
substrate H2O2, resulting in compound I formation, a higher oxidation state of the heme molecule characterized 
by the porphyrin ring cation radical (●+). The heme plane is indicated as lines enclosing an iron atom. The acid-
base catalytic histidine is indicated via its imidazole group. This figure was created using ChemDraw 15.0 
according to (Yoshida et al., 2011). 
An important difference between DypPrxs and other heme peroxidases is that DypPrxs lack 
the catalytic histidine that participates in compound I formation in classic heme peroxidases. 
Instead, an aspartic acid replaces the catalytic function of this distal histidine (Sugano et al., 
2007). In detail, the catalytic reaction of DypPrxs requires a swinging movement of this Asp 
towards the heme plane after the enzyme reacts with H2O2 to form compound I (Yoshida et 
al., 2011) (Figure 7). 
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Figure 7: Compound I formation by DypPrxs 
Compound I formation in the catalytic reaction of DypPrxs requires a swinging movement of the oxygen OD2 of 
the catalytic aspartic acid towards the heme plane in order to react with H2O2, followed by electron transfer from 
the heme molecule to H2O2 resulting in compound I formation, a higher oxidation state of the heme molecule 
characterized by the porphyrin ring cation radical (●+). The heme plane is indicated as lines enclosing an iron 
atom. This figure was created using ChemDraw 15.0, modified from (Yoshida et al., 2011). 
The exact physiological role of DypPrxs is still unclear. They could possess a biocatalytic 
function in lignin oxidation, due to the secretion of class V (former class D) DypPrxs from 
Basidiomycota and their lignin-degrading activity (Yoshida et al., 2015). They might play a 
role for the fungal detoxification of toxic aromatic compounds (Liers et al., 2013). 
Furthermore, it has been suggested that DypPrxs could have a protective function under 
oxidative stress since transcription of a putative DypPrx (VNG0798H) of Halobacterium 
salinarum is induced in response to H2O2 and paraquat (forms radicals after electron 
acceptance) treatment (Kaur et al., 2010). Besides, DypPrxs provide interesting 
biotechnological applications in litter composition, transformation of plant biomass, or the 
production of aroma compounds (Zorn et al., 2003; Zelena et al., 2009). 
1.4.2 Mycetinis scorodonius DyP-type peroxidase 1 
Mycetinis scorodonius (CBS strain number: 137.83; formerly Marasmius scorodonius), the 
edible garlic mushroom, grows on wood and manure (Ainsworth, 1973) and is used as a spice 
in human nutrition due to its intense garlic-like flavor. In a screening of 50 filamentous fungi, 
the cleavage of β-carotene in submerged cultures of M. scorondonius was observed (Zelena et 
al., 2009). Moreover, the volatile flavor compounds β-ionone, dihydroactinidiolide, 
cyclocitral, and 2-hydroxy-2,6,6-trimethyl-cyclohexanone were formed within mycelium-free 
culture supernatant, indicating activity of secreted extracellular enzymes (Zelena et al., 2009) 
later identified as MscDyP1 and 2 (Scheibner et al., 2008). MscDyP1 has been characterized 
biochemically in previous studies by Zorn and colleagues (Zorn et al., 2003; Scheibner et al., 
2008; Puhse et al., 2009; Zelena et al., 2009). MscDyP1 is a striking example of the 
exceptional substrate versatility of DypPrxs. Besides the aforementioned ability to degrade 
carotenoids, MscDyP1 also oxidizes phenolic and nonphenolic substrates, including lignin, as 
shown using the β-O-4 lignin model dimer, adlerol, 2,6-dimethoxyphenol, 1,3,5-
trimethoxybenzene, the anthraquinone dye Reactive Blue 5, the azo dye Reactive Black 5, and 
veratryl alcohol, although it oxidizes the two latter ones to a lower extent (Liers et al., 2013). 
Using a phenol oxidation method, a redox potential of 1.2 ± 0.1 V was estimated for 
MscDyP1, indicating it belongs to high-redox potential peroxidases (Liers, 2014).  
The oxidative degradation of carotenoids by MscDyP1 could have interesting 
biotechnological applications in the food industry, especially in dairy. In order to maintain a 
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constant standardized coloring of cheese independent from seasonal variations, e.g. in the 
production of cheddar, the colorant annatto is added. A part of annatto remains in the whey, 
which is therefore often bleached for further applications. MscDyP1 was patented for 
enzymatic whey whitening (MaxiBright®, DSM Food Specialties, Delft, the Netherlands) by 
Zorn et al. (US 2011/0262974 A1), is regarded as generally safe by food and drug 
administrations and is approved for industrially bleaching of whey (Kang et al., 2010). 
Enzymatic whey bleaching has advantages over older approved bleaching methods using 
hydrogen peroxide and benzoyl peroxide since the reaction is more specific than the chemical 
bleaching and reduces off-flavors (Kang et al., 2010). MaxiBright® also requires the addition 
of hydrogen peroxide, but as a substrate of MscDyP1 it is consumed, and therefore adding a 
catalase is not required (Kang et al., 2010). Furthermore, MscDyP1 has promising potential 
for the biotechnological, cost-effective, large-scale production of carotenoid-derived volatile 
aroma compounds, including β-ionone and β-cyclocitral, whose extraction from natural 
sources that contain only trace amounts is expensive and tedious (Zorn et al., 2003).  
The crystal structure of this highly interesting DypPrx with broad promising biotechnological 
potential was recently solved in our group, and it revealed interesting structural features that 
might contribute to catalysis and redox regulation of MscDyP1. In fact, a single cysteine 
residue is conserved among MscDyP1, BadDyP, and AauDyP, but had not yet been 
investigated. The conservation suggests this residue has an important function in DypPrxs. 
Moreover, this cysteine residue is accessible to small redox-active molecules and might 
therefore be redox regulated. Furthermore, the structure of MscDyP1 revealed the surface 
exposition of two methionine residues, Met302 and Met305, which are solely present in 
MscDyP1, appears to play an important structural role and might contribute to enzymatic 
activity.  
Due to the limited number of available DypPrx structures, the exact catalytic mechanism is 
still under debate. Therefore, elucidation of the function of these residues via mutational and 
kinetic studies within the scope of this dissertation might provide additional clues to the 
mechanism of action of this versatile peroxidase. 
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2 MATERIALS 
2.1 Instruments 
Instrument Company 
Autoclave Webeco, Bad Schwartau 
Autoclave VX-95 Systec, Wettenberg 
Äkta FPLC system (Pump P-920, monitor UPC-
900, injection valve INV-907, mixer M-925, 
Fraction collector Frac-900, column XK16/60, 
column material Superdex 200 prep grade) 
GE Healthcare, Freiburg 
Centrifuge Megafuge 1.0 R Heraus Instruments, Hanau 
Centrifuge MiniSpin Eppendorf 
Centrifuge Salvant SpeedVac SPD111V with Gel 
Pump GP110 
Thermo Life Sciences 
Centrifuge Sorvall RC5Plus (rotor SS-34 and 
SLA-3000) 
Kendro Laboratory Products, 
Langenselbold 
Centrifuge Sorvall RC 6+ (rotor SS-34 and F9S-
4x1000y) 
Thermo Scientific 
Centrifuge 5415R Eppendorf 
Cooling coil IKA RV 10 basic IKA Werke, Staufen 
Crystallization robot Honeybee 961 Digilab Marlborough 
Crystallization robot mosquito Crystal TTP Labtech, Melbourne 
Electrophoresis Chamber Mini-PROTEAN 3 cell BioRad 
Electrophoresis Chamber B1, B1A, B2 Owl Separation System Inc., 
Portsmouth, USA 
Electrophoresis Power Supply-EPS 200 Pharmacia Biotec, Dübendorf 
Switzerland 
Electroporator GenePulse Xcell BioRad 
GelDoc 2000 BioRad 
Heating block neoBlock II neoLab, Heidelberg 
Heating block Thermomixer comfort Eppendorf, Hamburg 
High-purity water system OPTILAB-Plus MembraPure, Bodenheim 
Icemaker F80C Icematic Deutschland, Meerbusch 
Incubation shaker mytron Thermo Scientific, Dreieich 
Incubation shaker KS 500 Junke & Kunkel, IKA-Werke, Staufen 
Incubation shaker SM25 Edmund Bühler GmbH, Tübingen 
Magnetic stirrer CAT M15 MAGV Laborbedarf, Rabenau-Londorf 
Magnetic stirrer color squid IKA Werke 
Magnetic stirrer HI 300N Hanna Instruments, Kehl am Rhein 
Magnetic stirrer RCTbasic IKA Werke 
Microscope Leica KL 1500 LED Leica Microsystems, Wetzlar 
Refrigerated circulator, Minichiller Huber, Offenburg 
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Multichannel pipette Discovery 1-10 µL HTL Lab Solutions, Warsaw 
Multichannel pipette Discovery 20-200 µL HTL Lab Solutions, Warsaw 
Multichannel pipette Transferpette 2-20 µL Brand GmbH, Wertheim 
OptimaTM TLX Ultracentrifuge Beckmann, Munich 
PCR cycler Mastercycler Eppendorf 
PCR cycler Mastercycler gradient Eppendorf 
pH meter model Ф 350 pH/Temp/mV Meter Beckman 
Pipette Eppendorf Research Eppendorf 
Pipette Gilson Pipetman P10, P20, P100, P200, 
P1000 
Gilson, Middleton 
Pipetting robot Lissy Zinsser Analytic, Frankfurt 
Precision scale ABT 120-5 DM Kern & Sohn, Balingen 
Precision scale AJ100 Mettler-Toledo, Giessen 
Precision scale SBC 22 Scaltec Instruments, Göttingen 
Scale 474-32 Kern & Sohn 
Scale Bosch PE626 Bosch & Sohn, Jungingen 
Shaker Heidolph Unimax 2010 MAGV GmbH 
Spectrophotometer BioPhotometer  Eppendorf, Hamburg 
Spectrophotometer Genesys 10 UV scanning Thermo Scientific 
Spectrophotometer NanoDrop ND-1000 Thermo Scientific 
Spectrophotometer U-2001 Hitachi, Schwäbisch Gmünd 
Stereomicroscope M165 C Leica Mikrosysteme, Wetzlar 
Stereomicroscope SMZ1000 Nikon GmbH, Düsseldorf 
Tecan infinite M 200 multiplate reader Tecan, Männedorf, Switzerland 
Ultrasound device (GM 2070; UW 2070; SH 
706; MS 73) 
Bandelin Electronic, Berlin 
Ultrasound waterbath Sonorex RK100 Bandelin Eletronic 
UV/VIS-Spectrophotometer Beckman DU® 650 Thermo Scientific, Dreieich 
Vacuum pump Vacubrand CVC 3000 VWR 
Vortex mixer MS2 Minishaker IKA Werke 
Water bath IKA HB 10 basic IKA Werke 
Western blot Trans-Blot SD semi-dry transfer 
cell 
BioRad 
X-ray cassette IEE 60406 Rego X-Ray GmbH, Augsburg 
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2.2 Chemicals 
Chemical Company 
ABTS (2,2’-Azino-di-(3-ethylbenzthiazoline-6-
sulfonic acid) 
Sigma 
Acetic acid Roth 
Acrylamide/Bisacrylamide (Rotiphorese Gel 30 
(37.5:1)) 
Roth, Karlsruhe 
S-Adenosylmethionine chloride Sigma 
Agar-agar Roth 
Agarose (peqGold Universal Agarose) Roth 
5-Amino-2,3,-Dihydro-1,4,-Phthalazinedione 
(Luminol) 
Sigma, Steinheim 
6-Aminohexanoic acid Merck, Hohenbrunn 
Δ-Aminolevulinic acid Sigma 
Ammonium molybdate tetrahydrate Sigma 
Ammonium persulfate (APS) Roth 
L-Ascorbic acid Sigma 
ATP (Adenosine triphosphate) Boehringer, Mannheim 
Bradford reagent (BioRad Protein Assay) BioRad 
Bromophenol blue Sigma 
Bovine serum albumin (BSA) Roth 
Calcium chloride Roth 
Carbenicillin Roth 
β-carotene Sigma 
CHAPS (3-[(3-
Cholamidopropyl)dimethylammonio]-1-
propanesulfonate) 
Roth 
Citric acid Sigma 
Coomassie Brilliant Blue R250 Sigma 
Cumaric acid Sigma 
Cystatin Sigma 
DMSO (Dimethyl sulfoxide) Roth 
DNaseI Roth 
DTNB (5,5’-dithiobis-2-nitrobenzoic acid), 
Ellman’s reagent 
Roth 
DTT (Dithiotreitol) Roth 
EDTA•2Na•2H2O (Ethylenediaminetetraacetic 
acid) 
Roche, Mannheim 
Ethanol Roth 
Ethidium bromide Roth 
Glycerol Roth 
GSH (glutathione) Sigma 
GSSG (glutathione disulfide) Roche 
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HCl (fuming, 37%) Roth 
HEPES (2-(4-(2-Hydroxyethyl)- 1-piperazine)-
ethanesulfonic acid) 
Roth 
Hydrogen peroxide Roth 
Iodoacetamine (IAA) Sigma 
Imidazole Roth 
IPTG (Isopropyl-β-D-1-thiogalactopyranoside) Roth 
Isopropanol Roth 
Kanamycin sulfate Roth 
Magnesium chloride Sigma 
2-Mercaptoethanol Sigma 
MES (2-(N-Morpholino)-ethanesulfonic acid) Roth 
Methanol Roth 
L-Methionine Serva Feinbiochimica, Heidelberg 
S-methyl methanethiosulfonate (MMTS) Sigma 
Milk powder Roth 
MPD (2-methyl-2, 4-pentanediol) Roth 
Nicotinamide adenine dinucleotide phosphate, 
reduced, NADPH 
Biomol 
Ni-NTA agarose (nickel nitrilotriacetic acid) Invitrogen, Karlsruhe 
PEG (Polyethylene glycol) Sigma 
Pepstatin A Sigma 
PMSF (Phenylmethanesulfonylfluoride) Roth 
Polyethylene glycol 550 Sigma 
Ponceau S Sigma 
Potassium chloride Roth 
Potassium dihydrogen phosphate Roth 
Di-potassium hydrogen orthophosphate Roth 
Potassium hydroxide Roth 
Rhamnose Becton Dickinson, Heidelberg 
Rubidium chloride Roth 
Select Agar® Invitrogen 
Sodium acetate Roth 
Sodium chloride, NaCl Roth 
Sodium citrate Sigma 
Sodium dodecyl sulfate (SDS) Sigma 
Sodium hydroxide, NaOH Roth 
TAPS (N-tris(Hydroxymethyl)methyl-3-
aminopropanesulfonic acid sodium-potassium 
salt) 
Sigma 
TEMED (N, N, N’, N’-
tetramethylethylenediamine) 
Sigma 
TRIS (Tris-(hydroxymethyl)-aminomethane) Roth 
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Triton X-100 Sigma 
Tryptone/Peptone Roth 
TWEEN 20 (Polyethylene glycol sorbitan 
monolaurate) 
Sigma 
Yeast extract Oxoid LTD, Basingstdoke Hampshire 
Zinc sulfate heptahydrate Sigma 
2.3 Consumables 
Consumables Company 
Cannula 0.7 x 50 mm Unimed, Lausanne 
Centriprep YM-30 Millipore, Eschborn 
Cover slips, round 21 mm Ø Menzel, Brunswick 
Crystallization plate 24 well, VDX plate Hampton Research, Aliso Viejo, 
California, USA 
Cuvettes, polystyrol Sarstedt, Numbrecht 
Cuvettes, micro, UV Brand 
Semi-micro cuvettes 10x4x45 mm, polystyrol Sarstedt 
HRP (horseradish peroxidase) anti-mouse 
antibody 
Thermo Scientific 
DNA ladder GeneRuler 1 kb Thermo Scientific 
DNA dye NonTox Applichem GmbH, Darmstadt 
Electroporation cuvette Gene Pulser 0.2 cm Bio-Rad Laboratories, Munich 
FalconTM tube 15 mL, 50 mL Greiner Bio-One, Frickenhausen 
High performance chemiluminescence film 
Amersham hyperfilmTMECL 
GE Healthcare, Freiburg 
Glass capillaries 5 µL Brand GmbH, Wertheim 
Membrane filter ME 25, 0.45 µM Whatman GmbH, Dassel 
Micro pipettes Brand, Wertheim 
Microplate 96 well, PP, V-bottom, transparent Greiner Bio-One 
Microplate 96 well, PP, half area, flat bottom, 
clear 
Greiner Bio-One 
Microscope lens paper Glaswarenfabrik Karl Hecht, Sondheim 
Mouse anti-His antibody Dianova, Hamburg 
Multiply PCR tube 0.2 Ml Sarstedt 
NAPTM-5 Column SephadexTM G-25 DNA 
Grade 
GE Healthcare 
Parafilm ’M’ laboratory film Pechiney Plastic Packaging, Menasha 
USA 
Pasteur pipette 150 mm Hirschmann Laborgeräte, Eberstadt 
Peleus ball Deutsch & Neumann, Berlin 
Petri dish, 15 cm Ø Sarstedt, Nümbrecht 
Pipette tips and tubes, disposable Eppendorf 
Pipette tips Omnitip FastRack 10 µL, 200 µL Ulplast, Warsaw 
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Protein ladder unstained protein MW marker Fermentas 
Protein ladder pre-stained MW marker Fermentas 
PVDF membrane Roth, Karlsruhe 
Serological pipette 5, 10, 25 mL Greiner Bio-One 
Silicone oil 550 Merck, Darmstadt 
Sterile filters 0.2 μm FP030 Schleicher & Schull, Kassel 
Syringe 1 mL Plastipak Becton Dickson, Madrid 
Syringe 10 mL B. Braun, Melsungen 
24 wells 1,7x1,6 cm MP Biochemicals Inc., U.S.A 
Vivaspin 20, 3,000 MWCO, 10,000 MWCO and 
30,000 MWCO 
Sartorium Stedim Biotech, Göttigen 
ZebaTM Desalt Spin Columns Thermo scientific, Rockford, USA 
2.3.1 Electrophoresis marker 
Ladder Company 
GeneRuler 1 kb DNA ladder Fermentas, St. Leon-Rot 
6x Loading dye solution Fermentas, St. Leon-Rot 
PageRulerTM prestained protein ladder Fermentas, St. Leon-Rot 
SpectraTM multicolor broad range protein ladder Fermentas, St. Leon-Rot 
Protein molecular weight marker Fermentas, St. Leon-Rot 
2.3.2 Kits 
2.4 Buffers and Solutions 
2.4.1 Stock solutions 
Stock solution Composition 
APS 10% (w/v) in ddH2O, storage at –20 °C 
Carbenicillin 50 mg*mL-1 in 50% (v/v) EtOH, storage at –20 °C 
Chloramphenicol 35 mg*mL-1, 100% EtOH, storage at -20 °C 
Cystatin 40 μM in US buffer, storage at –20 °C 
DTT 200 mM in ddH2O, storage at –20 °C 
IPTG 1 M in ddH2O, sterile filtration 0.2 µm, storage at –20 °C 
Kanamycin 25 mg*mL-1 in ddH2O, sterile filtration 0.2 µm, storage at –20 °C 
Pepstatin 0.3 mg*mL-1 in US buffer, storage at –20 °C 
PMSF 100 mM in DMSO, storage at 23 °C 
  
Kit Company 
Bradford assay kit Bio-Rad, Munich 
QIAprep spin miniprep kit Qiagen, Hilden 
QIAquick PCR purification kit Qiagen, Hilden 
Silver staining kit Pierce, Rockford 
Material 
27 
 
2.4.2 Buffer for molecular biology 
Buffer Composition 
DNA sample buffer 6x 0.1% bromophenol blue 
60% saccharose 
1 mM Tris  
pH 8.3, HCl adjusted 
TBE buffer 5x  89 mM Tris 
89 mM boric acid 
2 mM EDTA 
pH 8.3, HCl adjusted 
TFB1 buffer for chemocompetence 100 mM rubidium chloride 
30 mM manganese chloride 
30 mM potassium acetate 
10 mM calcium chloride 
15% glycerol 
pH adjusted to 5.8 with HCl, sterile filtered 
TFB2 buffer for chemocompetence 10 mM MOPS 
10 mM rubidium chloride 
75 mM calcium chloride 
pH 8.0 adjusted with KOH, steril filtered 
2.4.3 Buffer for Ni-NTA-affinity chromatography 
Buffer Composition 
Elution buffer (E. coli) rMscDyP1 50 mM Tris 
300 mM NaCl, pH 8.0 
with 20 mM 
200 mM or 500 mM imidazole 
Elution buffer PfalMAT 50 mM Tris 
300 mM NaCl, pH 8.0 
with 50 mM, 100 mM or 500 mM imidazole 
Elution buffer hMAT1a 50 mM Tris 
300 mM NaCl, pH 8.0 
with 50 mM, 200 mM or 500 mM imidazole 
Tris buffer 300 mM NaCl 
50 mM Tris, pH 8.0 
US buffer 50 mM Na2HPO4, pH 8.0 
300 mM NaCl 
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2.4.4 Buffer for electrophoresis 
Buffer Composition 
Stacking gel buffer 0.5 M Tris, pH 6.8 
Separating gel buffer 1.5 M Tris, pH 8.8 
SDS chamber buffer 192 mM glycine 
25 mM Tris-HCl, pH 8.3 
0.1% (w/v) SDS 
SDS sample buffer 1x 12.5 mL stacking gel buffer 
25 mL glycerin  
20 mL 10% (w/v) SDS 
2 mL 0.5% (w/v) bromophenol blue 
35 mL H2O 
storage at room temperature  
before usage 5% (v/v) 2-ME added 
SDS sample buffer 4x 3 mL stacking gel buffer 
300 mg DTT 
400 mg SDS 
2 mL glycerin 
tip of a spatula bromphenol blue 
Coomassie staining 0.2% (w/v) Coomassie Brilliant Blue R250 
40% (v/v) 2-propanol 
10% (v/v) acetic acid 
Coomassie destaining 7% (v/v) acetic acid 
5% (v/v) ethanol 
2.4.5 Buffer for semi-dry Western blot 
Buffer Composition 
Anode buffer I 300 mM Tris 
Anode buffer II 25 mM Tris 
Cathode buffer 40 mM 6-Aminohexanoic acid 
TBS 10 mM Tris 
55 mM NaCl, pH 7.4, adjusted with HCl (aq) 
TBST 10 mM Tris 
155 mM NaCl 
0.05% (v/v) TWEEN 20, pH 7.4 
Ponceau S staining 1% (w/v) Ponceau S 
5% (v/v) acetic acid 
Ponceau S destaining 1% (v/v) acetic acid 
Luminol 1.25 mM luminol 
0.0093% (v/v) H2O2 
0.1 M Tris-HCl, pH 8.6 
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2.4.6 SDS gels 
Gel Composition 
15% separating gel (4 gels) 3.6 mL ddH2O 
3.75 mL separating gel buffer 
7.5 mL acrylamide/bisacrylamid (30% (v/v)) 
0.15 mL SDS (10% (w/v)) 
75 μl APS (10%) 
7.5 μl TEMED 
12% separating gel (4 gels) 5.1 mL ddH2O 
3.75 mL separating gel buffer 
6 mL acrylamide/bisacrylamid (30% (v/v)) 
0.15 mL SDS (10%) 
75 μL APS (10%) 
7.5 μL TEMED 
4% stacking gel (4 gels) 3.05 mL ddH2O 
1.25 mL stacking gel buffer 
0.65 mL acrylamide/bisacrylamid (30% (v/v)) 
0.05 mL SDS (10%) 
25 μL APS (10%) 
5 μL TEMED 
2.4.7 Assay buffer and solutions 
Assay solution Composition 
Ammonium molybdate assay 
Ascorbic acid solution 12% (w/v) ascorbic acid in 12 N HCl 
Ammonium molybdate solution 2% (w/v) ammonium molybdate tetrahydrate 
in ddH2O 
Stop solution 3% (w/v) sodium citrate tribasic dehydrate, 
2% (w/v) sodium acetate in ddH2O 
Assay buffer 100 mM TAPS pH 8.4, 
100 mM KCl, 
20 mM MgCl2 in ddH2O 
ABTS assay 
Assay buffer 25 mM sodium acetate pH 3.5 
ABTS 2 mM in 25 mM sodium acetate pH 3.5 
H2O2 1 mM in 25 mM sodium acetate 
Carotene assay 
Assay buffer 50 mM sodium acetate pH 3.5 
β-carotene solution app. 0.18 mM in ddH2O 
H2O2 0.5 mM in ddH2O 
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2.4.8 Medium for bacterial cell culture 
Medium Composition 
Lysogeny broth (LB) 10 g*L-1 NaCl 
10 g*L-1 tryptone 
5 g*L-1 yeast extract 
Terrific Broth (TB) 12 g*L-1 tryptone 
24 g*L-1 yeast extract 
4 mL glycerol 
2.2 g*L-1 KH2PO4 
9.4 g*L-1 K2HPO4 
2xYT 5 g*L-1 NaCl 
16 g*L-1 tryptone 
10 g*L-1 yeast extract 
The medium was autoclaved for 30 minutes at 120 °C in 1 L Erlenmeyer flasks for protein 
expression or in 50 mL Erlenmeyer flasks and 1 mL culture tubes for overnight precultures. 
2.5 Enzymes 
2.5.1 Restriction enzymes 
Enzyme Company Restriction site 
NcoI Thermo Scientific 5’...C^CATGG...3’ 
XhoI Thermo Scientific 5’...C^TCGAG...3’ 
NdeI Thermo Scientific 5’...CA^TATG...3’ 
DpnI Thermo Scientific 5’...GA-CH3^TC...3’ 
EcoRI Thermo Scientific 5’...G^AATTC...3’ 
PstI Thermo Scientific 5’…CTGCA^G...3’ 
PaeI Thermo Scientific 5’…GCATG^C...3’ 
2.5.2 Enzymes for molecular biology 
Enzyme Company 
Pfu DNA polymerase 
RedTaq® polymerase 
Promega, Mannheim 
Sigma 
T4 ligase Fermentas, St. Leon-Rot 
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2.5.3 Recombinant enzymes 
Enzyme Expression system 
PfalMAT pQE30, E.coli M15 cells 
PfalMATC52S pQE30, E.coli M15 cells 
PfalMATC113S pQE30, E.coli M15 cells 
PfalMATC187S pQE30, E.coli M15 cells 
(E. coli) rMscDyP1 pET28 a, E.coli BL21 cells 
(E. coli) rMscDyP1C360G pET28 a, E.coli BL21 cells 
(E. coli) rMscDyP1 M302K, M305K pET28 a, E.coli BL21 cells 
(A. niger) rMscDyP1 MaxiBright®, source: DSM (Delft, The Netherlands) 
2.6 Cloning and expression vectors 
Vector Properties 
pEX K Kanamycin resistance, lac promotor,  
pET28 a(+) Kanamycin resistance, T7 promotor, His-tag coding sequence, T7 
tag coding sequence, lac I coding sequence, T7 terminator 
pQE30 Carbenicillin resistance, T5 promotor, His-tag coding sequence,lac 
operator,  
pG-Tf2 Chloramphenicol resistance, tetracycline resistance, Pzt1 promotor 
2.7 E. coli cells 
Strain Genotype 
XL-1 blue F’::Tn10 proA+B+ lacIq Δ(lacZ)M15/recA1 endA1 gyrA96 (NaIR) 
thi hdgR17 (rK- mK+) glnV44 relA1 lac 
BL21 (DE3) E. coli B F- dcm omp T hsdS(rB- mB-) gal λ(DE3) 
Single step (KRX) 
Competent cells 
[F’, traD36, ΔompP, proA+B+, lacIq, Δ(lacZ)M15] ΔompT, 
endA1, recA1, gyrA96(Nal(r)), thi-1, hsdR17 (r(k)-, m(k)+), e14- 
(McrA-), relA1, supE44, Δ(lac- proAB), Δ(rhaBAD)::T7 RNA 
polymerase 
M15 nalS, StrS, rifS, KmR, lac-, ara-, gal-, mtl-, F-, recA+, uvr+ 
2.8 Protein crystallization screens 
Screen Company 
Crystal screen I Hampton Research, Aliso Viejo, USA 
Crystal screen II Hampton Research, Aliso Viejo, USA 
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2.9 Oligonucleotides 
Oligonucleotide Sequence (5’-3’) 
Primer for PCR amplification of PfalMAT 
N-terminal ACGCGCATGCAGTCAGTTGAAAATTAAAAGAGG 
C-terminal ACGCCTGCAGTTAATTTTTTAATGCATTTTTTTCG 
Sequencing primer (E. coli) rMscDyP1 
OMSPs TCATGAACACTTTGGCTTTATG 
OMSPs1 CAGCGGAACAATAACTTTGAC 
OMSPr TCTCGGCATCAGTAACTTCC 
Primer for site-directed mutagenesis 
PfalMATC52Ss GCAAGGTTGCATGTGAAGTAAGTGCTAAAAAG 
PfalMATC52Sas CTTTTTAGCACTTACTTCACATGCAACCTTGC 
PfalMATC113Ss [Phospho]TGATATAGCTCAAAGTGTACATGAAAATAG 
PfalMATC113Sas [Phospho]CTATTTTCATGTACACTTTGAGCTATATCA 
PfalMATC187Ss [Phospho]GAATAAGGGTAGTAGTGGTGGACATT 
PfalMATC187Sas [Phospho]AATGTCCACCACTACTACCCTTATTC 
OMSPCs GAATCAGACACGCGGCCCTTTTAGTGC 
OMSPCas GCACTAAAAGGGCCGCGTGTCTGATTC 
OMSPMs CCATGCTCTGAACAAGCCGAATAAGACCTCCGAA 
OMSPMas TTCGGAGGTCTTATTCGGCTTCAGAGCATGG 
2.10 Software 
Software Webpage 
GraphPad Prism 6 (http://www.graphpad.com/) 
IBM SPSS Statistics 19  
ChemDraw 15.0 (http://www.cambridgesoft.com) 
UCSF Chimera 1.10.1 (http://www.cgl.ucsf.edu/chimera/) 
MOE 2013 (http://www.chemcomp.com) 
Gold 5.2 (http://www.ccdc.cam.ac.uk) 
Clustal Ω 1.2.1 (http://www.ebi.ac.uk) 
XDS (xds.mpimf-heidelberg.mpg.de) 
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3 METHODS 
3.1 General methods 
3.1.1 Molecular biological methods  
2.3.1.1 Plasmid preparation 
Plasmid DNA was purified with plasmid miniprep kits (Qiagen, Promega) following the 
instructions of the manufacturer. Briefly, after alkaline lysis of a bacterial over-night culture 
of a transformed E. coli strain containing the desired plasmid, neutralization, and 
centrifugation of bacterial chromosomal DNA and proteins, the plasmid DNA in supernatant 
was purified with a silica membrane column.  
2.3.1.2 Determination of DNA concentration 
DNA concentration was determined spectrophotometrically at 260 nm using an Eppendorf 
biophotometer and UV cuvettes or NanoDrop. The purity of DNA was examined using 
absorbance ratios from 260 nm to 280 nm, which should range between 1.6 and 1.8. 
2.3.1.3 Agarose gel electrophoresis 
An agarose gel electrophoresis was performed in order to separate and analyze DNA mixtures 
by size of the DNA fragments. Therefore, a DNA sample, e.g. a PCR product or restriction 
digested plasmid DNA, was mixed with a 6 x loading buffer and applied onto an 0.7-1.0% 
agarose gel (prepared in 1 x TBE buffer). DNA was separated electrophoretically in 1 x TBE 
running buffer for 40 minutes at 100 V. A 1 kb DNA ladder was used to estimate the size of 
the DNA bands. Gels were incubated with 1 µg*mL-1 ethidium bromide, which intercalates in 
the DNA, for 20 minutes, and DNA bands were visualized using UV light (254 nm).  
2.3.1.4 Restriction digest 
In order to subclone genes into desired expression vectors, plasmid DNA was digested using 
two or more restriction enzymes to generate ends compatible to the ends of a desired insertion 
fragment, which was synthesized commercially, with respective restriction enzyme 
recognition sites. Chapter 2.5.1 summarizes restriction enzymes used within this dissertation.  
2.3.1.5 Ligation 
After purification, the desired plasmid and the plasmid containing the target gene were 
digested with the same restriction enzymes and ligated using T4-DNA ligase for one hour at 
23 °C.  
3.1.2 Microbiological methods 
All working steps with E. coli were performed in a clean, sterile environment near a flame 
using autoclaved culture media and autoclaved or ethanol-bathed, flame-sterilized 
instruments.  
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2.3.2.1 Preparation of competent E. coli cells 
Chemo competent E. coli cells were prepared as follows: an aliquot of respective cells from a 
glycerine stock culture stored at –80 °C, was streaked onto an agar plate containing either no 
antibiotic or an antibiotic if the cell exhibited antibiotic resistance, as in the case of M15 cells 
resistant to kanamycin, and incubated overnight at 37 °C. A colony was transferred to 10 mL 
LB medium, either without an antibiotic or with kanamycin in the case of M15 cells and 
grown overnight at 37 °C. This pre-culture was diluted 1:10 with prewarmed LB medium to a 
total volume of 100 mL in a 250 mL Erlenmeyer flask and incubated at 37 °C until an optical 
density at 600 nm (OD600) of 0.7 was reached. The flask was placed on ice for five minutes 
then the culture was centrifuged for five minutes at 3,000 rpm. The supernatant was 
discarded, and the cells were resuspended in 30 mL TFB1 buffer containing 100 mM 
rubidium chloride and 10 mM calcium chloride and incubated on ice for 90 minutes. After 
centrifugation for five minutes at 2,000 rpm the supernatant was discarded and the cells were 
resuspended in TFB2 buffer containing 10 mM rubidium chloride and 75 mM calcium 
chloride. Aliquots of 125 µL were frozen in liquid nitrogen and stored at -80 °C. 
Electrocompetent E. coli cells were purchased from Invitrogen.  
2.3.2.2 Transformation 
Chemically competent E. coli cells were incubated on ice for 30 minutes with the desired 
plasmid DNA containing the gene of interest. After heat shock for 30 seconds at 42 °C, cells 
were allowed to rest for five minutes on ice before incubation at 37 °C in LB medium for one 
hour and streaking it onto an LB agar plate. The plates were incubated at 37 °C overnight and 
then stored at 4 °C until inoculation for heterologous gene overexpression. 
Electrocompetent E. coli cells were transformed with a desired plasmid using 0.2 mm Gene 
Pulser Cuvettes® (Bio-rad) and Gene Pulser Xcell® Electroporation System (Biorad) using the 
pre-set protocol for E. coli cells, which induces an electrical field for 5 ms at ~3000 V, and 
~750 Ω. Immediately after electroporation 1 mL LB medium was added to the cells followed 
by incubation at 37 °C for one hour before streaking it onto an LB agar plate.  
2.3.2.3 Heterologous overexpression in E. coli 
A single colony of transformed E. coli cells was inoculated into 3 mL LB medium containing 
the respective antibiotic and grown at 37 °C for eight hours in a shaking incubator. 50 mL rich 
medium containing antibiotics were inoculated with the 3 mL preculture and were allowed to 
grow overnight at 37 °C. One liter of a rich medium containing the respective antibiotics was 
inoculated with the 50 mL pre-culture and grown until mid or late log phase, controlled via 
measurement of OD600, at room temperature (23 °C) or 37 °C depending on the optimal 
expression conditions, following induction of gene expression with isopropyl-β-D-1-
thiogalactopyranoside (IPTG). After induction, cells were grown for four to 48 hours at 
optimal expression temperature. 
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2.3.2.4 Cell harvest 
E. coli cells were harvested via centrifugation for 15 minutes at 6,800 g and cell pellets were 
resuspended in buffer (50 mM Tris and 300 mM NaCl at pH 8.0) containing 100 µM PMFS, 
150 nM pepstatin and 40 nM cystatin and then stored at -20 °C. 
3.1.3 Protein biochemical methods 
2.3.3.1 Protein purification 
For protein purification, cell pellets were thawed and stirred with 10 µg*mL-1 cell culture 
lysozyme and 2 µg*mL-1 DNaseI on ice for 30 minutes for chemical cell lysis. Afterwards, 
cells were mechanically lysed four times for 20 seconds via ultrasound. Cell debris was 
centrifuged for 30 minutes at 25,279 g.  
Immobilized metal ion affinity chromatography 
PfalMAT and its cysteine mutants as well as (E. coli) rMscDyP1 and its mutants contained an 
N-terminal His6-tag that allowed for the purification of these enzymes from the supernatant 
via Ni-NTA affinity chromatography. Therefore, the supernatant containing the soluble 
fractions after cell disruption was applied onto a 1.5 mL Ni-NTA-column, which was 
previously equilibrated with 50 mM Tris and 300 mM NaCl, pH 8.0. The column was washed 
with ten column volumes of the same buffer in order to remove nonspecifically bound 
proteins, and then the His-tagged protein was eluted with increasing concentrations of 
imidazole (20-500 mM) from the Ni-NTA column.  
Preparative and analytical gel filtration chromatography  
Gel filtration experiments were conducted using native gel filtration by a HiLoad 16/60 
superdex 200 prep grade gel filtration column connected to an ÄKTA/Unicorn FPLC system 
(GE Healthcare). The column was calibrated using a low and high molecular weight standard 
kit (GE Healthcare). Before applying samples, the column was equilibrated with buffer 
(50 mM Tris, 300 mM NaCl, pH 8.0). Eluted fractions of the Ni-NTA affinity chromatography 
containing the protein, identified via SDS PAGE or Western blot, were pooled and 
concentrated using a Vivaspin® 20 with 30,000 MWCO (Sartorius) to a final volume of 1 mL 
and loaded onto the gel filtration column. Proteins were eluted at a flow rate of 1 mL*min-1 in 
a volume of 2 mL and detected spectrophotometrically at 280 nm. Areas under the peak were 
calculated using Unicorn 4.11 software (GE Healthcare). Pure fractions containing the 
respective enzyme were pooled and stored at 4 °C.  
2.3.3.2 Determination of protein concentration 
The protein concentration was determined by measuring the absorbance at 280 nm and using 
the Bradford assay (Bradford, 1976). The standard curve was prepared using 0-20 µg*mL-1 
bovine serum albumin.  
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2.3.3.3 Gel electrophoresis 
Denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed in order to separate proteins based on their molecular weights. SDS denatures and 
coats proteins and gives them a negative charge proportional to their molecular weight; thus 
proteins migrate in an electric field towards the positively charged electrode and are 
fractionated by size (Laemmli, 1970). Therefore, 4 x reducing SDS sample buffer containing 
DTT was added to the protein mixture and samples were boiled for five minutes at 95 °C in 
order to denature the proteins. Under a constant 200 V, proteins migrated through the gel for 
40 minutes. Gels were stained using Coomassie Brilliant Blue R250 in 40% (v/v) 2-propanol 
and 10% (v/v) acetic acid for ten minutes at room temperature (23 °C) after briefly heating 
using a microwave. Afterwards, gels were destained using a mixture of 5% (v/v) ethanol and 
7% (v/v) acetic acid for ten minutes at 23 °C after heating them in a microwave. If a Western 
blot analysis was performed, the gels were not stained but were directly used for blotting. 
2.3.3.4 Protein immunoblotting 
Western blot analysis was used to detect either His-tagged proteins or protein modifications 
including protein-S-glutathionylation or protein-S-nitrosylation using specific antibodies. 
Using semi-dry Western blot, proteins that had been previously separated by size via SDS-
PAGE were electrophoretically transferred to a polyvinylidene fluoride (PVDF) membrane. In 
detail, five filter papers were soaked in cathode buffer, three filters paper were soaked in 
anode buffer I, and two filter papers in anode buffer II for 15 minutes. A PVDF membrane 
was activated via incubation in 100% methanol for one minute and then soaked in anode 
buffer II for a few minutes. The graphite plates of the blot device were saturated with ddH2O. 
The SDS gel was soaked in cathode buffer for a few minutes before packing the blot. The blot 
sandwich was packed into the transfer cassette from cathode to anode with five filter papers 
from cathode buffer, followed by the SDS gel, the PVDF membrane, two filter papers from 
anode buffer II, and three filter papers from anode buffer I. Proteins were transferred from 
SDS gel to PVDF membrane at a constant current of 41 mA and 180 V per gel for 55 minutes. 
After blotting, the PVDF membrane was stained for blotting control with Ponceau S for one 
minute and destained with 1% (v/v) acetic acid until the protein bands appeared. Afterwards, 
the PVDF membrane was washed using TBST solution until all bands disappeared. The 
membrane was blocked with either 5% (w/v) non-fat milk or 5% (w/v) bovine serum albumin, 
depending on the primary antibody, for one hour at room temperature or overnight at 4 °C. 
Afterwards, the membrane was washed three times for five minutes with TBST before 
incubation with the primary antibody, i.e. mouse-anti-His-tag antibody (1:1,000) or mouse-
anti-GSH antibody (1:500), for one hour at room temperature or overnight at 4 °C. After 
incubation with the primary antibody, the membrane was washed three times for five minutes 
with TBST, and then incubated with the secondary antibody, i.e. anti-mouse IgG HRP-
antibody (1:20,000), for one hour at room temperature and then washed three times for five 
minutes with TBST. Since the secondary antibody is coupled to a horseradish peroxidase 
(HRP), antibody-labeled proteins can be visualized by incubating them for one minute with a 
mixture of 10 µL cumaric acid and 1 mL ECL-kit containing luminol, which is oxidized by 
HRP, thereby leading to chemiluminescence that can be detected with an x-ray film.  
Methods 
37 
 
3.2 PfalMAT methods 
3.2.1 Molecular biological methods 
The gene of PfalMAT was previously amplified via PCR from a P. falciparum 3D7 
gametocyte cDNA library by using primers that contained restriction sites for PaeI and PstI 
(Chapter 2.5.1). It was then cloned into the pHSG389 vector and subcloned into pQE30 using 
the respective restriction enzymes. In a master thesis written in parallel to this dissertation the 
gene of a human counterpart of PfalMAT, hMAT1a, was synthesized commercially and 
cloned into the pET28a vector for heterologous overexpression in E. coli KRX cells (Gehr, 
2014). 
3.2.2 Site-directed mutagenesis 
In a master thesis written prior to this dissertation selected cysteine residues Cys113 and 
Cys187 of PfalMAT were mutated to serine via site-directed mutagenesis (Eisenkolb, 2008). 
For this dissertation, site-directed mutagenesis via PCR was used to introduce the C52S 
mutation into the PfalMAT gene (Table 1) by using Pfu polymerase with pQE30 containing 
the PfalMAT gene as a template and oligonucleotide primers (0) containing the mutated 
codon. 
Table 1: Mutagenesis PCR for PfalMATC52S 
Reaction mix  
Template DNA 
Forward primer  
Reverse primer  
dNTP mix 
10x Pfu buffer 
Pfu polymerase  
Sterile H2O 
1 µL (176 ng*µL-1) 
1 µL (100 pmol*µL-1) 
1 µL (100 pmol*µL-1) 
1 µL (10 mM) 
5 µL 
1 µL (3 U*µL-1) 
40 µL 
PCR program 
Denaturation 90 s 94 °C 
Cycles 18 
Denaturation 30 s 94 °C 
Annealing 60 s 60 °C 
Elongation 11 min 68 °C 
Final elongation 13 min 68 °C 
 
The PCR reaction was validated on an agarose gel and purified using the QIAquick PCR 
purification kit. The non-mutated, methylated template plasmid was digested with DpnI. 
Clones containing the correct mutation were confirmed at an in-house sequencing facility.  
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3.2.3 Heterologous overexpression of PfalMAT 
Genes of PfalMAT, PfalMATC52S, PfalMATC113S, and PfalMATC187S were heterologously 
overexpressed in E. coli M15 cells in pQE30, adding an N-terminal His6-tag to the 
recombinant proteins. Cells were grown in 2xYT medium containing 50 µg*mL-1 kanamycin 
and 100 µg*mL-1 carbenicillin at 37 °C until an optical density (OD600) of 0.5. Temperature 
was decreased to 23 °C prior to induction of gene expression with 0.2 mM IPTG at an OD600 
of 0.8 was reached. After induction, cells were grown for 48 hours at 23 °C.  
3.2.4 Ammonium molybdate assay 
The enzymatic activity of PfalMAT, the cysteine mutants, and the human counterpart 
hMAT1a were determined using a spectrophotometric colorimetric endpoint assay, which was 
published to determine glutamine synthetase activity in a microplate format (Gawronski et al., 
2004) and adapted for PfalMAT in my master thesis prior to this dissertation (Pretzel, 2011). 
The basic principle of this assay is the detection of inorganic phosphate with ammonium 
molybdate. PfalMAT catalyzes the formation of SAM from ATP and L-methionine by forming 
tripolyphosphate which is subsequently hydrolyzed to pyrophosphate and orthophosphate. 
The inorganic phosphate reacts with ammonium molybdate and the reducing agent ascorbate 
to form a colored phosphomolybdate complex, which was measured spectrophotometrically at 
655 nm. The assay was performed in 96-well plates and measures in a multiplate reader 
(Tecan infinite M200). Controls lacking the enzyme were subtracted from the absorbance. The 
activity of PfalMAT was determined according to the release of inorganic phosphate using the 
linear function (y = ax + b) of a phosphate standard curve with 0-800 µM K2HPO4: 
Pi [µ𝑀] =
y−b
𝑎
 
The volume activity was calculated taking the 10 minutes incubation time and dilution factor 
(D) into account and then the specific activity corresponding to the enzyme concentration was 
calculated: 
 Volume activity [µmol*min-1*mL-1] = (
µ𝑚𝑜𝑙 𝑃𝑖
1000 𝑚𝐿∗10 𝑚𝑖𝑛
) ∗ 𝐷 
 Specific activity [µmol*min-1*mg-1] = (
µ𝑚𝑜𝑙
𝑚𝑖𝑛∗𝑚𝐿
) ∗ (
𝑚𝐿
𝑚𝑔
) 
Table 2: Ammonium molybdate assay 
Volume Reagent 
25 - x µL  100 mM TAPS, pH 8.4, 100 mM KCl, 20 mM MgCl2 
5 µL 10 mM ATP in ddH2O ad 2 mM 
5 µL 5 mM L-methionine in ddH2O ad 1 mM 
x µL PfalMAT/PfalMATC52S/PfalMATC113S/PfalMATC187S 
10 min, 37 °C 
25 µL 1% (w/v) ammonium molybdate in ddH2O 
50 µL 12% (w/v) L-ascorbic acid in 1 N HCl 
5 min, 23 °C 
75 µL 2% acetic acid, 2% sodium acetate in ddH2O 
15 min, 23 °C 
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3.2.5 Enzyme kinetics 
Steady state kinetic parameters KM and Vmax were determined by varying one of the 
substrates, with the second substrate constantly fixed at assay concentration, plotting the 
reaction velocity against the substrate concentration, and fitting it to the Michaelis-Menten 
equation by using the software GraphPad Prism. For PfalMAT, the respective cysteine 
mutants, and hMAT1a, the KM for ATP was determined in the presence of 10-2,500 µM ATP 
and 1 mM L-methionine, whereas the KM for L-methionine was determined by varying the L-
methionine concentration from 10-2,500 µM while ATP was fixed at the assay concentration 
of 2 mM. Importantly, in order to determine ATP kinetic, a control lacking the enzyme was 
subtracted from the absorption because ATP itself contributes to color formation probably via 
Pi contamination of the reagent.  
3.2.6 Protein-protein interactions 
In order to study the role of the selected cysteine residues Cys52, Cys113, and Cys187 in 
redox regulation of PfalMAT, the interactions of their mutants with the redox-active proteins 
PfTrx1, PfGrx and PfPlrx were determined by using the ammonium molybdate assay and then 
compared to PfalMAT. Therefore, 1-20 µM redoxin was incubated with 1-5 µM PfalMAT or a 
mutant protein.  
3.2.7 Protein-S-glutathionylation 
The effect of protein-S-glutathionylation on the enzymatic activity and oligomerization 
behavior of PfalMAT was studied in detail by using protein immunoblots with an anti-GSH 
antibody, the ammonium molybdate assay, and gel filtration experiments. Therefore, reduced 
PfalMAT or the reduced cysteine mutants were incubated with up to 10 mM GSSG for five 
minutes at 37 °C and desalted prior to measurement in the ammonium molybdate assay in 
order to remove excess GSSG using Zebaspin Desalting Columns. For deglutathionylation 
experiments, 12 µM of glutathionylated enzyme was incubated either with the reducing agent 
DTT (20 mM) or with the reduced redox proteins PfTrx1, PfGrx and PfPlrx (0-70 µM).  
3.2.8 Protein-S-nitrosylation 
In a master thesis concurrent to this dissertation, Marina Gehr studied the protein S-
nitrosylation of PfalMAT and PfalMATC113S with protein immunoblots using an anti-biotin 
antibody after a biotin switch assay and via enzymatic analysis using the ammonium 
molybdate assay (Gehr, 2014). For this dissertation, the effect of protein-S-nitrosylation on 
PfalMATC52S and PfalMATC187S was studied and compared to PfalMAT since the results for 
PfalMATC113S indicated that Cys113 is not S-nitrosylation’s only target in PfalMAT. In detail, 
PfalMAT and the cysteine mutants were reduced with 5 mM DTT and desalted to remove 
excess DTT, and the activity in response to adding different concentrations of GSNO (0-
800 µM) was determined relative to the enzyme without GSNO as a control using the 
ammonium molybdate assay.  
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3.2.9 Oligomerization studies 
In order to study the oligomerization behavior of PfalMAT and the cysteine mutants, the 
enzymes were incubated with either 20 mM DTT or 5 mM GSSG prior to analytical gel 
filtration chromatography. 
3.2.10 Molecular modeling 
Dr. Karin Fritz-Wolf modeled the structure of PfalMAT, using the crystal structures of Homo 
sapiens MATA2 (2p02) and Cryptosporidium hominis (2odj) MAT as templates in the 
SWISS-MODEL automated comparative protein modeling server (Schwede et al., 2003). The 
PfalMAT model was superimposed with other structures using the CCP4 software tool SSM. 
The insertion loop K184 to H190 was manually modeled with the interactive graphics 
program Coot (Emsley et al., 2004). Finally, the geometry of the new model was minimized 
with PHENIX (Adams et al., 2011). 
3.2.11 Statistical analyses 
Data were statistically analyzed using GraphPad Prism 6 software. The statistical test 
prerequisites, including balance of experimental design, Gaussian distribution, and 
homoskedasticity, were tested using automated GraphPad Prism functions and Bartlett’s test, 
respectively. Group means as well as means within groups were compared at 95% confidence 
level using One-Way ANOVA or Two-Way ANOVA, as indicated at the respective positions 
in the results. If p < 0.05 post hoc testing was performed with Dunnett’s test for comparing 
group means to the mean of control after One-Way ANOVA, or Bonferroni’s test for 
comparing every mean to every other mean after One-Way or Two-Way ANOVA.  
3.3 MscDyP1 methods 
3.3.1 Molecular biological methods 
The sequence of MscDyP1 was synthesized commercially (Eurofins MWG Operon) and 
provided in the pEX-K plasmid with a 5’ NcoI and a 3’ XhoI restriction site. Codon usage 
was optimized for E. coli. The construct is an N-terminally truncated form, lacking the 
putative targeting signal predicted by the program SignalP, starting at position 56. The 
construct was digested with XhoI, NcoI, and NdeI. The plasmid DNA was purified with the 
PureYieldTM Plasmid Miniprep System (Qiagen) by following the manufacturer’s instructions. 
Restriction enzyme digestion was confirmed with a 1% agarose gel. The gene was ligated into 
a pET28a vector (Novagen) and digested by XhoI and NcoI with T4 DNA ligase using the 
LigaFastTM Rapid DNA Ligation System (Promega) in accordance to the manufacturer’s 
instructions. The construct was then transformed into E. coli BL21 cells. The clones obtained 
were digested with NcoI and XhoI for analysis. Possible positive clones were sequenced 
(DNA concentration: 85 ng*µL-1, 260/280 ratio: 1.83) using sequencing primers obtained 
from Biolegio. An in-house sequencing facility confirmed the nucleotide sequence of a clone 
containing the (E. coli) rMscDyP1 gene, inserted into the pET28 a vector, by automated 
sequencing. This clone was selected for gene overexpression and site-directed mutagenesis. 
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The construct will be referred to as (E. coli) rMscDyP1 to distinguish it from the recombinant 
protein used for protein crystallization, which was produced in A. niger (rMscDyP1) and the 
wildtype expressed in M. scorodonius that was not used in this dissertation. 
3.3.2 Site-directed mutagenesis 
Site-directed mutagenesis of the single cysteine residue Cys306 of (E. coli) rMscDyP1 (which 
corresponds to Cys360 of native MscDyP1) was performed by substituting thymine from the 
cysteine codon (TGC) with guanine in order to obtain a triplet coding for glycine (GGC). 
Both methionine residues Met248 and Met251, which contribute to Met302 and Met305 of 
native MscDyP1, were substituted by replacing the thymine from the methionine codon 
(ATG) with adenine to obtain the triplet AAG coding for lysine, in a double mutation. PCR 
based site directed mutagenesis was carried out using Pfu polymerase with pET28a containing 
the (E. coli) rMscDyP1 gene as a template and oligonucleotide primers (0) containing the 
mutated codon, which were synthesized by Biolegio. 
Table 3: Mutagenesis PCR for (E. coli) rMscDyP1 
Reaction mix C360G M302K, M305K 
Template DNA 
Forward primer  
Reverse primer 
dNTP mix 
10x Pfu buffer 
DMSO 
Pfu polymerase  
Sterile H2O 
0.5 µL (104 ng*µL-1) 
1 µL (100 pmol*µL-1) 
1 µL (100 pmol*µL-1) 
4 µL (40 mM) 
5 µL  
2.5 µL  
1 µL (3 U*µL-1) 
35 µL 
1 µL (79.3 ng*µL-1) 
1 µL (100 pmol*µL-1) 
1 µL (100 pmol*µL-1) 
5 µL (40 mM) 
5 µL 
0.5 µL 
1 µL (3 U*µL-1) 
35.5 µL  
PCR program 
Denaturation 90 s 94 °C 2 min 95 °C 
Cycles 20 x 30 x 
Denaturation 30 s 94 °C 30 s 95 °C 
Annealing 60 s 60 °C 45 s 45 °C 
  45 s 50 °C 
  45 s 55 °C 
Elongation 15 min 68 °C 19 min 68 °C 
Final elongation 16 min 68 °C 23 min 68 °C 
 
PCR reactions were validated with an agarose gel and purified using a QIAquick PCR 
purification kit. The non-mutated, methylated template plasmid was digested with DpnI. An 
in-house sequencing facility confirmed the clones containing the correct mutation. In order to 
avoid confusions, the mutated amino acids were named C360G and M302K, M305K 
according to the numbering of the native MscDyP1 protein. 
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3.3.3 Heterologous overexpression of (E. coli) rMscDyP1 and mutants 
Genes of (E. coli) rMscDyP1, (E. coli) rMscDyP1C360G, and (E. coli) rMscDyP1M302K, M305K 
were overexpressed in the pET28a vector in E. coli BL21 cells together with a pG-Tf2 vector 
for overexpression of the chaperone pair GroES-GroEL-tig according to the protocol of the 
manufacturer (Takara Bio Inc.). Expression in the pET28a vector added an N-terminal His6-
tag to the recombinant proteins. Cells were grown in Terrific Broth (TB) medium containing 
50 µg*mL-1 kanamycin, 17.5 µg*mL-1 chloramphenicol and 5 ng*mL-1 tetracycline, as 
inductor of the chaperone expression, at 37 °C until an OD600 of 0.5 was reached. The heme 
precursor δ–aminolevulinic acid in a final concentration of 0.5 mM was added to the cell 
culture prior to inducing protein expression with 0.6 mM IPTG in order to facilitate heme 
incorporation into the recombinantly produced enzymes. After induction, cells were grown at 
23 °C overnight. 
3.3.4 Heterologous overexpression of (A. niger) rMscDyP1 
(A. niger) rMscDyP1 gene was heterologously overexpressed in A. niger, obtained from DSM 
(Delft, The Netherlands) and kindly provided by Prof. H. Zorn (Institute of Food Chemistry 
and Food Biotechnology, Justus Liebig University Giessen). 
3.3.5 Determination of heme incorporation and purity of (E. coli) rMscDyP1 
Purity of eluted fractions containing (E. coli) rMscDyP1 or the respective mutants and heme 
incorporation were determined by measuring absorbance of the Soret band at 405 nm and 
calculating the Reinheitszahl value (RZ=A405/A280).  
3.3.6 Assay systems 
2.3.6.1 ABTS assay 
Peroxidase activity was determined using the ABTS assay according to (Puhse et al., 2009) in 
half area micro-titer plates. The ABTS assay uses ABTS as an electron donor. The principle of 
the assay is based on detection of ABTS oxidation by hydrogen peroxide catalyzed by 
MscDyP1. The increasing absorbance of oxidized ABTS at 420 nm was measured for 10 
minutes at 30 °C in a microplate reader (Tecan infinite M200). Controls without the enzyme 
were subtracted from the absorbance. The mean slope was calculated based on an increase of 
absorbance at 420 nm, and enzymatic activity was calculated with the Lambert Beer’s law 
using the extinction coefficient of ABTS (ε420 = 36.8 mM-1*cm-1) and a path length of 0.5 cm. 
The path length was calculated according to the well and plate dimensions provided by the 
manufacturer (Greiner Bio One) for 96-well half-area plates, filled with a total well volume of 
80 µL, and the formula for the calculation of cylinder height: 
ℎ =
4 ∗ V
𝜋 ∗ 𝑑2
 
Activity of the cysteine mutant and the methionine double mutant was calculated as a 
percentage of the specific activity of (E. coli) rMscDyP1. 
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Table 4: ABTS assay 
Volume Reagent 
8 µL  rMscDyP1 or mutant (in 50 mM Tris, 300 mM NaCl, pH 8.0) 
32 µL  25 mM Na-acetate pH 3.5 
20 µL  2 mM ABTS (in 25 mM Na-acetate pH 3.5) ad 0.5 mM 
20 µL 1 mM H2O2 (in 25 mM Na-acetate pH 3.5) ad 0.25 mM 
2.3.6.2 β-carotene degradation assay 
Degradation of β-carotene by rMscDyP1 and mutants, expressed in E. coli, was determined 
using the β-carotene assay reported in (Puhse et al., 2009). The β-carotene solution was 
prepared from 5 mg β-carotene and 0.5 g Tween 80 solubilized in dichloromethane. The 
organic solvent was removed via rotary evaporation (40 °C, 250 rpm, 800 mbar, 20 min). The 
residue was solubilized in distilled water and remaining solvent was removed (40 °C, 
250 rpm, 800 mbar to 200 mbar in 200 mbar steps, each step for 15 min) under N2. The 
obtained β-carotene solution was filtered and diluted with demineralized water to a total 
volume of 50 mL. Stored at 4 °C in the dark, the solution was stable for one week. The assay 
was performed in half area micro titer plates. The decreasing β-carotene absorbance at 450 nm 
was measured for 10 minutes at 30 °C in a microplate reader (Tecan infinite M200). Controls 
without enzyme were subtracted from absorbance and the mean slope calculated from 
decrease of absorbance at 450 nm.  
Table 5: β-carotene degradation assay 
Volume Reagent 
8 µL  rMscDyP1 or mutant (in 50 mM Tris, 300 mM NaCl, pH 8.0) 
32 µL  50 mM Na-acetate pH 3.5 
20 µL  β-carotene (in ddH2O) 
20 µL 0.5 mM H2O2 (in ddH2O) ad 0.125 mM 
 
Enzymatic activity of rMscDyP1 and respective mutants was calculated according to Lambert 
Beer’s law using the extinction coefficient of β-carotene (ε=95 mM-1*cm-1) and well path 
length of 0.5 cm. The path length was calculated according to the well and plate dimensions 
provided by the manufacturer (Greiner Bio-One) for the used 96-well half-area plates, filled 
with a total well volume of 80 µL as mentioned before. Activity of the cysteine mutant and 
the methionine double mutant was calculated as a percentage of the specific activity of (E. 
coli) rMscDyP1. 
3.3.7 Enzyme kinetics 
Steady state kinetic parameters for (E. coli) rMscDyP1 were determined in the ABTS assay. 
Regarding the KM value for H2O2 for (E. coli) rMscDyP1, the hydrogen peroxide 
concentration was varied ranging from 60 µM to 1,500 µM, whereas the concentration of 
ABTS was fixed to 500 µM. ABTS KM was determined in the presence of 4-500 µM ABTS 
and 250 µM H2O2. 
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3.3.8 Statistical analyses 
Statistical test prerequisites such as balance of experimental design, Gaussian distribution, 
and homoskedasticity were tested, and either a parametric or non-parametric test was chosen 
for statistical analysis. For assessing differences in the specific activity between the mutants 
(E. coli) rMscDyP1C306G, and (E. coli) rMscDyP1M248K + M251K, and the recombinant wildtype 
(E. coli) rMscDyP1 as well as kinetic analyses, a Kruskal Wallis One-Way ANOVA at 95% 
confidence level with a Dunn’s nonparametric multiple comparison for post hoc testing was 
performed using IBM SPSS Statistics 19 software. A Dunnett’s multiple comparison test after 
One-Way ANOVA at 95% confidence level was performed for the blocking experiment of 
sulfur-containing amino acids (Figure 40) using GraphPad Prism 6 software.  
3.3.9 Protein crystallization 
rMscDyP1 produced in A. niger was provided by DSM (Delft, The Netherlands) (Scheibner et 
al., 2008). All crystals (N, D, A, B) were grown at 25 °C using the hanging drop technique. 
The initial protein concentration in the drop (with a ratio of protein to reservoir of 1:2) was 10 
and 8 mg*mL-1 for crystals N and D, respectively, and 4 mg*mL-1 for crystals A and B. The 
reservoir solution contained 100 mM MgCl2 in 100 mM Tris, pH 8.5 with 30% PEG 4000 and 
1.5% of the additive 1,2,3-heptane triol, which was identified to improve crystallization of 
MscDyP1 using additive screens (Additive screen HT, Hampton Research; JCSG Core Suite I 
and II, Qiagen). Crystals A and B were co-crystallized with 84.4 µM annatto or bixin (1:1.5 
excess), respectively. Crystal D originates from a batch that is believed to be a dimer 
(personnel communication Katharina Schmidt, Zorn group, Institute of Food Chemistry and 
Food Biotechnology, Justus Liebig University Giessen). Crystal D was obtained via 
microseeding. In detail, previously obtained small crystals of MscDyP1 were destroyed by 
vortexing them with small beads. Dilutions of the obtained micro-seed solution were used to 
inoculate a novel protein drop for crystallization via the hanging drop technique. Prior to 
measurement, crystals were soaked in mother liquor containing a final concentration of 30% 
glycerol for cryoprotection. 
2.3.9.1 Data collection 
Dr. Karin Fritz-Wolf collected data and refined the structure at the Max Planck Institute for 
Medical Research, Heidelberg. Diffraction data of crystals N, A, and B were collected at the 
X10SA beam line of the Swiss Light Source, Villigen, Switzerland, (rotation/image: 0.25°, λ 
=1 Å (crystal N), λ =0.97940 Å (crystal A and B), detector: Pilatus, 6M Pixel detector) at 
100 °K. Diffraction images of crystal D were recorded at 100 °K by an image plate detector 
(Mar345 image plate, X-ray-Research, Norderstedt, Germany) using Cu Kα radiation from a 
rotating anode (Rigaku, MicroMax-007HF, operating at 40 kV and 30 mA) at the Max Planck 
Institute for Medical Research in Heidelberg. All diffraction datasets were processed with 
XDS (Kabsch, 2010). Reflection phasing and structure refinements were performed using the 
PHENIX program suite. 
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2.3.9.2 Molecular docking studies 
MscDyP1 subunit A structure was prepared for docking using MOE 2013 software. All water 
atoms except H2O #40, which is located in the active site cleft and is replaced by H2O2 upon 
catalysis, were removed. Furthermore, all ligands except heme were removed; in detail, all 
PEG, glycerol, and N-acetylglucosamine molecules were removed. Force field Amber 
10:EHT was chosen, which is suitable for proteins and ligands, as well as protonation. 
Charges and hydrogen atoms of the protein and ligand were fixed. Other parameters were set 
as default. In order to prepare it for docking, the whole structure was protonated using MOE 
2013 software. Furthermore, the chemical structure of selected potential substrates, 2,6-
dimethoxyphenol and β-carotene, was drawn using MOE 2013, energy minimized, and saved 
as a .mol2 file. Docking was performed using Gold 5.2 software with 200 GA (genetic 
algorithm) runs in order to predict a binding pose. All H+-bond donors and acceptors were 
forced to be treated as solvent accessible. In the case of 2,6-dimethoxyphenol, ligand 
flexibility was allowed, whereas for β-carotene these parameters were set as default. Scoring 
function ChemPLP was selected. Search efficiency was set to highest (200%) for binding 
mode prediction. Generated docking poses were ranked for PLP-fitness from highest to 
lowest.  
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4 RESULTS 
4.1 P. falciparum methionine adenosyltransferase 
One aim of this dissertation was to study the redox regulation of PfalMAT. Therefore, it was 
necessary to identify possible surface-exposed and solvent accessible cysteines that might be 
involved in redox regulatory processes affecting PfalMAT. A sequence alignment of PfalMAT 
with MAT of different species whose crystal structures were available, including E. coli MAT 
(cMAT), Crytosporidium hominis MAT (ChMAT), human MAT I/III and human MAT II 
(hMAT), and rat liver MAT (rlMAT) highlights conserved cysteines and those that are 
exclusively found in PfalMAT (Figure 8).  
 
  PfalMAT      -------------MSQLKIKRGNFLFTSESVNEGHPDKICDQISDAILDSCLREDPYSKV    47 
  ChMAT        MDSSRLSGNKSTYTD-LQTTSEQFLFSSESVCSGHPDKLCDQISDAILDACLEQDPESFV    59 
  cMAT         --------------------MAKHLFTSESVSEGHPDKIADQISDAVLDAILEQDPKARV    40 
  rlMAT        -----MNGPVDGLCDHSLSEEGAFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKV    55 
  hMAT_I/III   -----MNGPVDGLCDHSLS-EGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKV    54 
  hMAT_II      -----MNGQLNGFHE-AFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKV    54 
                                      .:*:**** .*****:.******:**: *.:** : * 
 
  PfalMAT      ACEVCAKKNYIFIFGEITTKAKVNYDKVTRDVLKHIGYDDESKGLDYKTAEIKVSIDEQS    107 
  ChMAT        ACETCTKTGFIMVFGEITTKANVNYERVVRETVKEIGYDSEEKGLDYKTMDVIIKLEQQS    119 
  cMAT         ACETYVKTGMVLVGGEITTSAWVDIEEITRNTVREIGYVHSDMGFDANSCAVLSAIGKQS    100 
  rlMAT        ACETVCKTGMVLLCGEITSMAMIDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQS    115 
  hMAT_I/III   ACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQS    114 
  hMAT_II      ACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQS    114 
               ***.  *.  ::: ****: * :: :.:.*:.::.***  .  *:* ::  :   : :** 
 
  PfalMAT      PDIAQCVHENRSPELIGAGDQGIMFGYATDETENYMPLTHHYATLLGKRLTEVRKLG---    164 
  ChMAT        NQIAGCVHVDKNVEDIGAGDQGMMFGYATNETKELMPLTHVLATSITRELDYIRMKGVSS    179 
  cMAT         PDINQGVDRA-DPLEQGAGDQGLMFGYATNETDVLMPAPITYAHRLVQRQAEVRKNG---    156 
  rlMAT        PDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIVLAHKLNTRMADLRRSG---    172 
  hMAT_I/III   PDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSG---    171 
  hMAT_II      PDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNG---    171 
                :*   *.   .    ******:******:**.  **     *  :  .   :*  *    
 
  PfalMAT      ILPYLGPDGKTQITIEYKNKGSCGGHLEPLRVHTVLISTQHAEDIKYEQLKTDLMENVIK    224 
  ChMAT        RVGWLRPDGKAQVTVEYNCK---HGVLIPKRIHTILVSVQHDENIENEEIREFVLENVIK    236 
  cMAT         TLPWLRPDAKSQVTFQYDDGK-------IVGIDAVVLSTQHSEEIDQKSLQEAVMEEIIK    209 
  rlMAT        VLPWLRPDSKTQVTVQYVQD---NGAVIPVRVHTIVISVQHNEDITLEAMREALKEQVIK    229 
  hMAT_I/III   LLPWLRPDSKTQVTVQYMQD---NGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIR    228 
  hMAT_II      TLPWLRPDSKTQVTVQYMQD---RGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIK    228 
                : :* **.*:*:*.:*              :.::::*.** *::  . ::  : *::*: 
 
  PfalMAT      YVIPEKLLDNETLYYLNPSGKFVLGGPAADAGLTGRKIICDTYGGWGAHGGGAFSGKDAS    284 
  ChMAT        KVCPSDLMDKETRILINPSGRFTIGGPAADAGLTGRKIIVDTYGGWGAHGGGAFSGKDAT    296 
  cMAT         PILPAEWLTSATKFFINPTGRFVIGGPMGDCGLTGRKIIVDTYGGMARHGGGAFSGKDPS    269 
  rlMAT        AVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYT    289 
  hMAT_I/III   AVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYT    288 
  hMAT_II      AVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYT    288 
                : * . : . *   ::*:*:*.:*** .*.*:****** ***** . ********** : 
 
  PfalMAT      KVDRSAAYYLRFIAKSLVANKFCRRVLVQASYSIGIANPISLNVNSYGTVSTGYTDYDLE    344 
  ChMAT        KVDRSGAYMARLVAKSIVFSGLCSRCLVQVSYGIGIARPLSLYINTFGTAKDGYNDTKLL    356 
  cMAT         KVDRSAAYAARYVAKNIVAAGLADRCEIQVSYAIGVAEPTSIMVETFGTEKV--PSEQLT    327 
  rlMAT        KVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSKK--TERELL    347 
  hMAT_I/III   KVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQK--TERELL    346 
  hMAT_II      KVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQK--SERELL    346 
               *****.**  * :**.:*   :. *  :*.**.**::.* *: :  :** .    . .*  
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  PfalMAT      QIILRNFDLRPGFIIQELKLTEPVFSKTSAYGHFGREGDTFTWEKIKDLSHEKNALKN-     402 
  ChMAT        EIVNKVFDFRPGILIKQLNLKSPIFKKTSSGGHFGRSEKEFLWEKPIILQ---------     406 
  cMAT         LLVREFFDLRPYGLIQMLDLLHPIYKETAAYGHFGREH--FPWEKTDKAQLLRDAAGLK     384 
  rlMAT        EVVNKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSE--FPWEVPKKLVF--------     396 
  hMAT_I/III   DVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSE--FPWEVPRKLVF--------     395 
  hMAT_II      EIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDS--FPWEVPKKLKY--------     395 
                :: . **:**  ::: *.*  *::..*:. *****.   * ** 
Figure 8: Sequence alignment of MAT from different species 
* Identical residues, : Very similar residues, . Similar residues. Cysteines are shown in bold and those conserved 
among PfalMAT and other species are highlighted in gray. Cys52, Cys113 and Cys187 of PfalMAT, which were 
mutated during this dissertation are colored in red. The conserved substrate binding motif and the phosphate 
binding P-loop are underlined with a straight line, 1st and 2nd positons, respectively. The loop above the active 
site is underlined with a wavy line. Active site residues are enclosed in a box. This alignment was prepared using 
Clustal Omega 1.2.1. 
PfalMAT displays a sequence similarity of 40-60% to homologs of other species (ChMAT 
57.3%, hMAT 6.7%, rlMAT 57.2% and cMAT 48.8%). PfalMAT contains eight cysteine 
residues, with four of them conserved among MATs. Interestingly, PfalMAT shares most of its 
cysteine residues with ChMAT. 
4.1.1 Homology model of PfalMAT 
Chiang et al. published a homology model of PfalMAT in 1999. This model was based on the 
crystal structure of cMAT (Chiang et al., 1999). The sequence alignment of PfalMAT with 
cMAT reveals that cMAT lacks most of the cysteines that are present in PfalMAT (Figure 8) 
but conserved in other MAT species. These include Cys121 of rlMAT, which has been 
demonstrated to undergo S-nitrosylation and therefore likely participates in the redox 
regulation of rlMAT (Avila et al., 1997) and corresponds to Cys113 of PfalMAT. Furthermore, 
this cysteine is located at the beginning of the loop above the active site, which has been 
suggested to regulate substrate access. Therefore, the homology model of PfalMAT based on 
cMAT published by Chiang et al. is not suitable for studying the redox-regulation of 
PfalMAT, in its entirety. Since the crystal structure of PfalMAT is not yet available, we 
constructed a homology model based on the crystal structures of MAT from different 
organisms, the alpha subunit of human MAT isoform 2 (hMAT2A) (PDB ID 2p02) and C. 
hominis MAT (PDB ID 4odj) (Figure 9). According to this model, three cysteine residues are 
solvent accessible and therefore possible targets of redox-active agents. The formation of 
intermolecular disulfide bridges in the dimeric assembly of PfalMAT, which might change the 
oligomeric state of PfalMAT upon redox modification, is possible between Cys52-Cys52’ and 
Cys187-Cys187’ since these residues are close enough to each other (~4 Å). Cys187 is 
located on top of a loop that connects two beta-barrel strands (Figure 9, highlighted in 
purple). Residues at the other site of these strands, e.g. Lys174, are involved in binding the 
substrate ATP. In PfalMAT this loop contains an insertion of 3-7 residues including Cys187. 
Furthermore, the sequence of this loop (KGSCGGH) suggests possible hinges, G185 and 
G189, that allow for the opening and closing of the intermolecular disulfide between Cys187 
and Cys187’ of the other subunit. Furthermore, the surface-exposed Cys113 and Cys113’ 
might contribute to a redox regulation of PfalMAT. Cys113 is located at the beginning of the 
conserved flexible loop above the active site and corresponds to Cys121 of rlMAT, which can 
be S-nitrosylated, indicating Cys113 might also undergo redox-based thiol modifications. 
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Figure 9: Homology model of PfalMAT 
Homology model of PfalMAT based on the crystal structures of ChMAT (PDB ID 4odj) and MATII (PDB ID 
2p02). The two subunits of the PfalMAT dimer are shown in petrol and blue, respectively. A: Overview of 
PfalMAT cysteines (shown as yellow balls and sticks). B: A triphosphate (orange) and a SAM molecule (light 
green) are shown in the active sites based on the superposition of different MAT structures. Two beta-strands 
and an insertion loop are shown in purple. C: The active site of each subunit is indicated as a green ball. Possible 
intermolecular disulfide bonds are indicated with red dashes between cysteine residues (yellow).  
4.1.2 Site-directed mutagenesis of PfalMAT 
Cysteines that were proposed to be accessible to oxidizing or reducing agents, based on the 
homology model of PfalMAT were selected for site-directed mutagenesis to serine. 
Accordingly, Maike Eisenkolb created PfalMATC113S and PfalMATC187S mutants for her 
master thesis (Eisenkolb, 2008). Additionally, a PfalMATC52S mutant was constructed via site-
directed mutagenesis for this dissertation.  
4.1.3 Heterologous overexpression and purification of PfalMAT and hMATIII 
The heterologous overexpression of PfalMAT gene in pQE30 E. coli M15 cells was optimized 
in Eisenkolb’s master thesis (Eisenkolb, 2008). For the production and purification of the 
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mutants PfalMATC52S, PfMMATC113S, and PfalMATC187S the same protocol as for the wild 
type enzyme was used. Figure 10 shows respective purifications via immobilized metal ion 
affinity chromatography for PfalMAT and mutants (44.8 kDa). The proteins were eluted with 
an imidazole gradient from the Ni-NTA column, and the purest fractions were pooled. A 
sufficient amount of approximately 15 mg enzyme was obtained per liter of E. coli culture. 
The enzymes were stable and active for approximately one to two weeks at 4 °C.  
 
  
A B 
  
C D 
Figure 10: Purification of PfalMAT and mutants via Ni-NTA affinity chromatography 
A: PfalMAT, B: PfalMATC52S, C: PfalMATC113S, D: PfalMATC187S; M: marker, P: cell pellet, SN: supernatant, 
FT: flow through, W: wash, 50-500: fraction eluted with 50-500 mM imidazole. 
In order to compare the recombinant PfalMAT with a human counterpart, the hMAT1a gene 
was heterologously overexpressed in pET28a E. coli KRX cells for a master thesis (Gehr, 
2014). Figure 11 shows its purification via immobilized metal ion affinity chromatography. 
The protein was eluted with an imidazole gradient from the Ni-NTA column. 
 
 
Figure 11: Purification of hMATIII via Ni-NTA affinity chromatography 
M: marker, P: cell pellet, SN: supernatant, FT: flow through, W: wash, 50-500: fractions eluted with 50-500 mM 
imidazole. 
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The eluted fractions were pooled and stored at 4 °C. Under these conditions the enzyme was 
relatively unstable. The reduction of hMATIII with 2 mM DTT directly after elution from the 
Ni-NTA column increased the stability. However, the protein remained stable for only two 
days. Since the protein yield was relatively high (~100 mg per liter E. coli culture), hMATIII 
was used without further concentration for activity assays after reduction with DTT. 
4.1.4 Oligomerization behavior of PfalMAT and mutants 
In order to study the effects of oxidation and reduction on the oligomerization state of 
PfalMAT and the cysteine mutants as well as the contribution of disulfide bridges to the 
dimeric assembly of PfalMAT preparative gel filtration experiments were carried out (Figure 
12). These experiments confirmed that the recombinant PfalMAT was a dimer (molecular size 
of a monomer: 44.8 kDa). Treatment with the reducing agent DTT didn’t show any major 
effects on the oligomerization state of PfalMAT, suggesting that disulfides were not involved 
in the dimerization of PfalMAT. PfalMATC113S showed a similar oligomerization behavior 
before and after treatment with DTT as PfalMAT. However, the size exclusion experiments 
with PfalMATC52S and PfalMATC187S showed a mixture of monomers and oligomers. 
Moreover, the reduction of these cysteine mutants with DTT shifted the oligomerization state 
towards a dimer.  
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Figure 12: Oligomerization of PfalMAT 
A, C, E, G: oligomeric state of PfalMAT, PfalMATC52S, PfalMATC113S, and PfalMATC187S, respectively. B, D, F, 
H: Oligomerization behavior of PfalMAT, PfalMATC52S, PfalMATC113S, and PfalMATC187S, respectively, after 
treatment with 20 mM DTT. 
The human mat1a gene encodes two MAT isoforms: MATI, a homotetramer, and MATIII, a 
homodimer. In order to examine whether the recombinant hMAT is present in a dimeric or 
tetrameric form, the oligomerization state of the enzyme was investigated via gel filtration 
experiments, either with the untreated protein after Ni-NTA affinity chromatography or with 
the reduced enzyme treated with DTT (Figure 13).  
 
Figure 13: Oligomeric state of hMATIII 
Oligomerization behavior of untreated hMATIII (A) and after treatment with DTT (B). 
These gel filtration experiments showed that directly after Ni-NTA affinity chromatography a 
mixture of monomers (43.6 kDa), dimers and tetramers was present. However, in the reduced 
state under conditions within the performed experiments, predominantly dimeric hMATIII 
was present. Therefore, the protein encoded by hmat1a used here for comparison with 
PfalMAT is referred to as hMATIII. 
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4.1.5 Enzymatic characterization of PfalMAT 
In order to assay the activity of PfalMAT, its mutants, and hMATIII, the enzymes were 
prepared freshly for each experiment, stored at 4 °C, and measured within one to five days 
after purification. Since reducing PfalMAT with DTT increased the enzymatic activity (Figure 
21 A), the enzymes were reduced with 2 mM DTT and desalted to remove excess DTT, prior 
to the measurements. In order to maintain the reduced state during the experiments, the 
measurements were performed within three to four hours after reduction. After this period of 
time, the enzymes were incubated again with DTT and were desalted. Each measurement with 
hMATIII was performed within 48 hours after purification due to the short period of time in 
which this enzyme remained stable.  
Although PfalMAT had been previously characterized on a molecular level (Chiang et al., 
1999), this enzyme had not been characterized kinetically. Initial enzymatic characterization 
of PfalMAT was attempted in two master theses in this group (Eisenkolb, 2008; Pretzel, 
2011). However, the coupled assay previously used (Eisenkolb, 2008) was not suitable for a 
detailed kinetic analysis. In two master theses (Pretzel, 2011; Gehr, 2014), the ammonium 
molybdate-based assay system, which is based on the detection of released inorganic 
phosphate during PfalMAT reaction, was established and optimized for PfalMAT, which 
paved the way for an in-depth enzymatic characterization of PfalMAT for this dissertation.  
A phosphate standard curve, linear up to 800 µM orthophosphate (Figure 14 A), was used to 
determine the amount of inorganic phosphate released by the PfalMAT reaction, which was 
proportional to the concentration of PfalMAT in the assay (Figure 14 B). 
 
 
Figure 14: Phosphate standard curve and PfalMAT titration 
A: The phosphate standard curve shows high linearity up to 900 µM inorganic phosphate. Data represent means 
± SD, whereas SD is smaller than symbol size here. B: The amount of orthophosphate detected is directly 
proportional to the concentration of PfalMAT in the ammonium molybdate assay. Data represent means ± SD. 
The PfalMAT reaction showed a broad pH optimum between 7.4 and 9 (Figure 15 A), and 
mono- and divalent cations were found to be essential for the MAT-catalyzed reaction. 
Accordingly, PfalMAT showed its maximal activity with MgCl2 at 40 mM which was above 
the concentration of ATP. Lower concentrations of Mg2+ and K+ as well as higher MgCl2 
concentrations inhibited the activity of PfalMAT (Figure 15 B and C). 
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Figure 15: pH and salt profile of PfalMAT 
A: pH-dependent PfalMAT activity and salt preference for MgCl2 (B) and KCl (C) was determined using the 
ammonium molybdate assay. Data represent means ± SD. 
2.3.5.1 Kinetic parameters 
The specific activity and steady-state kinetic parameters of PfalMAT, cysteine mutants, and 
the selected human homolog hMATIII, were determined using the ammonium molybdate 
assay. Kinetic parameters were determined by varying the concentration of one of the two 
substrates, ATP or L-methionine, with the other one being fixed, plotting the reaction velocity 
against the substrate concentration, and fitting it to the Michaelis-Menten equation. Table 6 
summarizes the kinetic parameters of PfalMAT, the cysteine mutants, and hMATIII. 
Table 6: Kinetic parameters of PfalMAT 
 PfalMAT PfalMATC52S PfalMATC113S PfalMATC187S hMATIII 
Specific activity 
[nmol*min-1*mg-1] 
379 ± 67 367 ± 63 446 ± 71** 335 ± 54 1,331 ± 204*** 
KM [µM] Met 34 ± 6 46 ± 5* 51 ± 4** 43 ± 9 168 ± 23*** 
KM [µM] ATP 560 ± 45 680 ± 64*** 206 ± 23*** 176 ± 12*** 330 ± 53*** 
kcat/KM (Met) 
[mM-1*s-1] 
31.2 ± 
12.3 
22.3 ± 9.0** 32.2 ± 9.3 24.5 ± 9.7 14.4 ± 2.2*** 
kcat/KM (ATP) 
[mM-1*s-1] 
1.9 ± 0.7 1.5 ± 0.6 7.2 ± 2** 5.9 ± 2.3** 7.3 ± 1.1** 
Values are mean values ± SD of at least three independent experiments with at least two measurements each. The 
given kinetic characteristics were determined using the ammonium molybdate assay. A One-Way ANOVA with a 
95% confidence level was performed in order to compare means. *p < 0.05, **p < 0.01, ***p < 0.001 
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The mutants PfalMATC52S and PfalMATC187S showed no major differences in the specific 
activity compared to PfalMAT, whereas PfalMATC113S had a higher activity. The substitution 
of Cys52 and Cys113 for serine significantly decreased the affinity to the substrate L-
methionine, compared to PfalMAT. This could also be observed for PfalMATC52S for the 
second substrate ATP. In contrast, PfalMATC113S and PfalMATC187S displayed a higher affinity 
to ATP compared to PfalMAT. Representative KM curves for PfalMAT are shown in Figure 
16. Furthermore, PfalMATC113S and PfalMATC187S showed a higher turnover number than 
PfalMAT with respect to the substrate ATP, whereas PfalMATC52S converted more L-
methionine molecules per second than PfalMAT. 
 
Figure 16: KM for ATP and L-methionine of PfalMAT 
A: KM determination of PfalMAT in the presence of 2 mM ATP. B: KM determination in the presence of 1 mM 
L-methionine. Data represent means ± SD. 
The specific activity of hMATIII obtained under these assay conditions was more than 3-fold 
higher than that of PfalMAT. Representative KM curves for hMATIII are shown in Figure 17.  
 
Figure 17: KM for ATP and L-methionine of hMATIII 
A: KM determination of hMATIII in the presence of 1 mM L-methionine. B: KM determination of hMATIII in 
the presence of 2 mM ATP. Data represent means ± SD. 
2.3.5.2 Allosteric regulation of PfalMAT 
The product of the MAT-catalyzed reaction, SAM, is a potent feedback inhibitor of MAT of 
different species (Markham et al., 1983; Reguera et al., 2002). Accordingly, both PfalMAT 
(IC50 264 µM) and hMATIII (IC50 1076 µM) are inhibited by their product SAM, albeit 
weakly (Figure 18). 
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Figure 18: Allosteric regulation of PfalMAT and hMATIII by SAM 
IC50 of SAM for PfalMAT (A) and hMATIII (B). Data represent means ± SD. Lineweaver-Burk plots for 
PfalMAT indicate SAM uncompetitively inhibit PfalMAT with ATP (C) and non-competitively with L-
methionine (D). 
A detailed analysis of the inhibition type has been performed in my master thesis, showing a 
non-competitive inhibition of PfalMAT for L-methionine (0.01-1 mM) with SAM indicated 
by a decrease of Vmax and no effect on the KM for L-methionine (Ki of 0.7 ± 0.2 mM). In 
contrast, increasing concentrations of SAM decreased both the KM for ATP and Vmax, 
suggesting an uncompetitive inhibition pattern to ATP (Ki 3.6 ± 0.4 mM) (Pretzel, 2011).  
4.1.6 Redox regulation of PfalMAT 
In order to study the effect of the redox active proteins PfTrx1, PfGrx, and PfPlrx on PfalMAT 
activity, the enzyme was incubated with different concentrations of these redoxins in a 
reduced state (Figure 19). Noteworthy, for this experiement PfalMAT was not prereduced 
with DTT. Both PfTrx1 and PfPlrx increased the activity of PfalMAT, compared to the 
untreated enzyme, in a concentration-dependent manner. However, in a direct comparison, 
lower concentrations of PfTrx1 than PfPlrx were necessary to activate PfalMAT. At a molar 
ratio of 1:1.2 (2.5 µM PfalMAT, 3 µM PfTrx), PfTrx1 was already capable of increasing the 
activity of PfalMAT to ~130%, whereas a higher molar ratio of PfalMAT (2.9 µM) to PfPlrx 
(10 µM) (1:3.4) was required for a similar activation (to ~125%) (p < 0.01, Two-Way 
ANOVA). In contrast, PfGrx had no effect on PfalMAT activity.  
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Figure 19: PfalMAT activity depending on redoxin concentration 
Relative activity of PfalMAT in the presence of PfTrx1, PfGrx, and PfPlrx. 0 to 20 µM of the reduced redox 
proteins were added directly to the reaction mixture without prior incubation. Enzymatic activity of PfalMAT 
without redoxin and without prereduction with DTT was set to 100%. A One-Way ANOVA with a 95% 
confidence level was performed in order to compare means. *p < 0.05, **p < 0.01, ***p < 0.001 
Since PfTrx1 potently activated PfalMAT, their interaction was addressed in more detail. In 
order to identify the cysteine residue presenting the target of PfTrx1, the activity of the 
cysteine mutants in the presence of PfTrx1 was compared to PfalMAT (Figure 20).  
 
Figure 20: Activation of PfalMAT and mutants by PfTrx1 
Activity of not prereduced PfalMAT, PfalMATC52S, PfalMATC113S, and PfalMATC187S in the presence of PfTrx1. 
0 to 20 µM of PfTrx1 were added directly to the reaction mixture without prior incubation. Two-Way ANOVA 
with a 95% confidence level was performed in order to compare means within groups. *p < 0.05, **p < 0.01, 
***p < 0.001 
PfTrx1 activated PfalMATC52S and PfalMATC113S only weakly (PfalMATC52S by ~20% and 
PfalMATC113S by ~40% after adding 20 µM PfTrx1). For activity and kinetic analysis, the 
enzymes were prereduced with DTT. In order to study the reducing effect of PfTrx1, the 
enzymes were not prereduced here. In this context, it was observed that while PfalMAT, 
PfalMATC52S, and PfalMATC113S exhibited a similar activity as in the reduced state, 
PfalMATC187S had only ~15% residual activity compared to the respective prereduced protein, 
which was completely restored by 10 µM PfTrx1.  
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4.1.7 Protein-S-glutathionylation of PfalMAT 
It had been shown before, that PfalMAT can be S-glutathionylated in the presence of GSSG 
(Kehr et al., 2011) and that this post-translational modification is in principle reversible 
(Pretzel, 2011). Indeed, protein-S-glutathionylation of PfalMAT (PfalMAT-SG) resulted in a 
~50 % loss of activity (Figure 21 A and B) which could be fully reconstituted by DTT (Figure 
21 A). Deglutathionylation of PfalMAT-SG by DTT was proved by the disappearance of the 
signal upon adding DTT on Western blots using an anti-glutathione antibody (Figure 23). 
Moreover, PfalMAT-SG activity increased to a similar extent to PfalMAT in response to the 
addition of DTT, to ~180% of the activity of untreated PfalMAT (Figure 21 A). In contrast to 
inhibition by GSSG, PfalMAT was activated by incubation with reduced glutathione (three-
fold activation in the presence of 10 mM GSH, Figure 21 B), which is most likely due to the 
reduction of a disulfide bond and does not lead to S-glutathionylation of the enzyme, as 
indicated by the absence of a signal on Western blots using an anti-GSH antibody (Figure 21 
C).  
 
 
Figure 21: Reversible protein-S-glutathionylation of PfalMAT 
A: Inhibition of PfalMAT 5 mM GSSG and deglutathionylation mediated by DTT. One-Way ANOVA with a 
95% confidence level was performed in order to compare means between groups. B: Activity of PfalMAT 
incubated with different concentrations of reduced glutathione. Kruskal-Wallis One-Way-ANOVA with a 95% 
confidence interval and Dunn’s multiple comparisons test was performed. C: Western blot of PfalMAT 
incubated with different concentrations of GSH using anti-GSH antibody. *p < 0.05, **p < 0.01, ***p < 0.001. 
Protein-S-glutathionylation of PfalMAT was not only reversible with DTT. The redox-active 
proteins PfTrx1 and PfPlrx were also able to deglutathionylate PfalMAT-SG, as indicated by 
restored activity of PfalMAT upon incubation with these redoxins (Figure 22 A) and 
decreasing signals on Western blots using an anti-glutathione antibody with increasing 
redoxin concentration (Figure 22 B). In comparison, PfGrx was unable to deglutathionylate 
PfalMAT-SG up to a molar ratio between PfalMAT and PfGrx of 1:5 (Figure 22 A, B). 
C 
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Figure 22: Deglutathionylation of PfalMAT by redoxins. 
A: Activity of glutathionylated PfalMAT upon incubation with different concentrations of redoxins. One-Way 
ANOVA with a 95% confidence level was performed in order to compare means between groups. *p < 0.05, **p 
< 0.01, ***p < 0.001. B: Western blot of glutathionylated PfalMAT incubated with different concentrations of 
redoxins using anti-GSH antibody. 
In order to identify S-glutathionylation sites of PfalMAT, the effect on the cysteine deletion in 
PfalMATC52S, PfalMATC113S, and PfalMATC187S was investigated. Interestingly, each of the 
cysteine mutants could be S-glutathionylated as shown via Western blots using an anti-GSH 
antibody (Figure 24).  
 
Figure 23: Formation of mixed disulfides between PfalMAT and glutathione 
Western blots of PfalMAT (A), PfalMATC52S (B), PfalMATC113S (C), and PfalMATC187S (D) incubated with 
different concentrations of GSSG using anti-GSH antibody. 
A 
B 
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Even low concentrations of GSSG of 0.1-0.5 mM were sufficient for inhibiting enzymatic 
activity. PfalMATC52S showed an inhibition pattern similar to PfalMAT, whereas 
PfalMATC187S was more susceptible to inhibition in response to S-glutathionylation (by ~ 
40%, after adding 3-5 mM GSSG, p < 0.001 Two-Way ANOVA) (Figure 24).  
The lack of Cys113 resulted in a weaker inhibition (by ~ 20% by 0.5-5 mM GSSG, p < 0.01 
Two-Way ANOVA) than PfalMAT, which 3-5 mM GSSG inhibited by ~50-60%. 
Nevertheless, each of the cysteine deletion mutants could still be S-glutathionylated. 
 
Figure 24: Activity of S-glutathionylated PfalMAT and mutants 
Activity of reduced PfalMAT, PfalMATC52S, PfalMATC113S, and PfalMATC187S incubated with different 
concentrations of GSSG. One-Way ANOVA with a 95% confidence level was performed in order to compare 
means within. *p < 0.05, **p < 0.01, ***p < 0.001 
Besides an effect on enzymatic activity, there are hints that the oligomerization states of 
MATs are possibly regulated via S-glutathionylation, as demonstrated for rlMAT, which was 
monomerized in response to this post-translational modification (Pajares et al., 1992). Based 
on this, the oligomerization behavior of PfalMAT-SG and glutathionylated mutants was 
determined via gel filtration (Figure 25). Protein-S-glutathionylation indeed affected the 
oligomerization of PfalMAT. It partly shifted the predominantly dimeric state of the untreated 
enzyme (Figure 12 A) to high molecular weight oligomers as observed for PfalMAT-SG. This 
trend was similarly observed for the cysteine deletion mutants. Furthermore, glutathionylation 
also resulted in a partial monomerization of PfalMAT and the mutants, represented by the 
shoulders of the peak at ~85 minutes. 
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Figure 25: Oligomerization behavior of PfalMAT upon S-glutathionylation 
Oligomerization behavior of PfalMAT (A), PfalMATC52S (B), PfalMATC113S (C), and PfalMATC187S (D) after 
treatment with 5 mM GSSG. 
4.1.8 Protein-S-nitrosylation of PfalMAT 
In pull-down experiments, PfalMAT hab previously been demonstrated to undergo S-
nitrosylation (Wang et al., 2014). The interaction of PfalMAT with the physiologically 
relevant NO donor S-nitrosoglutathione (GSNO) was further characterized in a master thesis 
via Western blots using an anti-biotin antibody after a biotin switch assay and ammonium 
molybdate assay, showing that PfalMAT is S-nitrosylated in a concentration and time-
dependent manner (Gehr, 2014). In this dissertation, the effect of S-nitrosylation on the 
selected cysteine mutants as potential S-nitrosylation sites for PfalMAT was addressed. 
 
Figure 26: Protein-S-nitrosylation of PfalMAT 
Inhibition of PfalMAT and mutants after incubation with different concentrations of GSNO. One-Way ANOVA 
with a 95% confidence level was performed in order to compare means within groups. *p < 0.05, **p < 0.01, 
***p < 0.001 
PfalMAT as well as the cysteine mutants were only weakly inhibited by GSNO (Figure 26). A 
Two-Way ANOVA was performed in order to compare the activity of each protein at each 
GSNO concentration, revealing that there are no significant differences in the extent of 
inhibition between the three mutants. However, PfalMATC52S, PfalMATC113S, and 
PfalMATC187S were found to be less susceptible to S-nitrosylation than PfalMAT. While 
PfalMAT was inhibited upon incubation with 200-1000 µM GSNO by ~35%, the mutants 
PfalMATC52S, PfalMATC113S, and PfalMATC187S were inhibited only by ~15-20% (p < 0.01, p 
< 0.001, and p < 0.01, respectively).  
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4.2 M. scorodonius DyP-type peroxidase 1 
One aim of my dissertation was to provide high quality crystals of MscDyP1 for solving the 
three-dimensional structure of the protein via X-ray crystallography. Based on the structure of 
MscDyP1 the yet unknown catalytic structure of MscDyP1 was elicidated via mutational 
analyses of selected stuctural features. 
4.2.1 Crystallization of MscDyP1 
During this dissertation the crystallization conditions for MscDyP1 were systematically 
optimized by screening various conditions including buffer, pH, salt, precipitant and protein 
concentrations, temperature, crystal additives, and seeding using small crystals which were 
previously vortexed using beads (Hampton Research) to generate a seed stock, which was 
then titrated into new drops. Recombinant MscDyP1 produced in A. niger, desalted and stored 
in H2O, was used for protein crystallization experiments in a ratio 1:2 to reservoir solution 
using the hanging drop technique. Initially, crystal N (native protein) was obtained under the 
following conditions (10 mg*mL-1 rMscDyP1 in H2O, 100 mM Tris, pH 8.5 with 100 mM 
MgCl2, 3 % PEG 4000 and 1.5% 1,2,3-hetane triol) using the additive screen 1 (Hampton 
Research). Then, crystal D was obtained under the same conditions, but with 8 mg*mL-1 
rMscDyP1. Crystal D provided better resolution than crystal N and was derived from a highly 
pure protein fraction that was suggested to be dimeric (personal communication with 
Katharina Schmidt, Zorn lab, Department of Food Chemistry and Food Biotechnology, Justus 
Liebig University Giessen). Additionally, rMscDyP1 was either co-crystallized with the 
pseudo substrates annatto and bixin or previosly obtained native crystals were soaked in 
mother liquor containing excess amount of the pseudo substrate. Upon soaking with either 
annatto or bixine, the crystals immediately cracked. However, co-crystallization experiments 
under the same conditions as crystal N, led to growth of crystal A (4 mg*mL-1 rMscDyP1 
crystallized in the presence of annatto) and crystal B (4 mg*mL-1 rMscDyP1 crystallized in 
the presence of bixine). All crystals grew within five days at 25°C. All together, four crystals 
in complex with the heme cofactor with corresponding structures were obtained (Figure 27). 
    
1.6 Å 1.6 Å 2.5 Å 2.2 Å 
A B C D 
Figure 27: Protein crystals of MscDyP1 
A: crystal A. 4 mg*mL-1 (A. niger) rMscDyP1 crystallized in the presence of excess amounts of annatto. B: 
crystal B. 4 mg*mL-1 (A. niger) rMscDyP1 crystallized in the presence of excess amounts of bixin. C: crystal N. 
10 mg*mL-1 (A. niger) rMscDyP1 crystallized without substrates. D: crystal D. 8 mg*mL-1 dimeric (A. niger) 
rMscDyP1. All crystals grew at 25°C in 100 mM Tris, pH 8.5 with 100 mM MgCl2, 3 % PEG 4000 and 1.5% 
1,2,3-hetane triol.  
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Dr. Karin Fritz-Wolf collected the diffraction data and refined the structures. The X-ray 
diffraction datasets were processed using the XDS software package (Kabsch, 2010). The 
structures were solved via molecular replacement using BadDyP (PDB ID 3mm1) as a search 
model. MscDyP1 displays 51.6% and 54.8% sequence identity to BadDyP and AauDyP, 
respectively (Figure 28). These fungal proteins are secreted and therefore contain a target 
sequence (residues 1-55 of MscDyP1), which was excluded during structure determination of 
the processed protein starting at position 56. 
 
 MscDyP1  ASSSAGLNLTDIQGDILIGMKKNKELFFFFSITDAATFKAKLGSDILGLITS-TNQLLAV 114 
 BadDyP   -ANDTILPLNNIQGDILVGMKKQKERFVFFQVNDATSFKTALKTYVPERITSAAILISDP  59 
 AauDyP   ---ATSLNTIDIQGDILVGMHKQKQLFYFFAINDPATFKTHLASDIAPVVAS-VTQLSNV  56 
              : *   :******:**:*:*: * ** :.* ::**: * : :   ::* .  :    
 
 MscDyP1  ATQPVTAVNVAFSSTGLKALGITDDLKDPVFEAGMLSNAVSDLSDPGTGNWVPGFVGTSV 174 
 BadDyP   SQQPLAFVNLGFSNTGLQALGITDDLGDAQFPDGQFADAANL--GDDLSQWVAPFTGTTI 117 
 AauDyP   ATQPLVALNIAFSNTGLLALGVTDNLGDSLFANGQAKDATSF--KESTSSWVPQFAGTGI 114 
          : **:. :*:.**.*** ***:**:* *  *  *   :*..       ..**  *.** : 
 
 MscDyP1  HGVFLLASDTIDNVNTELANIQTILNGSITEIHRLQGEARPGDQQGHEHFGFMDGISNPA 234 
 BadDyP   HGVFLIGSDQDDFLDQFTDDISSTFGSSITQVQALSGSARPGDQAGHEHFGFLDGISQPS 177 
 AauDyP   HGVIILASDTTDLIDQQVASIESTFGSSISKLYSLSASIRPGNEAGHEMFGFLDGIAQPA 174 
          ***:::.**  * ::    .*.: : .**:::  *... ***:: *** ***:***::*: 
 
 MscDyP1  VDGFTPPAEIRPGQALIPPGIMLLGEANDTFQNDRPPWAKDGSFLVFRQMQQRAPEFNKF 294 
 BadDyP   VTGWET--TVFPGQAVVPPGIILTGRDGDT--GTRPSWALDGSFMAFRHFQQKVPEFNAY 233 
 AauDyP   INGFNT---PLPGQNIVDAGVIITGATNDP--ITRPSWAVGGSFLAFRQLEQLVPEFNKY 229 
          : *:       *** ::  *::: *   *     ** **  ***:.**:::* .**** : 
 
 MscDyP1  LQDHALNM---PNMTSEQGADLLGARIVGRWKSGAPIDLTPLVDDPVLAADNQRNNNFDF 351 
 BadDyP   TLANAIPANSAGNLTQQEGAEFLGARMFGRWKSGAPIDLAPTADDPALGADPQRNNNFDY 293 
 AauDyP   LLDNAPA----GSGSLQARADLLGARMVGRWKSGAPIDLTPTADDPALGADAQRNNNFTY 285 
             .*       . : :  *::****:.***********:* .***.*.** ****** : 
 
 MscDyP1  SDA-----TNQTRCPFSAHIRKANPRGDLGGINKFPN-----QHIIRAGIPYGPEVTDAE 401 
 BadDyP   SDT----LTDETRCPFGAHVRKTNPRQDLGGPVDT-------FHAMRSSIPYGPETSDAE 342 
 AauDyP   SHAGFDLGSDQSHCPFSAHIRKTRPRADLGGSLTPPNLSAGANSIMRSGIPYGPEVTSAE 345 
          *.:     :::::***.**:**:.** ****              :*:.******.:.** 
 
 MscDyP1  KASNSSSTDPSLERGLAFVAYQSNIQNGFVFLQKNWVDNTNFFRP----GTGVDPLIGTN 457 
 BadDyP   LASGVT----AQDRGLLFVEYQSIIGNGFRFQQINWANNANFPFSK-PITPGIEPIIGQT 397 
 AauDyP   SASNTT----TQERGLAFVAYQAQLSQGFHFLQQTWADNANFPPGKTPATVGLDPIIGQN 401 
           **  :    : :*** ** **: : :** * * .*.:*:**         *::*:** . 
 
 MscDyP1  SRNSGTDAPNTPRVVSGLDPNNATSTIEIGIDFVVSRGGEYFFSPSLSAIRTVLSV     513 
 BadDyP   ----------TPRTVGGLDPLNQNETFTVP-LFVIPKGGEYFFLPSISALTATIAA     442 
 AauDyP   N--------GQPRVVNGLLPSNSSASLSIP-QFVVSHGGEYFFSPPISAIGGRLSA     448 
                     **.* ** * * . :: :   **: :****** * :**:   ::. 
Figure 28: Sequence alignment of MscDyP1, BadDyP, and AauDyP 
* Identical residues, : Very similar residues, . Similar residues. The catalytic conserved GXXDG motif is 
highlighted in gray. Residues involved in the formation of the H2O2 binding pocket are enclosed in a box. 
Cys306, M302 and M305 of MscDyP1, which were mutated during this dissertation, are colored red. The 
alignment was prepared using Clustal Omega 1.2.1. 
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4.2.2 Crystal structure of MscDyP1 
A PDB file of the unpublished, deprotonated, and minimized structure of crystal D of 
MscDyP1 was used for preparing the figures in this dissertation. Figures were used to 
illustrate the underlying hypothesis for mutational studies performed here, to discuss their 
structural and functional roles for MscDyP1, and to propose and discuss a possible catalytic 
mechanism. 
The three dimensional structure of MscDyP1 indicates all typical structural characteristics of 
other members of the DypPrx superfamily, including all residues at the heme distal site, 
Asp228, Arg388, Leu417, and Phe419. Those residues correspond to Asp171, R329, L354 
and F356 of BadDyP (Yoshida et al., 2011), are conserved among DypPrx, form the hydrogen 
peroxide binding pocket, and are necessary for catalytic activity. Furthermore, the structure 
strongly binds a water molecule at the heme distal site, which will probably be replaced by 
H2O2 upon catalysis. 
The superposition of MscDyP1 with BadDyP, the search model used for structure 
determination and the first and eponymous member of this enzyme family, and superposition 
with AauDyP indicates highly conserved secondary structure elements (Figure 29). MscDyP1 
is highly glycosylated with N-acetyl glucosamine (NAG) and β-D-mannose (BMA). Six sugar 
molecules were identified in the crystal structure model, whereas the glycosylation pattern 
differed between the four crystals in the Asn position, depending on whether NAG or BMA 
was bound. However, BMA and NAG at Asn304 are present in each of the four structures, 
with NAG likewise being conserved in BadDyP.  
 
Figure 29: Superposition of MscDyP1, BadDyp, and AauDyP 
MscDyP1 subunit A and its respective sugar molecules are colored blue, the BadDyP structure is green, and 
AauDyP is purple. The heme central atom is indicated in brown. GXXDG motif of MscDyP1 is enclosed in a 
circle. Conserved sugar molecules, residues of the heme cavity, a single conserved cysteine, and two methionine 
residues are depicted as sticks and highlighted with a red circle. Superposition was performed using Needleman-
Wunsch algorithm and BLOSUM 55 matrix using the program UCSF Chimera. 
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A single cysteine residue is worthy of note in the superposition, which is conserved among 
MscDyP1, BadDyP, and AauDyP. In MscDyP1, Cys360 is surrounded by hydrophobic 
residues; for example I366 which contributes to the formation of the heme-binding pocket. 
Additionally, two methionine residues, Met302 and Met305, is noteworthy at the surface of 
MscDyP1. MscDyP1 is suggested to adapt a dimeric assembly (Hayashi et al., 2012) and both 
methionine residues are located at the possible dimer interface. Furthermore, Met302 and 
Met305 are located in a hydrophobic pocket and at the top of a helix, which is involved in the 
formation of the heme-binding pocket.  
Although they are suggested to form a biochemically active dimer, interestingly, only weak 
intersubunit interactions are present in MscDyP1, whereas the main contact is mediated via 
conserved sugar molecules (BMA and NAG) located in the subunit interface as shown in 
Figure 30. In detail, intersubunit interactions are mediated via NAG, which is covalently 
bound between both subunits via hydrogen bonds to Asp138’ of subunit B and mediated via a 
water molecule to Thr306 and the backbone of Asn304 of subunit A. Furthermore, Asp138’ 
accepts a hydrogen bond from BMA. Direct monomer-monomoer interaction is facilitated by 
Asn304, that covalently binds to the nitrogen backbone of Trp272’, and by van der Waals 
forces between Pro303 of subunit A and Thr509’ and Val510’ of subunit B, as well as between 
the flexible Met305 of subunit A and Pro271’ of subunit B (Figure 30).  
 
 
Figure 30: Dimer interface of MscDyP1 
Dimer interface of MscDyP1 crystal D. Subunit A is indicated in blue, subunit B in green, and the sugar 
molecule mediating dimerization is orange. Possible intersubunit interactions mediated via hydrogen bonds are 
indicated with light blue lines, and via van der Waals forces in light gray. Residues of subunit B are indicated by 
a single quotation mark to distinguish them from residues of subunit A. This figure was created using UCSF 
Chimera.  
Two solvent-accessible cavities are observable in the structure of MscDyP1 (Figure 31), 
including the accession channel through Lys76, Asn78, Gln219, and Gly229 toward the heme 
plane for H2O2 entry (Figure 31 A).  
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Figure 31: Solvent accessible cavities of MscDyP1 
A: Channel toward heme (brown) plane of MscDyP1 with a bound PEG molecule (green) and conserved water 
atoms (red balls). B: Second solvent-accessible cavity with a bound glycerol molecule (purple) and conserved 
water molecules [heme to water 265 (3.1 Å) and from water to glycerol (2.2 Å)]. C: Cysteine cavity. Two 
possible entrances to Cys (yellow) are connected via water molecules to the protein surface. The position of the 
first entrance is indicated by the protecting NAG molecule (orange) and the second entrance is located at the two 
Met residues (purple), indicated by the black arrow. Here, the solvent is indicated by the violet GOL molecule. 
The main chain backbone is colored light green. This figure was created using UCSF Chimera and subunit A of 
crystal D.  
Interestingly, in each of the crystal structures of MscDyP1, a PEG molecule is present in the 
heme cavity, except in crystal A, where it is missing. A further cavity is approximately located 
on the opposite side enclosed by the residues Asn164, Arg287, Pro466, Asn467, and Val492 
(Figure 31 B). Although this second cavity is too narrow for substrate binding it at least 
allows small molecular weight compounds to enter, as represented by a glycerol observable in 
the crystal structure. A third cavity could be identified containing the conserved cysteine 
residue (Figure 31 C). This cysteine cavity is accessible to small molecules, e.g. H2O or H2O2. 
180° 
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H2O is suggested to form a hydrogen bond to the sulfur atom of Cys360 (distance of 4.2 Å 
between SG of Cys360 and conserved H2O). The cysteine cavity is formed by conserved 
hydrophobic residues, e.g. Ile366 in MscDyP1, which contribute to the formation of the 
heme-binding pocket. The cysteine cavity has two possible entrances: one is protected by a 
NAG molecule, the other entrance is not solvent exposed but rather connected via a network 
of water molecules to the methionine residues in the dimer interface.  
4.2.3 Molecular docking of substrates into MscDyP1 structure 
Co-crystallization attempts of MscDyP1 using the carotenoid pseudo-substrates bixin and 
annato were not successful. As a result, crystals A and B did not contain the expected ligands. 
Therefore, molecular docking of the substrates β-carotene and 2,6-dimethoxyphenol into the 
crystal structure of MscDyP1 without constraints was performed using the provided pdb file 
of crystal D with the program Gold 5.2. The docking poses were ranked according to PLP-
fitness from highest to lowest. Selected docking poses are shown in Figure 32. 
   
A B C 
Figure 32: Docking poses of β-carotene and 2,6-dimethoxyphenol 
A: Best-scored docking pose of β-carotene (BCR, purple) #167. B: Best-scored docking pose of 2,6-
dimethoxyphenol (3MD, orange) #72. C: Docking pose #56 of 3MD with scoring rank 25. Subunit A is colored 
petrol, and the heme cofactor is depicted in brown. This figure was created using UCSF Chimera. 
The first 196 docking poses of β-carotene showed a similar pose in the cleft at the entrance to 
the heme accession channel as seen in the best scored energetically favorable position #167. 
Docking 2,6-dimethoxyphenol into the MscDyP1 structure revealed three different clusters of 
docking poses. In the best-ranked poses, the substrate was docked into the entrance of the 
heme accession channel in a manner similar to the PEG molecule bound in crystals N, B, and 
D. The predominant part of the residual docking poses displayed 3MD near and around the 
heme accession cavity. One remarkable docking position was #56, which was ranked at 
scoring position 25 and showed 3MD docked into the second solvent-accessible cavity of 
MscDyP1, similarly to the solvent component glycerol present in the crystal structure. 
4.2.4 Site-directed mutagenesis of structural features of MscDyP1 
One aim of this dissertation was to study in detail the role of the sulfur-containing residues 
Met302, Met305, and Cys360 of MscDyP1. In order to mutate these three residues, the 
MscDyp1 gene was synthesized commercially, with codon usage optimized for E. coli and 
180
° 
Results 
67 
 
cloned into a pET28a vector in order to heterologously overexpress it in E. coli BL21 cells. A 
mutant lacking the sole and conserved cysteine residue was created by substituting Cys360 
with glycine via site-directed mutagenesis. Furthermore, a double mutant was created by 
substituting Met302 and Met305 with lysine.  
In order to distinguish the recombinant protein produced in E. coli from the one produced in 
A. niger, which was used for crystallization, the respective enzymes will be called (E. coli) 
rMscDyP1 and (A. niger) rMscDyP1. 
4.2.5 Heterologous overexpression and purification of rMscDyP1 variants 
First attempts to heterologously overexpress the (E. coli) rMscDyP1 gene were performed in 
pET28a in KRX cells with the addition of the heme precursor δ-aminolevulinic acid to the 
expression medium. Using this approach the main fraction remained insoluble (Figure 33).  
 
Figure 33: Heterologous overexpression of (E. coli) rMscDyP1 in pET28a in KRK cells 
Western blot after IMAC using anti-His antibody. P: cell pellet, FT: flow through, W: wash, 50-500: fractions 
eluted with 50-500 mM imidazole. 
Several efforts were made to increase protein solubility: decreasing expression temperature or 
IPTG concentration to induce gene expression, increasing time for cell lysis with lysozyme 
and DNaseI from one hour to overnight, increasing buffer volume during lysis to a volume 
ten-times larger than the cell pellet, using different buffers, adding detergents such as Triton 
X100, and adding 1-10% glycerol or urea ranging from 0.5 M up to 8 M. However, none of 
these efforts could increase solubility of (E. coli) rMscDyP1. Therefore, several chaperones 
were tested to assist correct folding and thereby probably increase solubility (Figure 34). 
  
A B 
Figure 34: Co-expression of (E. coli) rMscDyP1 with chaperones 
M: protein ladder, P: cell pellet, 10: 10 mM imidazole for column washing, 500: elution with 500 mM imidazole. 
SDS PAGE after IMAC (A) and Western blots using anti-His-antibody (B) for coexpression of (E. coli) 
rMscDyP1 with chaperones dnaK, dnaJ, and grpE (plasmid pG-KJE7); with chaperones groEL, groES, and tig 
(plasmid pG-Tf2); and with chaperone tig (plasmid pTf16).  
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The GoEL/GroES chaperone pair was selected for coexpression with (E.coli) rMscDyP1 in 
pET28a in KRX cells with δ-aminolevulinic acid. This approach increased the soluble protein 
fraction (Figure 35). The purest fraction eluted with 500 mM imidazole was used for 
biochemical evaluation of the mutants. 
 
 
 
Figure 35: Purification of (E. coli) rMscDyP1 via Ni-NTA affinity chromatography 
Purification of (E. coli) rMscDyP1 (A), (E. coli) rMscDyP1C360G (B), and (E. coli) rMscDyP1M302K + M305K (C). M: 
protein ladder, P: cell pellet, SN: supernatant, FT: flow through, 20-500: fractions eluted with 20-500 mM 
imidazole. The proteins were coexpressed with groEL, groES, and tig. 
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4.2.6 Kinetic characterization of rMscDyP1 mutants 
The peroxidase activity of the recombinantly produced (E. coli) rMscDyP1 and the mutants 
lacking either the single conserved cysteine (Cys360) or the two selected methionine residues 
(Met302 and Met305) was assessed using the ABTS assay. Table 7 summarizes the respective 
specific activities. The specific activity of both mutants differs significantly from the specific 
activity of (E. coli) rMscDyP1 within the ABTS assay, indicating that both mutants display a 
lower peroxidase activity. As shown before, MscDyP1 degrades β-carotene (Zelena et al., 
2009). Therefore, ABTS was replaced with β-carotene as a substrate in order to follow β-
carotene degradation by (E. coli) rMscDyP1 and by both mutants in comparison. Similar 
results were obtained revealing that both mutants displayed a lower β-carotene degradation 
activity than (E. coli) rMscDyP1. Conspicuously, the relative residual activity following 
mutation was higher than that obtained within the ABTS assay (Table 7). Additionally, the 
apparent KM values of the substrates H2O2 and ABTS (Figure 36) were determined 
(summarized in Table 8). 
Table 7: Specific activity of (E. coli) rMscDyP1 and mutants 
 Specific activity [nmol*min-1*mg-1]a 
 ABTS assay β-carotene assay 
(E. coli) rMscDyP1 1,460 ± 1,340 (100) 9.2 ± 5.0 (100) 
(E. coli) rMscDyP1C360G 39.1 ± 21.1 (2.7)*** 1.2 ± 0.9 (13.0)*** 
(E. coli) rMscDyP1M302K + M305K 37.3 ± 20.7 (2.6)*** 1.2 ± 0.7 (12.6)*** 
a Values in parentheses are relative activity (%) with the value for (E. coli) rMscDyP1 set at 100%. Values are 
mean values ± SD of at least 5 independent experiments with at least 3 measurements each. *** p < 0.001 
Dunn’s nonparametric multiple comparison for post-hoc testing after Kruskal-Wallis One-Way-ANOVA. 
Table 8: Apparent KM values of (E. coli) rMscDyP1 and mutants 
 KM, app [µM]a 
 ABTS H2O2 
(E. coli) rMscDyP1 51.5 ± 16.7 235 ± 57.1 
(E. coli) rMscDyP1C360G 60.4 ± 12.7 372 ± 103*** 
(E. coli) rMscDyP1M302K + M305K 78.6 ± 8.6** 293 ± 86.8 
a Apparent KM of H2O2 in the presence of 0.5 mM ABTS and apparent KM of ABTS in the presence of 0.25 mM 
H2O2 determined using the ABTS assay. The values represent mean values ± SD of at least three independent 
experiments with at least three reproductions. ** p < 0.05, *** p < 0.001 Dunn’s nonparametric multiple 
comparison for post hoc testing after Kruskal-Wallis One-Way-ANOVA using (E. coli) rMscDyP1 as a control. 
Cys360 appears to contribute to H2O2 reduction by (E. coli) rMscDyP1, but does not 
contribute to the affinity to the substrate ABTS. The lack of the methionine residues has no 
effect on enzyme affinity to the substrate H2O2. In contrast, these data suggest that at least one 
of the mutated methionine residues affects ABTS binding. 
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Figure 36: KM curves for H2O2 and ABTS for (E. coli) rMscDyP1 and mutants 
The graphic shows representative graphs of apparent KM curves for H2O2 (left) in the presence of 0.5 mM ABTS 
and for ABTS (right) in the presence of 0.25 mM H2O2 obtained in the ABTS assay for (E. coli) rMscDyP1 (A, 
B), (E. coli) rMscDyP1C360G (C, D), and (E. coli) rMscDyP1M302 + M305 (E, F), respectively.  
Furthermore, both mutants appear to possess a higher H2O2 resistance than (E. coli) 
rMscDyP1 (Figure 37). While (E. coli) rMscDyP1 is strongly inhibited by H2O2 
concentrations above 1 mM to approximately 65% activity, both mutants retain about 80% 
residual activity.  
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Figure 37: Inhibition of (E. coli) rMscDyP1 by excess H2O2 
The graphic shows representative graphs of activity of (E. coli) rMscDyP1 (A), (E. coli) rMscDyP1C360G (B), and 
(E. coli) rMscDyP1M302 + M305 (C) depending on different H2O2 concentrations in the presence of 0.5 mM ABTS 
obtained in the ABTS assay. 
In order to study the contribution of Met305 to the dimerization of (E. coli) rMscDyP1, the 
protein was loaded onto a Superdex 200 prep grade gel filtration column (Figure 38).  
The spectrum observed at 280 nm during gel filtration chromatography indicated that the 
IMAC protein fractions contained a mixture of a ~50 kDa protein, a ~160 kDa protein, and 
high molecular weight oligomers (~500-2200 kDa). Western blots, using anti-His antibodies 
to detect His-tagged (E. coli) rMscDyP1, indicated that the ~50 kDa protein was a different 
protein than (E. coli) rMscDyP1 (Figure 39) and contributed to the band at around 25 kDa 
that was co-purified with (E. coli) rMscDyP1 via IMAC. It is not the band for the chaperones, 
since this band was also present in the previous expression approaches without chaperones. 
Furthermore, an anti-His Western blot assigned all remaining peaks to (E. coli) rMscDyP1 
and confirmed the presence of these different oligomerization states in (E. coli) rMscDyP1. 
Both mutants exhibited similar oligomerization states to (E. coli) rMscDyP1, suggesting that 
neither Cys360, Met302 nor Met305 contributed to the oligomeric assembly of (E. coli) 
rMscDyP1. 
 
Results 
72 
 
 
Figure 38: Size exclusion chromatography of (E. coli) rMscDyP1 and mutants 
Oligomerization behavior of (E. coli) rMscDyp1 (A), (E. coli) rMscDyp1C360G (B), and (E. coli) rMscDyp1M302 + 
M305 (C).  
 
Figure 39: Western blot of (E. coli) rMscDyP1 after gel filtration chromatography 
Western blot (left) using anti-His antibody and SDS-PAGE of the 1st to 5th eluted peaks detected at 280 nm via 
gel filtration chromatography. M: protein ladder. 
Attempts to partly unfold the high molecular weight aggregates of (E. coli) rMscDyP1 by 
increasing or decreasing the buffer salt concentration (0-500 mM NaCl), reducing the enzyme 
with 10-20 mM DTT, or partly denaturation with 0.5 M urea had no effect on the 
oligomerization state. 
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In order to confirm the role of sulfur-containing amino acids in the enzymatic activities of 
MscDyP1 and (E. coli) rMscDyP1, the recombinant (A. niger) rMscDyP1 was treated with the 
thiol-blocking agents methylmethanethiosulfonate (MMTS) and iodoacetamide (IAA). 
MMTS blocks the sulfhydryl group of cysteine via sulfenylation, whereas excess 
iodoacetamide was reported to alkylate cysteine, methionine, lysine, and histidine residues 
(Fruchter et al., 1967; Kruger et al., 2005). Blocking Cys360 with MMTS or blocking 
cysteine and methionine residues with excess iodoacetamide from (A. niger) rMscDyP1 had 
no effect on the enzyme activity, whereas (E. coli) rMscDyP1 was inhibited by 40% following 
treatment with MMTS or IAA (Figure 40). 
 
Figure 40: Blocking the sulfur-containing amino acids of MscDyP1 
Mean values ± SD of at least three independent experiments with at least three reproductions. ***p < 0.001 
Dunnet’s multiple comparisons test after One-Way ANOVA. IAA: iodoacetamide, MMTS: methyl 
methanethiosulfonate. 
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5 DISCUSSION 
5.1 PfalMAT 
Previous mass spectrometric analyses of the S-glutathionylome and S-nitrosylome of P. 
falciparum identified PfalMAT as a potential target of these post-translational modifications 
in the parasite cell lysate. This suggested a potential role for these redox modifications in 
regulating of the PfalMAT activity. Furthermore, similar approaches indicated an interaction 
of PfalMAT with the plasmodial thiol disulfide reductases PfTrx1, PfGrx, and PfPlrx. The aim 
of this dissertation was to characterize the interaction of PfalMAT with these redox partners in 
detail and to identify the target sites of the thiol modifications S-glutathionylation and S-
nitrosylation as well as their conformational and catalytic consequences for PfalMAT. 
5.1.1 Homology model of PfalMAT 
Chemical modifications of MAT cysteine thiols and site-directed mutagenesis studies pointed 
to a role of cysteines in the activity and oligomerization of MATs (Pajares et al., 1991; 
Mingorance et al., 1996). Therefore, their contribution to the oligomerization and activity of 
PfalMAT had been investigated here. PfalMAT contains eight cysteines. However, the 
homology model using ChMAT and hMATII as templates indicated that only two 
intermolecular disulfide bridges capable of mediating monomer-monomer interactions are 
possible, namely between Cys52 and Cys52’ and between Cys187 and Cys187’ (Figure 9). 
Furthermore, these residues, as well as Cys113, are solvent accessible and hence potential 
targets of redox-based modifications. They were therefore selected for further investigation.  
Cys52 and Cys187 are not conserved in rlMAT, cMAT, or human homologs, but Cys52 is 
present in ChMAT. Cys187 is located on top of a loop connecting two beta-barrel strands. 
This loop is a typical structure among MATs; however, in PfalMAT this loop contains an 
insertion along with Cys187. Furthermore, the loop contains possible hinges, Gly185 and 
Gly189, which allow the intermolecular disulfide between Cys187 and Cys187’ to open and 
to close. Cys113 is located at the beginning of the conserved flexible loop above the active 
site and corresponds to Cys121 of rlMAT, which has been shown to be S-nitrosylated (Avila et 
al., 1997). This loop is involved in binding the adenine ring of the substrate ATP and can 
adapt two conformations (Taylor et al., 2002). Structures of homologous MAT with bound 
substrates, e.g. SAM, ATP analogs, or L-methionine (1p7I, 1rg9, 4odj), show an ordered 
helical conformation of this loop (Taylor et al., 2002; Taylor et al., 2003). In MAT structures 
without substrates the loop that opens the entrance to the active site is disordered (Komoto et 
al., 2004).  
5.1.2 Oligomerization of PfalMAT 
As it had been shown here via gel filtration analysis, recombinant PfalMAT is a homodimer, 
as previously suggested by a homology model using cMAT as a template (Chiang et al., 
1999). In contrast, it was later reported that PfalMAT might be a monomer, however, without 
published experimental evidence (Muller et al., 2008). The two active sites are located at the 
dimer interface and consist of residues of both subunits, as shown for cMAT (Takusagawa et 
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al., 1996) and also indicated by our homology model. Therefore, an active monomer is rather 
unlikely. Most MAT isoenzymes appear as homotetramers (e.g. cMAT, rlMAT, human 
MATα2) (Markham et al., 2009) composed of two subunits that forms a tight dimer, and a 
pair of these dimers form a tetrameric enzyme (Takusagawa et al., 1996). 
Since it was reported that the MAT oligomerization depends on disulfide bridges (Corrales et 
al., 1990; Markham et al., 2009), here the influence of selected cysteine residues on the 
oligomerization behavior of PfalMAT was investigated in detail. These cysteines were 
conservatively mutated to isosteric serine in order to minimize any effects on protein function 
and integrity via mutation itself as well as to study the role of these cysteine residues. 
The reduction of disulfide bridges with the reducing agent DTT did not affect the 
oligomerization of PfalMAT. This result alone indicated that PfalMAT dimerization is not 
mediated exclusively via disulfide bridges. Nevertheless, the PfalMAT variants lacking Cys52 
or Cys187 showed a mixture of monomers and dimers in gel filtration experiments. These 
seemingly contrary results can be explained by numerous additional intersubunit interactions 
observable in the homology model of PfalMAT. Monomer-monomer contacts are mainly 
mediated via ionic interactions such as salt bridges. Therefore, reducing and thereby cleaving 
the two disulfide bridges might not affect dimerization, but a lack of Cys52 or Cys187 might 
lead to insufficient dimerization. Interestingly, reducing these mutants shifted the 
monomer/dimer mixture exclusively towards dimers, which might be due to a reduction of 
false/non-native disulfides in these protein variants, which were solved with DTT to enable a 
correct folding and conformation. A cysteine corresponding to Cys52 or Cys187 in PfalMAT 
is present in neither mammalian MAT nor cMAT. However, altered oligomerization behavior 
after cysteine mutation was likewise reported for cMAT, where a mutation of Cys90 (Ala97 in 
PfalMAT) shifted the oligomerization state from a tetramer to a mixture of dimers and 
tetramers (Reczkowski et al., 1995). Furthermore, mutations of Cys69 (Phe61 in PfalMAT), 
Cys312 (Cys307 in PfalMAT), and Cys377 (Ala374 in PfalMAT) in rlMAT led to a 
dimerization of the tetramer/dimer mixture in the wildtype (Mingorance et al., 1996). 
Additionally, folding studies with L. donovani MAT showed a proper folding pattern only 
under reducing conditions. Here, Cys22 (Cys27 in PfalMAT), Cys44 (Cys49 in PfalMAT), 
and Cys305 (Val310 in PfalMAT) participated in the oligomerization process (Perez-Pertejo et 
al., 2003). 
5.1.3 Enzymatic characterization of PfalMAT 
In this dissertation, a sensitive colorimetric endpoint assay detecting the formed amount of 
orthophosphate by ammonium molybdate was used to monitor PfalMAT activity. This assay 
was previously developed for glutamine synthetase (Gawronski et al., 2004). It is non-
radioactive, therefore safer and more time and cost effective, than the methods using 
radioactive labelling. A similar assay had been used to monitor hMATI/III and rlMATI/III 
(Gonzalez et al., 2000; Sanchez del Pino et al., 2002). A number of different assay systems 
had been employed for monitoring MAT activity; the use of radioactive labels following SAM 
formation is the most widespread method (Markham et al., 1980; Chiang et al., 1999). 
The pH profile of PfalMAT revealed a broad pH optimum between 7.5 and 9.0, which was in 
the range of reported pH optima (pH 6-10) of MATs from other organisms (Pajares et al., 
2011). However, the TAPS assay buffer limited the testable pH range, it might actually be 
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even broader. PfalMAT activity depended on the presence of the monovalent cation K+ and 
the divalent cation Mg2+, as shown for other MATs (Takusagawa et al., 1996; Mato et al., 
1997). Crystal structures of MAT from different species indicate the presence of two 
magnesium ions and one potassium ion within the active site (Takusagawa et al., 1996). These 
cations are essential for catalysis and contribute to stability and substrate binding 
(Takusagawa et al., 1996; Mato et al., 1997). Mg2+ directly interacts with the tripolyphosphate 
chain of ATP, which might explain the decreasing activity of PfalMAT with decreasing 
magnesium concentration in the assay. Interestingly, high magnesium concentrations also 
inhibited PfalMAT. This might be due to a greater ionic strength (Geller et al., 1986). 
Furthermore, low potassium concentrations inhibited PfalMAT. One potassium ion is located 
in the intersubunit interface (Takusagawa et al., 1996). It probably does not directly contribute 
to catalysis, since neither crystallographic, spectroscopic nor mutagenesis data indicated a 
direct binding to the substrates (McQueney et al., 1995; Pajares et al., 2011), but has been 
suggested to help assemble the subunits and thus maintain the geometry of the active site, 
which is located in the intersubunit interface (Takusagawa et al., 1996; Komoto et al., 2004).  
The specific activity of recombinant PfalMAT is in a similar order of magnitude as the 
activity of recombinant L. infantum MAT (Reguera et al., 2002) and Bacillus subtilis MAT 
(Kamarthapu et al., 2008). However, the corresponding enzyme in other human pathogenic 
organisms such as E. coli, T. brucei and M. smegmatis; and in the archea P. furiosus, 
Methanocaldococcus jannaschii, or Thermococcus kodakarensis, and the human counterpart 
hMATIII exhibit a higher activity than PfalMAT (Table 9).  
Table 9: Specific activity of MAT from different species 
Species 
Specific 
activity 
[nmol*min-1 
*mg-1] 
KM ATP  
[µM] 
KM Met 
[µM] 
Reference 
P. falciparum 379 588 32 this work 
L. infantum 200 5,000 (native),  
370 (recombinant) 
35 
n. d. 
(Reguera et al., 1999; 
Reguera et al., 2002) 
B. subtilis 362 110 80 (Kamarthapu et al., 2008) 
E. coli 2,200 920 260 (Markham et al., 1980) 
T. brucei 2,800 1750 150 (Yarlett et al., 1993) 
M. smegmatis 1,300 n. d. 96 (Berger et al., 2003) 
P. furiosus 4,300 115 31 (Porcelli et al., 2015) 
M. janaschii 3,000 350 140 (Graham et al., 2000) 
T. kodakarensis 1,950 6,540 310 (Schlesier et al., 2013) 
H. sapiens 
(hMATIII) 
1,331 330 168 this work 
H. sapiens 
(erythrocytic) 
n.d. n.d. 2.2 (Oden et al., 1983) 
H. sapiens 
(lymphocytic) 
n.d. 31 3.3 (Kotb et al., 1985) 
n.d.: not determined 
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Although the same assay reagents were used in order to determine MAT activity of different 
organisms, the assay systems varied in terms of the detection method used, ranging from 
spectrophotometric measurements and HPLC based methods to scintillation detection 
(Markham et al., 1980; Chamberlin et al., 2000; Berger et al., 2003). Therefore, the published 
specific activity of MAT of different organisms is difficult to compare, and inter-species 
differences in MAT activity would require a comparison within one assay system. However, 
PfalMAT and hMATIII activity were determined using the ammonium molybdate-based 
assay within this dissertation, thereby allowing a direct comparison.  
The specific activity of hMATIII obtained under assay conditions in this dissertation was by a 
factor of 30-100 higher than the specific activity reported in the literature (12.02 to 39.84 
nmol*min-1*mg-1, (Chamberlin et al., 1997; Chamberlin et al., 2000). This might be 
explained by the different assay systems that were used. Chamberlin et al. measured the 
activity using radioactive labelled L-methionine in order to determine SAM synthesis 
(Chamberlin et al., 2000), whereas the tripolyphosphatase activity of hMATIII was monitored 
here using the ammonium molybdate assay. Therefore, the results are hardly comparable. 
However, the KM for L-methionine of hMATIII that was determined here (168±23 µM) was in 
a similar range of the one previously reported (220 µM) (Chamberlin et al., 2000).  
As shown for most other organisms (Table 9) PfalMAT exhibited a higher affinity towards L-
methionine than towards ATP. The physiological concentration of L-methionine is 430 ± 
290 µM; the intracellular ATP concentration is in a low millimolar range (1-3 mM) as 
reported for saponin-isolated P. falciparum parasites (van Schalkwyk et al., 2008; Teng et al., 
2009). Therefore, the KM values determined for both substrates of PfalMAT, which were 
lower than the reported cellular concentrations, suggest substrate saturation of PfalMAT under 
physiological conditions.  
Interestingly, deleting Cys113 increased the activity of PfalMAT and its affinity to the 
substrate ATP. The homology model of PfalMAT indicated that Cys113 is located on the 
“gate” loop above the active site. The lack of Cys113 might result in conformational changes 
to this loop, favoring ATP binding since this loop is important for ATP binding (Deigner et al., 
1995). Deleting Cys187 had no effect on enzymatic activity, whereas the affinity and turnover 
of ATP was increased. This matches the homology model well, showing that Cys187 is 
structurally connected to residues participating in ATP binding, i.e. via a possible shift in the 
affiliated β-strand, which is connected to the active site residue Lys174. Likewise, Cys52 
mutation decreased substrate affinity, which might be due to conformational changes affecting 
substrate binding, since it is located in the intersubunit interface between both active sites. In 
the future it might be worth testing the effect on the substrate binding for these PfalMAT 
variants in comparison to the wildtype with additional methods, e.g. surface plasmon 
resonance (SPR), with PfalMAT immobilized on a sensor chip and ATP or L-methionine used 
as an analyte.  
5.1.4 Inhibition of PfalMAT 
Even if only weakly, PfalMAT had been shown to be allosterically regulated by SAM in a 
non-competitive manner with L-methionine (Ki 0.7 ± 0.2 mM with L-methionine) and 
uncompetitively with ATP (Ki of 3.6 ± 0.4 mM). This indicated that SAM does not bind 
directly to the ATP binding site of PfalMAT, but can only bind to the enzyme-ATP complex. 
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Thus, according to the kinetic data, SAM can bind both to the enzyme without methionine 
and to the enzyme-methionine complex, but not to the enzyme without ATP. This suggests 
that ATP leads to a conformational change that allows SAM binding, while SAM binds 
independently from L-methionine. The same feedback inhibition pattern were observed for 
MAT from human lymphocytes (Kotb et al., 1985), whereas for human erythrocytic MAT, an 
uncompetitive inhibition by SAM with respect to L-methionine was observed (Oden et al., 
1983). SAM competively inhibits L. infantum MAT to ATP and non-competitively towards L-
methionine (Perez-Pertejo et al., 2003), which was also observed for cMAT (Markham et al., 
1983). SAM uncompetively inhibits MAT from Saccharomyces cerevisiae towards both 
substrates ATP and L-methionine (Greene, 1969). Therefore, there appear to be different 
binding modes and different regulatory mechanisms for feedback inhibition by SAM. The fine 
tuning of this regulation is not yet fully understood.  
Likewise, other parasitic MATs, e.g. from T. brucei (Ki 0.24 mM, (Yarlett et al., 1993)) and L. 
infantum (Ki 1.5 mM, (Perez-Pertejo et al., 2003)) , are weakly inhibited by SAM in contrast 
to other organisms showing Ki values in the micromolar range (Oden et al., 1983; Geller et 
al., 1986). The weak inhibition of PfalMAT suggests that SAM synthesis might be regulated 
in vivo on a transcriptional level rather than protein level via enzymatic activity. This is 
reasonable because SAM synthesis efforts a high amount of energy (ATP). Since SAM is 
especially needed as a polyamine precursor for rapidly reproducing, fast-growing cells, 
necessiating a high amount of energy, a tight regulation of SAM synthesis according to the 
temporal demands of the cell is necessary.  
Chiang et al. tested the classic MAT inhibitor cycloleucine, an amino acid analog, against 
PfalMAT, and it also showed weak inhibition (Ki 17 mM) (Chiang et al., 1999). However, 
cycloleucin generally inhibits MATs in a millimolar range (0.2-17 mM) (Lombardini et al., 
1983; Yarlett et al., 1993). Nevertheless, the promiscuous metabolic roles of SAM encouraged 
the search for potent MAT inhibitors. The most potent reported isozyme-selective MAT 
inhibitors include intermediate analogs, e.g. diimidotriphosphate (Ki 2 nM, (Reczkowski et 
al., 1999)) and substrate analogs, such as the methionine analog inhibitor L-2-amino-4-
methyl-cis-but-3-enoic acid (Ki 5.7-21 µM, (Sufrin et al., 1993)). The later one inhibits T. 
brucei MAT in vivo (Goldberg et al., 1998). However, these compounds are synthezised via 
complex synthetic routes that limit their therapeutic potential. Therefore, further selective 
bioavailable MAT inhibitors are required. 
For this purpose, PfalMAT was screened against the Open Access Malaria Box in a master 
thesis (Gehr, 2014). This inhibitor library contains 200 drug-like and 200 probe-like, diverse 
antimalarial compounds active against blood stage Plasmodium parasites (Spangenberg et al., 
2013). PfalMAT (62 µM) was screened in the ammonium molybdate assay with ATP and L-
methionine at KM concentrations against the Malaria Box at a final concentration of 1 mM. 
None of the 400 tested compounds inhibited PfalMAT at pharmacological concentrations. 
Therefore, none of the compounds was investigated further. However, the ammonium 
molybdate assay monitors tripolyphosphatase activity of PfalMAT; therefore, the screen only 
provided a limited view of PfalMAT inhibition by compounds from the Malaria Box. For 
example, active site mutants of rlMAT (D180G, K182G, F251G, and F251D) nearly incapable 
of SAM synthesis still retained tripolyphosphatase activity, suggesting that both reactions 
occur at different areas of the active site (Gonzalez et al., 2000). Thus, inhibitors binding to 
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the catalytic site of SAM synthesis might not have been detected using the ammonium 
molybdate assay used here. A secondary assay with a divergent detection method that 
determines the SAM synthesis activity of PfalMAT, e.g. via radioactively labelled L-
methionine or via an HPLC-based assay, might identify potential inhibitors of PfalMAT that 
were not detected with the ammonium molybdate based assay.  
5.1.5 Redox regulatory processes affecting PfalMAT 
It was previously shown that PfalMAT interacts with the plasmodial thiol disulfide reductases 
PfTrx1, PfGrx, and PfPlrx (Sturm et al., 2009). However, it has been shown here that the 
effect size of these oxidoreductases on PfalMAT activity differs. While PfGrx had no major 
effects, PfTrx1 and Plrx potently increased PfalMAT activity, even at low molecular ratios at 
subcellular concentrations. PfTrx1 is present at a concentration of 10 µM and mainly in its 
reduced form due to the cytosolic reducing milieu. This indicates that PfTrx1 and PfPlrx 
likely regulate PfalMAT under physiological concentrations in vivo. Since the strongest 
activation was observed upon addition of PfTrx1, the interaction of PfalMAT with this 
redoxin was studied in more detail. PfTrx1 could increase the activity of each of the three 
cysteine deletion mutants. However, the extent of this activation was weaker for PfalMATC52S 
and PfalMATC113S than for PfalMAT, indicating that both residues contribute to the interaction 
of PfalMAT with PfTrx1. During these experiments it was observed that partly oxidized 
PfalMATC187S was barely active. Interestingly, PfTrx1 completely restored its activity. This 
suggests that Cys187 is somehow involved in the activity, probably by contributing to the 
necessary conformation. This is consistent with the results of the oligomerization studies, 
where a mixture of dimers and oligomers was observed for PfalMATC187S, when it was not 
pre-reduced, which was shifted to a dimeric state upon reduction with DTT. The presence of 
dimers within this mixture might explain the residual activity of ~20% of PfalMATC187S 
before reduction with PfTrx1. This suggests the presence of wrong, non-native disulfides in 
PfalMATC187S that negatively affected the activity, which could be cleaved upon reduction.  
Furthermore, another plasmodial enzyme, ornithine aminotransferase (PfOAT), has been 
shown to be regulated by PfTrx1, PfGrx, and PfPlrx (Jortzik et al., 2010). Similar to 
PfalMAT, PfOAT was activated by PfTrx1 and even though to a lesser extent by PfPlrx, 
whereas PfGrx did not affect the enzymatic activity. It has been experimentally validated that 
the interaction between PfOAT and PfTrx1 is mediated covalently via a disulfide bond 
between both proteins, whereas PfGrx bound unspecifically to PfOAT (Jortzik et al., 2010). 
Therefore, it might be worth testing the interaction of PfalMAT and the cysteine mutants with 
PfTrx1 using surface plasmone resonance (SPR) or co-crystallization experiments to validate 
the binding mode. OAT converts ornithine, which presents another precursor for the 
polyamine synthesis beside dcSAM, to glutamate-5-semialdehyde and glutamate. Therefore, 
increasing activity of PfOAT by PfTrx1 might impair polyamine synthesis, whereas activation 
of PfalMAT by PfTrx1 likely promotes polyamine synthesis by providing the precursor 
dcSAM. This strengthen the hypothesis of a redox regulation of enzymes involved in 
polymamine synthesis by PfTrx1 in Plasmodium. An upregulation of the polyamine synthesis 
may favor proliferation and growth of the parasite and might be advantageous for 
Plasmodium. Nevertheless, this hypothetical differential regulation of the pathway by PfTrx1 
raises the question of the in vivo relevance, since both result were obtained in vitro with 
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purified enzymes. Increasing OAT mRNA and protein levels decrease cellular polyamine 
levels in Caco-2 intestinal cells (Dekaney et al., 2008). Mat2A silenced colon cancer cells 
exhibit reduced levels of the polyamine putrescine (Tomasi et al., 2013). However, the 
regulatory role of PfTrx1 in vivo should be addressed in the future.  
MAT from different organisms are redox regulated (Pajares et al., 1992; Martinez-Chantar et 
al., 1996; Avila et al., 1997), even though, evidence for a direct involvement of cysteines in 
catalysis is missing. Purified rlMATI/III was inactivated dose-dependently by H2O2 and his 
inactivation was reversible in the presence of GSH (Sanchez-Gongora et al., 1997). Hydrogen 
peroxide treatment of hamster ovary CHO cells overexpressing rlMATI/III induced enhanced 
cell death compared to wildtype CHO cells. Moreover, the rlMATI/III overexpressing CHO 
cells did not show altered MAT protein levels compared to the wildtype but a reduced MAT 
activity (Sanchez-Gongora et al., 1996). In vivo studies with rats showed that drug-induced 
changes in GSH levels dcreased MATI/III activity (Corrales et al., 1991). These effects were 
neither mediated by a change in mRNA nor protein levels, but by regulation of the enzymatic 
activity. 
2.3.5.1 Protein-S-glutathionylation of PfalMAT 
Protein-S-glutathionylation was shown to regulate activity by activating or inhibiting 
numerous enzymes via S-glutathionylation of structurally or functionally critical cysteines. 
Phosphofructokinase (Yoshitake et al., 1994), protein tyrosine phosphatase-1B (Barrett et al., 
1999), carbonic anhydrase III (Cabiscol et al., 1996), and NF-κB (Pineda-Molina et al., 2001) 
are reversibly inactivated by protein-S-glutathionylation, whereas other enzymes, e.g. 
microsomal glutathione-S-transferase (Dafre et al., 1996), and matrix metalloproteinase 
(Okamoto et al., 2001), are activated upon glutathionylation.  
Likewise, PfalMAT was previously identified as a member of P. falciparum S-
glutathionylationylome (Kehr et al., 2011). Indeed, protein-S-glutathionylation of PfalMAT 
resulted in a 50% loss of activity. Even low concentrations of GSSG (e.g. 100 µM) inhibited 
enzymatic activity, suggesting that protein-S-glutathionylation likely occurs in vivo.  
The inhibition of PfalMAT after adding GSSG was based on formation of mixed disulfides 
with GSH and the formation of intrasubunit disulfides as shown for rlMAT (Pajares et al., 
1992), or wrong intersubunit interactions leading to the formation of higher molecular weight 
oligomers. Protein-S-glutahionylation via formation of mixed-disulfides is suggested to be 
restricted to GSH, whether reaction with GSSG rather leads to a thiol-disulfide exchange 
(Priora et al., 2010). Western blots, using an anti-glutathione antibody clearly demonstrated 
the formation of mixed disulfides between PfalMAT and glutathione in the presence of GSSG. 
Nevertheless, formation of mixed disulfides between PfalMAT and GSSG is unlikely based 
on the redox potential of cysteines and the slow reaction rate. Furthermore, this reaction 
would lead to formation of GSH which, taken the high cellular GSH concentration of 1-10 
mM into account, would be kinetically as well as thermodynamically unfavourable (Priora et 
al., 2010). Therefore, treatment of PfalMAT with GSSG rather led to formation of mixed 
disulfides between PfalMAT and GSH, which might have been present in small portions in the 
reagent. However, the presence of GSSG in this reaction appeared to be necessary since anti-
GSH Western blots using PfalMAT treated with different concentrations of reduced 
glutathione showed signal intensities equal to the untreated control even with high GSH 
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concentrations. Furthermore, the plasmodial cytosol represents a highly reducing environment 
with an estimated glutathione redox potential of -314 (Kasozi et al., 2013). Therefore, the 
reduced form GSH is predominantly present in the parasitic cytosol and S-glutahionylation of 
PfalMAT is likely to occur under conditions of oxidative stress, where the GSH/GSSG ratio 
(10,000:1 (Ostergaard et al., 2004)) is shifted towards GSSG, rather than under physiological 
conditions.  
The reduced activity of S-glutathionylated PfalMAT was fully restored by PfTrx1 and PfPlrx, 
whereas PfGrx was not able to deglutathionylate PfalMAT up to a molar ratio between 
PfalMAT and PfGrx of 1:5. This was consistent with the results for redox regulation of 
PfalMAT by these redoxins, where PfGrx was less able to activate PfalMAT than PfTrx1 and 
PfPlrx. This suggests that PfTrx1 and PfPlrx rather than PfGrx regulate PfalMAT activity in 
vivo. All three redoxins are located in the cytosol of the parasite (Kehr et al., 2010). PfalMAT 
wass likewise suggested to be cytosolic, because it lacks a sequence for nuclear localization, 
as observed for rat MATI in extrahepatic tissues (Lys340, Lys341, Arg344, Lys393) (Reytor et 
al., 2009). Likewise to PfalMAT, addition of Trx (0.5 mM) to rlMAT previously incubated 
with GSSG (0-30 mM) increased the Ki value from 4 mM (rlMAT + GSSG) to 18 mM 
(rlMAT + GSSG + Trx) (Martinez-Chantar et al., 1996). 
Comparing the activity of the cysteine deletion mutants upon S-glutathionylation with 
PfalMAT revealed that Cys113 contributed to the inhibition of PfalMAT with GSSG, since 
GSSG inhibited the respective mutant less than PfalMAT. While the effect of GSSG on 
PfalMATC52S showed no major differences to those on PfalMAT, PfalMATC187S was more 
strongly inhibited upon S-glutathionylation than PfalMAT. An intresting fact since 
PfalMATC187S was also more susceptible to reduction by PfTrx1, as mentioned before. The 
lack of Cys187 might result in conformational changes, increasing the accessibility and 
susceptibility of other cysteines e.g. Cys113 to GSSG. 
Taken together, these results indicate that neither Cys52 nor Cys187S formed mixed 
disulfides with GSH in the presence of GSSG, whereas Cys113 contributed at least partially 
to the S-glutathionylation of PfalMAT. However, since even the Cys113 deletion mutant was 
still inhibited, albeit to a lesser extent than PfalMAT, these results further suggest that at least 
one more cysteine of PfalMAT can be S-glutathionylated. This could be confirmed with 
Western blot results using an anti-GSH antibody that shows the formation of mixed disulfides 
between GSH and a cysteine for each of the PfalMAT variants in the presence of GSSG. 
Similar to PfalMAT, PfOAT was inhibited upon S-glutathionylation (Jortzik et al., 2010). 
Moreover, the bifunctional S-adenosylmethionine decarboxylase/ornithine decarboxylase was 
identified as a target of protein-S-glutathionylation in Plasmodium (Kehr et al., 2011), 
supporting the suggestion that structually or functionally important cysteines are likely 
protected via S-glutathionylation of critical enzymes of the polyamine synthesis pathway 
under oxidative stress in vivo in P. falciparum. An inhibition upon S-glutathionylation was 
also observed for rlMAT (Pajares et al., 1992). Here, the effect was suggested to be based on 
monomerization of rlMAT, but not on the formation of mixed disulfides between rlMAT and 
GSh in the presence of GSSG (Pajares et al., 1992; Martinez-Chantar et al., 1996). Likewise, 
S-glutathionylation of PfalMAT probably resulted at least partly in monomerization. However, 
the main effect of S-glutathionylation observed with respect to the oligomerization behavior 
of PfalMAT was the formation of higher molecular weight oligomers. This was probably 
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based on disulfide bridges being formed. The restored activity and deglutathionylation with 
DTT or the disulfide reductases PfTrx1 and PfPlrx might be explained by cleavage of these 
disulfide bonds upon reduction, thereby enabling a correct conformation. 
2.3.5.2 Protein-S-nitrosylation of PfalMAT 
Our group’s previous studies have demonstrated that PfalMAT is a target of S-nitrosylation by 
using the physiologically relevant NO donor GSNO (Gehr, 2014; Wang et al., 2014). 
Interestingly, as with S-glutathionylation of PfalMAT, S-nitrosylation did not completely 
abolish PfalMAT activity. Likewise, S-nitrosylation only partly inhibited rlMAT, however to a 
higher extent (~80% inhibition by GSNO) than PfalMAT (~35% inhibition by GSNO) (Ruiz 
et al., 1998). MAT from Arabidopsis thaliana was also inhibited upon S-nitrosylation of 
Cys114 of the SAM1 isoenzyme; however, it is not conserved in PfalMAT. In rlMAT Cys121 
was shown to be the target of S-nitrosylation, which corresponds to Cys113 in PfalMAT and is 
located on the flexible loop above the active site (Takusagawa et al., 1996; Sanchez-Gongora 
et al., 1997; Perez-Mato et al., 1999). Site-directed mutagenesis studies of rat liver MATI/III 
indicated that the acidic Asp355 and the basic Arg357 and Arg363 in the vicinity of Cys121 
are important for deprotonating the cysteine sulfur group and subsequently facilitate S-
nitrosylation of Cys121 (Perez-Mato et al., 1999). These acidic and basic amino acids 
localized next to Cys113 are conserved in PfalMAT (Asp352, Arg354, and Gln360, a 
conservative substitution, respectively). It was suggested that this ”gate loop” to the active 
site adapts a closed conformation to prevent access to the active site upon S-nitrosylation of 
Cys121 (Takusagawa et al., 1996). Moreover, S-nitrosylation of rlMAT corresponded to 
decreased SAM levels in vivo (Ruiz et al., 1998). Accordingly, GSNO inhibited the respective 
mutant, PfalMATC113S, to a lesser extent than PfalMAT, indicating that this residue indeed 
mediated S-nitrosylation of PfalMAT. However, here it was shown that each of the cysteine 
deletion mutants was inhibited to a lesser extent than PfalMAT, indicating that Cys52, 
Cys113, and Cys187 contributed to the S-nitrosylation of PfalMAT. Nevertheless, each of 
these mutants could still be S-nitrosylated suggesting that they were not the only targets of S-
nitrosylation in PfalMAT. Therefore, unlike rlMAT, several cysteines likely regulate PfalMAT 
activity, including Cys52, Cys113 and Cys187, in response to NO stress.  
S-nitrosylation was studied in this dissertation by using the ammonium molybdate assay. 
Although ascorbate, the reducing agent used within the ammonium molybdate assay, can 
reverse S-nitrosylation (Foster et al., 2009; Huang et al., 2010), this assay was still suitable 
for studying the effect of nitrosylation on PfalMAT activity, since the PfalMAT reaction was 
finished before ascorbate was added to the reaction mixture.  
Induction of the endogenous NO-production in rats via intraperitoneal injection of bacterial 
lipopolysaccharides lead to rlMATI/III inhibition, whereas the mRNA and protein levels 
remained constant (Avila et al., 1997). An NO synthase has not yet been identified in P. 
falciparum (Pajares et al., 1992); however, endogenous NO production was observed in 
intraerythrocytic P. falciparum parasites and in isolated food vacuoles of P. falciparum 
(Pajares et al., 1991). To gain more hints for the in vivo relevance it might be worth treating P. 
falciparum parasites with drugs inducing NO stress and subsequently measure the PfalMAT 
activity in cell lysates e.g by HPLC-based detection of SAM.  
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5.1.6 Conclusion and outlook 
Figure 41 provides an overview of the redox processes affecting PfalMAT activity or structure 
that were studied during this dissertation and possible affected downstream pathways. 
 
Figure 41: Regulation of SAM metabolism via the redox state of PfalMAT 
SAM is a precursor for polyamine synthesis and the generation of radical SAM. It is also the most important 
methyl group donor involved in the trans-methylation of DNA and proteins and may be transported into the 
nucleus of P. falciparum, although this has not yet been proved (gray dotted arrow). Dashed arrows indicate a 
regulatory effect by activating (+) or reducing (-) the enzyme activity via cysteine reduction, protein S-
glutathionylation, or protein S-nitrosylation. The origins of NO production are indicated with black dotted 
arrows. An NO synthase has not yet been identified in P. falciparum (Pajares et al., 2013); however, endogenous 
NO production was observed in intraerythrocytic P. falciparum and in isolated food vacuoles (Pajares et al., 
1991). Abbreviations: AdoMetDC/ODC bifunctional S-adenosylmethionine decarboxylase/ornithine 
decarboxylase, dAdo* 5’-deoxyadenosyl radical, dcSAM decarboxylated S-adenosylmethionine, GR glutathione 
reductase, GSH reduced glutathione, GSSG glutathione disulfide, MTA 5ʹ-methylthioadenosine, NO nitric 
oxide, PfalMAT methionine adenosyltransferase of P. falciparum, Plrx plasmoredoxin, SAM S-
adenosylmethionine, Trx1 thioredoxin 1, TrxR thioredoxin reductase. 
A regulation of PfalMAT activity and thus SAM synthesis in response to the GSH/GSSG ratio 
as well as alterations to the redox state of the cell are reasonable with respect to the central 
position of SAM in multiple vital downstream pathways of P. falciparum. An activation of 
PfalMAT with PfTrx1 and PfPlrx preserves polyamine biosynthesis, which is crucial for this 
rapidly growing and multiplying parasite, especially under the harsh conditions it has to cope 
with within its host organisms. Protecting critical cysteine residues of PfalMAT under 
oxidative and nitrosative stress via S-glutathionylation and S-nitrosylation and restoring the 
activity via deglutathionylation with PfTrx1 and PfPlrx maintains the functionality of this 
important enzyme. It also regulates and protects downstream pathways. Inhibiting PfalMAT 
under oxidative stress might cause DNA/histone hypomethylation resulting in increased gene 
expression (Lu et al., 2001; Jani et al., 2009) which might be necessary to counteract 
increased ROS or RNS levels. However, whether PfalMAT itself is translocated or its product 
SAM is transported into the nucleus has yet to be verified. Therefore, it would be of great 
interest to study the subcellular localization of PfalMAT in the parasite, e.g. with confocal 
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microscopy. Furthermore, it might be interesting to measure the intracellular SAM level after 
challenging the parasite with redox-active compounds to prove the in vivo relevance of 
PfalMAT redox regulation, S-glutathionylation, and S-nitrosylation e.g. by HPLC detection of 
SAM in P. falciparum cell lysate after drug treatment. 
The results pointed towards an additional cysteine that participates in redox regulation of 
PfalMAT. Cys52, Cys113, and Cys187 were selected as potential candidates because all of 
them are located in the dimer interface and are clearly surface exposed (Figure 9 A). 
However, Cys38 and Cys307 might also be accessible, since they are located on the surface of 
PfalMAT. Nevertheless, both residues project into the protein core, and thus appeared 
incapable of interacting with redox-active small molecules and forming an intermolecular 
disulfide bridge. The other three cysteine residues Cys264, Cys27, and Cys49, are integrated 
into the protein backbone and buried inside the protein core. They are therefore unable to 
interact with oxidizing or reducing agents, and none of them has a cysteine in their direct 
structural neighborhood that could act as an interaction partner for disulfide bond formation. 
According to the homology model of PfalMAT, Cys187 might be capable of forming an 
intramolecular disulfide with Cys307. This corresponds to Cys312 of rlMAT, which probably 
contributes to oligomerization since a site-directed mutagenesis shifted the tetramer/dimer 
mixture towards a dimeric state of rlMAT (Mingorance et al., 1996). Taking all results into 
account, it would be interesting to study the contribution of Cys38 and Cys307 to S-
glutathionylation and S-nitrosylation of PfalMAT in order to draw a complete picture of the 
redox-regulatory modifications affecting PfalMAT. Furthermore, crystallographic data of 
PfalMAT and the cysteine deletion variants may provide more insights into the contribution of 
these residues to the regulation of PfalMAT activity and oligomerization.  
Although PfalMAT is a promising drug target, the homology model revealed a high structural 
similarity to its human counterparts that hampers development of selective inhibitors of the 
plasmodial enzyme. Nevertheless, Cys52 and Cys187 are only present in PfalMAT and 
therefore might be worth focussing on with respect to rational design of covalent inhibitors 
selectively targeting PfalMAT. Computational approaches such as virtual screening of 
compound databases e.g. PubChem, ChEMBL, eMolecules, or ZINC using the homology 
model of PfalMAT and docking studies, may provide promising molecular scaffolds as 
starting points for a rational drug design. 
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5.2 MscDyP1 
5.2.1 Crystal structure of MscDyP1 
The crystal structure indicated that MscDyP1 is highly glycosylated, which is typical for 
secreted heme peroxidases (Sugano et al., 2000; Sugano, 2009; Hofrichter et al., 2010). 
Glycosylation stabilizes the secreted, extracellular proteins within hostile environments (Nie 
et al., 1999). Furthermore, it was proposed that carbohydrate side chains are not required for 
activity but rather increase thermostability (Nie et al., 1999) and protect from proteolytic 
degradation (Hayashi et al., 2012). Likewise, glycosylation of MscDyP1 appeared to play an 
important role. BMA and NAG at Asn304 were present in each of the four crystal structures, 
located between the subunits and therefore strongly bound. As a result, the structure strongly 
implied that dimerization requires glycosylation. NAG is also conserved in BadDyP at this 
position. However, BadDyP is a monomer (Yoshida et al., 2011). This indicates that further 
residues contribute to dimerization of MscDyP1. Since only weak intersubunit interactions 
were present in MscDyP1, the crystal structures also indicated that it is a monomer rather than 
a dimer, but they allowed for possible dimerization. Moreover, the enzyme biochemically 
appeared as an active dimer (Zelena et al., 2009). Therefore, MscDyP1 was treated as a dimer 
based on the intersubunit contacts observed.  
The sequence and tertiary structure are highly conserved within DypPrxs. However, the 
structure of MscDyP1 revealed interesting structural features, including two methionine 
residues, Met302 and Met305, at the surface of MscDyP1. Hydrophobic residues such as 
methionine are normally buried inside the protein core. Hydrophobic residues are likewise 
present in BadDyP in these positions (Leu247 and Ala244, respectively). Met302 and Met305 
are located at the possible dimer interface. In fact, Met305 participates in intersubunit 
interactions and thus facilitates dimerization. Furthermore, both residues were located in a 
hydrophobic pocket and on top of a helix involved in the formation of the heme-binding 
pocket, suggesting modification of these amino acids via redox-active agents, for example, 
and they might affect enzymatic activity.  
Remarkably, a single cysteine residue is conserved within MscDyP1, BadDyP, and AauDyP, 
but has not been previously investigated. The conservation suggests an important function of 
this residue for either catalytic activity or structural integrity. This cysteine residue is located 
in a small cavity accessible to small molecules such as H2O or H2O2. H2O is suggested to 
form a hydrogen bond to the sulfur atom of Cys360 (distance of 4.2 Å between SG of Cys360 
and conserved H2O). Residues forming this cavity are conserved among these three DypPrx. 
The thiol group of Cys360 is connected via hydrogen bonds to the oxygen atom of Pro361 
backbone (3.7 Å distance of SG of Cys360 to oxygen of P361, Figure 42). Therefore, 
modifying Cys360 might induce a shift in the main chain at the heme proximal site, including 
His365, one of the coordination partners of the central heme atom, thereby affecting the 
geometry of the heme cavity that might inhibit enzyme activity. The cysteine cavity has two 
possible entrances. In comparison to BadDyP and AauDyP where both entrances are 
accessible without hindrance, in MscDyP1 one of them is protected by a NAG molecule. The 
other entrance is exposed to solvent in BadDyP and AauDyP but in MscDyP1 the cysteine 
cavity is connected via a network of water molecules to the methionine residues in the dimer 
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interface. This suggests that the second entrance to the Cys cavity is blocked in the dimeric 
assembly of MscDyP1. However, the weak intersubunit interactions of the MscDyP1 dimer 
allow a restricted movement of both subunits, which might allow entrance to the Cys cavity. 
However, further experimental validation would be necessary to prove this movement, e.g. 
molecular dynamic simulation. 
 
Figure 42: Cys cavity and second H2O binding site of MscDyP1 
The conserved H2O34, which is probably replaced by H2O2 is connected with a distance line to the SG of 
Cys360 (dark blue). SG is also connected via a hydrogen bond to the oxygen atom of Pro361, which is 
connected to the main chain (light green) leading to His365. His365 represents the proximal fifth ligand of heme. 
Thus oxidation of Cys360, which solves the H-bond, might induce a shift in the main chain affecting the activity. 
Two possible entrances to the Cys cavity could be identified, which are connected via conserved water 
molecules to the surface. The position of the first entrance is indicated by the protecting NAG molecule; the 
second entrance is located at the two Met residues (purple). Here, the violet GOL molecule indicates the solvent. 
The heme molecule is depicted as a brown stick model. Sugar molecules are colored in orange, and residues of 
the main chain leading to the proximal heme side are highlighted in light green. The second subunit is indicated 
in green. This figure was prepared using UCSF Chimera.  
The role of the three sulfur-containing amino acids Cys360, Met302, and Met305 was studied 
in greater detail during this dissertation. 
5.2.2 Characterization of MscDyP1 variants 
The specific activity varied between several enzyme batches, represented by a high standard 
deviation. This was likely due to impurity of the enzyme and the resulting divergence between 
the measured protein concentration and the real concentration of (E. coli) rMscDyP1 due to 
contaminations with E. coli proteins. Accordingly, the Reinheitszahl value for the enzymes 
produced in E. coli was rather low (~0.4), it should be around three for pure heme proteins 
(Theorell, 1950). Nevertheless, the activity of both mutants was significantly reduced 
compared to the unmodified rMscDyP1 produced in E. coli, indicating that inhibition is based 
on the mutation. The impurity of the enzymes necessitated verification of these results in a 
more specific assay system using β-carotene as a substrate since according to current 
knowledge MscDyP1 is the only DypPrx capable of degrading β-carotene, and to the current 
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C360 
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F362 
S363 
A364 
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knowledge E. coli lacks β-carotene-degrading enzymes (e.g. carotenoid dehydrogenase, 
oxidase or desaturase gene has not been deposited in the National Center for Biotechnology 
Information, (NCBI)). The relative residual activity following mutation was higher than 
obtained within the ABTS assay. This might be explained by the higher specificity of the β-
carotene degradation assay compared to the ABTS assay or a divergent catalysis of both 
substrates. Since substrate saturation of MscDyP1 with β-carotene could not be accomplished 
within a measureable absorption range, it was impossible to determine a KM for β-carotene. 
The specific activity of (E. coli) rMscDyP1 was 100 times lower than that of the respective 
recombinant enzyme produced in A. niger (~110 µmol*min-1*mg-1, personal communication 
with Katharina Schmidt, Zorn lab, Department of Food Chemistry and Food Biotechnology, 
Justus Liebig University Giessen), which was used for protein crystallization. Additionally, 
the KM value for H2O2 of (E.coli) rMscDyP1 was 47 times higher than the one reported for 
the respective enzyme produced in A. niger (5 µM) (Liers et al., 2013). Furthermore, a lower 
pH stability of the enzymes produced in E. coli was observed. This might be explained by the 
lacking glycosylation of (E. coli) rMscDyP1 since it was produced in a bacterial expression 
system. Therefore, overexpression of the mutants in a eukaryotic expression system and 
comparison with the data obtained for the enzmyes produced in E. coli would be of high 
interest for future studies. 
Although MscDyP1 was suggested to be a dimer, no experimental data are available on the 
recombinant enzyme produced in A. niger, that claim that the dimer is the only active form. 
The enzyme produced in E. coli contained a mixture of dimers and higher molecular weight 
oligomers because gel filtration chromatography was not suitable for clearly separating these 
fractions. Further purification methods, e.g. based on charge, would therefore be necessary in 
order to distinguish between dimer activity and higher molecular weight fractions.  
A lack of Cys360 decreased enzymatic activity. Since residues that form the Cys cavity also 
contribute to form the heme-binding pocket, deleting Cys360 likely induced a conformational 
change in the heme-binding pocket that affected activity. Furthermore, the cysteine deletion 
mutants showed less affinity to the substrate H2O2. This might be explained by the size of the 
Cys cavity, which is accessible to H2O2 but too narrow to allow ABTS access. Nevertheless, it 
might also be explained by a shift in the mainchain due to the mutation that affects geometry 
of the heme cavity and thus H2O2 binding in the heme distal site. Therefore, deleting the 
cysteine might affect H2O2 binding in the distal or proximal heme site.  
In contrast, the methionine double mutant showed decreased activity and affinity to the rate-
limiting electron donor ABTS. Both residues are not conserved within DypPrx. Mutating the 
methionine residues may have induced structural changes that affected activity, e.g. shifting a 
closely neighboring helix involved in the formation of the heme-binding pocket. They might 
also present substrate binding sites for bulky substrates, e.g. anthraquinone dyes, since the 
weak intersubunit interactions of the MscDyP1 dimer allow restricted movement of both 
subunits, which might allow access to the Cys cavity. However, this requires further 
investigation. The main function of these surface-exposed hydrophobic residues remains 
unclear. The observed partial loss of activity of both mutants, compared to (E. coli) MscDyP1, 
might not only be due to a possible functional role of these residues in enzyme activity but 
might also be a result of the mutation itself. Polar cysteine was mutated into non-polar 
glycine, which might have affected the structural integrity of the enzyme affecting the 
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activity, probably by shifting the loop on which Cys360 is located, which projects into the 
direct heme environment. Furthermore, the non-polar methionine residue was replaced by the 
basic, electrostatically charged, lysine, which might similarly have induced structural changes 
affecting enzymatic activity. Additional mutants containing the polar and structurally similar 
serine instead of Cys360 and the non-polar residues alanine or leucine instead of Met302 and 
Met305, might provide more hints. However, chemically modifying the sulfur-containing 
amino acids with excess IAA and MMTS confirmed that these residues contribute to the 
activity of (E. coli) rMscDyP1 since the activity was decreased, albeit to a lesser extent than 
upon mutation. However, the enzyme produced in A. niger, which was glycosylated, was not 
inhibited. A possible explanation is that glycosylation protects these residues. The first 
entrance to the cysteine cavity is blocked by NAG, as observed in the crystal structure, and 
glycosylation contributes to dimerization. Dimerization blocks access for bigger molecules to 
Cys360 via the second entrance to the cysteine cavity from the methionine side. This might 
explain why the recombinant enzyme produced in A. niger was not inhibited upon adding 
IAA or MMTS. The loop containing Met302, Met305, and Asn304, which mediates 
intersubunit contact, is flexible in the E. coli-derived recombinant MscDyP1 due to a lack of 
NAG and BMA, which probably affects dimerization and opens the entrance to the cysteine 
cavity. This enables MMTS and IAA to access Cys360 in (E. coli) rMscDyP1. Treatment with 
deglycosylases, e.g. N-acetlyglucosaminidase, in order to remove N-linked sugar molecules 
from (A. niger) MscDyP1 would be necessary to prove this hypothesis.  
5.2.3 Substrate inhibition of MscDyP1 
The mutant variants of MscDyP1 appeared to possess a greater H2O2 stability. Hydrogen 
peroxide-mediated oxidation of Cys360 might induce a shift in the main chain, including 
His365, one of the coordination partners of the central heme atom, thereby affecting the 
geometry of the heme cavity and inhibiting enzyme activity. In the bacterial DypPrx AnaPX 
methionine mutation has been shown to increase H2O2 stability compared to the wildtype 
(Ogola et al., 2010). However, these residues are not conserved in MscDyP1. Non enzymatic 
methionine oxidation with ROS forming methionine sulfoxide can induce conformational 
changes (von Eckardstein et al., 1991) and alterations in hydrophobicity (Chao et al., 1997) 
and can lead to a loss of activity (Brot et al., 1983; Stadtman et al., 2003). Generally, 
methionine sulfoxide reductases (Msr A and B) can reduce methionine sulfoxides in a 
thioredoxin-dependent manner (Bigelow et al., 2011). However, Msr is yet to be found in M. 
scorodinius. A comparison to (A. niger) rMscDyP1 would be interesting, as would spectral 
analysis in order to determine possible compound III formation and heme bleaching. H2O2 is 
required for activity, but at a certain threshold concentration, in the submillimolar range, it has 
an inhibitory effect on MscDyP1 under acidic conditions. The mechanism-based H2O2 
inhibition of heme peroxidases, the so-called suicide inactivation, has been observed in 
numerous cases (Valderrama et al., 2002), e.g. HRP (Hiner et al., 2001), lignine peroxidase 
(Wariishi et al., 1990), manganese peroxidase (Wariishi et al., 1988) and cytochrome c 
peroxidase (Villegas et al., 2000). If a substrate is absent or if high concentrations of H2O2 are 
present, hydrogen peroxide mediates conversion of compound II of the heme molecule to 
compound III, a highly reactive peroxy-iron(III)porphyrin free radical (Valderrama et al., 
2002).  
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5.2.4 Proposed catalytic mechanism of MscDyP1 
The MscDyP1 structure indicated the presence of two heme accession channels. The first one 
represents the classic channel towards the active site composed of conserved residues. The 
second channel towards the heme cavity was proposed based on the MscDyP1 structure. A 
second, similar channel towards the heme plane is present in BadDyP (Yoshida et al., 2011) 
and AauDyP (Strittmatter et al., 2015) but has not yet been discussed. 
Attempts to co-crystallize MscDyP1 with the substrates bixin or annatto failed. Remarkably, 
except for crystal additives or solvent components (Strittmatter et al., 2015), none of the 
published DypPrx crystal structures contained a substrate in the heme cavity of the active site. 
Therefore, β-carotene and 2,6-dimethoxyphenol were docked here, revealing poses in or near 
the active site cleft. These poses appeared to present possible binding modes since a water 
network connected the entrance of this heme accession channel with the heme molecule 
enabling electron transfer from the substrates to the central heme molecule. β-carotene was 
chosen for docking studies because MscDyP1 is the only DypPrx known to be capable of 
degrading β-carotene. 2,6-dimethoxyphenol was selected for molecular docking in order to 
compare it to the binding mode indicated by the structure of BadDyP, which was solved upon 
co-crystallization with 2,6-dimethoxyphenol (Yoshida et al., 2012). In this structure 2,6-
dimethoxyphenol was exclusively bound to residues on the surface, but not within the classic 
heme accession channel. However, the presence of a PEG molecule at this position in the 
crystal structure of MscDyP1 indicated the heme accession channel is wide enough to allow 
entrance of selected small molecules despite H2O2 to reach the direct heme environment. This 
is supported by docking studies performed for AauDyP with imidazole, which showed a 
similar pose at the distal heme side (Strittmatter et al., 2015). Interestingly, one of the best-
ranked docking poses of 3MD indicated localization within the second heme cavity. The 
presence of the solvent component glycerol in the crystal structure indicated that small 
molecules can access this cavity. It contained a conserved water molecule that allows electron 
transfer to the heme cofactor.  
Recently, is was suggested that substrate oxidation in DypPrx occurs at redox-active sites on 
the protein surface, probably catalyzed by surface radicals (Strittmatter et al., 2013; Linde et 
al., 2015) as indicated for ascorbic acid (PDB ID 3vxi) and 2,6-dimethoxyphenol (PDB ID 
3vxj) (Yoshida et al., 2012). This is reasonable taking the broad substrate specificity of 
DypPrx into account, which includes large molecules such as lignin, which are unlikely to fit 
into the heme cavity. Weak substrate binding and oxidation on the surface of MscDyP1 might 
explain the unsuccessful co-crystallization with the pseudo substrates annatto and bixin.  
Substrate oxidation on the surface requires electron transfer from the protein surface to the 
heme molecule. Accordingly, several long-range electron transfer (LRET) pathways via 
conserved potentially redox-active tryptophan and tyrosine residues have been proposed 
(Liers et al., 2013; Strittmatter et al., 2013; Linde et al., 2015), as shown for BadDyP and 
AauDyP (Liers et al., 2013). Recently, two possible LRET pathways were proposed for 
MscDyP1 (Figure 43) based on a homology model using the AauDyP crystal structure (Liers, 
2014). 
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A B 
Figure 43: Possible LRET pathways in MscDyP1 
Two hypothetical long-range electron transfer (LRET) pathways were proposed by (Liers, 2014), the 
participating residues are depicted as ball-and-stick models: A: via Tyr393, Gly 416, and Leu417 to heme. B: via 
Trp437 and Leu433 to heme. The heme molecule is colored brown, the protein backbone in light gray. This 
figure was prepared using UCSF Chimera. 
The crystal structure of MscDyP1 confirmed the possibility of the first LRET pathway via 
Tyr393, Gln416, and Leu417 to Cβ of heme ring B since the distances are in a reasonable 
range (Figure 43 A). Unlike the homology model of MscDyP1 created by Liers et al., the 
crystal structure of rMscDyP1 contained leucine at position 433 instead of isoleucine. 
However, this is a synonymous substitution of isosteric amino acids with similar functions 
and properties. Thus, the second proposed LRET pathway via Trp437 and Leu433 to Cβ heme 
ring C also appeared to be reasonable (Figure 43 B). Residues participating in these proposed 
LRET pathways are partly conserved in BadDyP, AauDyP, EglDyP, and MepDyP.  
5.2.5 Conclusion and Outloook 
In conclusion, the enzyme produced in E. coli exhibited structural differences to the enzyme 
produced in A. niger due to the lack of glycosylation. Therefore, overexpression of the 
mutants in a eukaryotic expression system and comparison with the enzmyes produced in E. 
coli or deglycosylation of (A. niger) MscDyP1 would be necessary to prove this hypothesis. 
Mutating the cysteine and methionine residues resulted in a partial loss of function that might 
be a result of an impaired structural integrity of the enzyme in response to mutation. The 
remaining residual activity upon deleting cysteine implied that the single conserved cysteine 
of MscDyP1 has a structural rather than catalytic function. Furthermore, the crystal structure 
of MscDyP1 indicated that oxidation of small molecular weight substrates might occur in 
three possible protein cavities: the classic heme cavity leading to the distal heme site, the 
second heme accession cavity leading to Cβ of heme ring C, and the Cys cavity at the 
proximal heme site. Furthermore, substrate oxidation on the protein surface at conserved 
potentially redox-active tryptophan and tyrosine residues, via LRET pathways to the central 
heme molecule, is likely. Additional mutational studies with Trp437 and Tyr393 as possible 
binding sites and might provide further insights into possibility of these LRET pathways. 
Altogether the crystal structure of MscDyP1 and the performed mutational, kinetic, 
crystallographic and docking studies indicated that as broad as the substrate versatility of 
MscDyP1 is, the catalytic properties appear to be equally versatile. 
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